Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3008401	s-pujoe	— (—)	4144	4298	100.00%	Distribution not available
3008401	s-pujoe	u/ml (u/ml)	3536	3813	0.03%
3008401	pujo	— (—)	627	652	100.00%	Distribution not available
3008401	pujo	u/ml (u/ml)	118	121	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Desensitization to allergens

463

656

8.50

320.81

1.1

1.71

1.10

u/ml

0.93

342

297

Chronic rhinitis, nasopharyngitis and pharyngitis

803

1881

4.43

311.49

1.1

1.0

0.85

1.12

u/ml

0.58

416

662

Asthma, unspecified (mode)

1064

2168

3.78

309.39

1.1

1.0

1.05

1.25

u/ml

0.30

487

684

Asthma, unspecified (mode), excluding more controls

1060

2145

3.79

307.85

1.1

1.0

1.05

1.26

u/ml

0.32

486

675

Asthma, excluding more controls

2312

2433

5.15

307.65

1.1

1.0

1.15

1.24

u/ml

0.16

1262

780

Asthma (diagnoses ohter than nonallergic)

2545

5421

4.04

307.65

1.1

1.0

1.12

1.14

u/ml

0.05

1471

2046

Allergic asthma (mode), excluding more controls

1259

1548

8.65

307.65

1.1

1.0

1.28

1.32

u/ml

0.05

859

521

Atopic dermatitis

1731

4822

3.04

307.65

1.1

2.04

0.82

u/ml

6.15

985

1914

Other diseases of upper respiratory tract

2053

3854

2.83

307.65

1.1

1.0

1.15

1.07

u/ml

0.18

1082

1364

Asthma, hospital admissions , main diagnosis only

2442

5561

4.02

307.65

1.1

1.0

1.16

1.10

u/ml

0.14

1406

2120

1320

3268

4.18

307.65

1.1

1.17

1.19

u/ml

0.03

784

1314

Conjunctivitis

1862

5823

2.74

307.65

1.1

1.47

0.99

u/ml

2.08

1085

2341

Asthma/COPD (KELA code 203)

2543

4852

3.70

307.65

1.1

1.14

1.13

u/ml

0.04

1331

1866

Chronic lower respiratory diseases

3163

4881

3.55

307.65

1.1

1.13

1.12

u/ml

0.03

1635

1874

Asthma and allergy, excluding more controls

932

987

10.55

307.65

1.2

1.0

1.50

1.59

u/ml

0.08

663

350

Asthma-related infections

1513

3896

3.93

307.65

1.1

1.22

1.17

u/ml

0.08

897

1519

Pollen allergy

1501

2047

8.41

307.65

1.1

1.41

1.07

u/ml

0.93

1011

842

Asthma (only as main-diagnosis)

2267

2466

5.54

307.65

1.1

1.0

1.17

1.22

u/ml

0.08

1263

794

Asthma and allergy

930

973

10.68

307.65

1.2

1.0

1.50

1.63

u/ml

0.12

661

338

Asthma (mode)

2347

2474

5.27

307.65

1.1

1.0

1.14

1.22

u/ml

0.14

1282

796

Asthma, hospital admission 2, infections

1513

3896

3.93

307.65

1.1

1.22

1.17

u/ml

0.08

897

1519

Vasomotor and allergic rhinitis

1965

2872

7.29

307.65

1.1

1.0

1.49

1.08

u/ml

1.29

1254

1050

Asthma, including avohilmo

3439

4555

4.39

307.65

1.1

1.0

1.10

1.19

u/ml

0.23

1745

1743

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1549

4859

3.21

307.65

1.1

1.48

0.96

u/ml

2.16

926

1871

Asthma (only as main-diagnosis), excluding more controls

2253

2433

5.52

307.65

1.1

1.0

1.18

1.24

u/ml

0.11

1259

780

Allergic conjunctivitis

1601

5151

3.13

307.65

1.1

1.46

0.99

u/ml

1.83

957

2007

Allergic rhinitis

1890

2876

7.20

307.65

1.1

1.47

1.13

u/ml

0.88

1231

1076

Allergic asthma (mode)

1259

1551

8.64

307.65

1.1

1.0

1.28

1.31

u/ml

0.03

859

524

Asthma

2338

2466

5.16

307.65

1.1

1.0

1.14

1.22

u/ml

0.13

1269

794

Disorders of conjunctiva

1903

5984

2.61

302.54

1.1

1.45

0.98

u/ml

2.09

1103

2397

Chronic sinusitis

916

2444

3.86

296.04

1.1

1.0

1.09

1.12

u/ml

0.04

460

815

Atopic dermatitis, strict definition with reimbursement

1089

3176

3.47

292.11

1.2

1.1

2.52

0.91

u/ml

5.80

718

1315

Dermatitis and eczema

2202

5667

2.45

289.25

1.1

1.70

0.79

u/ml

5.44

1159

2210

Nasal polyp

456

720

6.62

276.39

1.2

1.0

0.62

1.49

u/ml

1.23

270

248

Suggestive for eosinophilic asthma

304

315

10.39

264.91

1.2

1.0

0.60

1.95

u/ml

1.20

203

113

Obesity related asthma

734

1840

4.12

259.84

1.1

1.0

0.90

0.98

u/ml

0.09

353

631

Atopic dermatitis, strict definition

1043

3545

3.01

222.13

1.1

2.57

0.89

u/ml

6.13

698

1560

Other pulmonary diagnosis

1378

2502

2.80

220.20

1.1

1.0

1.22

1.21

u/ml

0.01

658

807

Cough

875

2593

3.28

218.17

1.1

0.94

1.32

u/ml

0.91

433

1087

ILD differential diagnosis

1358

2474

2.79

215.68

1.1

1.0

1.23

1.22

u/ml

0.01

648

796

COPD differential diagnosis

1357

2475

2.79

215.10

1.1

1.0

1.23

1.22

u/ml

0.01

648

796

Excluding asthma or asthma-COPD overlap

1358

2502

2.76

211.41

1.1

1.0

1.23

1.21

u/ml

0.03

647

807

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

885

2857

3.07

200.37

1.1

1.0

0.76

1.08

u/ml

1.15

393

961

Childhood asthma (age<16)

546

1034

4.39

191.59

1.1

1.0

2.09

1.45

u/ml

0.68

332

387

Childhood asthma (age<16), excluding more controls

546

1035

4.38

191.22

1.1

1.0

2.09

1.45

u/ml

0.68

332

387

Oral corticosteroids

1849

5265

2.11

171.17

1.1

1.32

1.02

u/ml

0.83

919

2085

ILD medications: prednisolone, methylprednisolone, prednisone

1956

5372

2.06

168.07

1.1

1.39

0.97

u/ml

1.46

969

2192

Diseases of the respiratory system

1020

1853

2.80

163.01

1.1

1.0

1.42

1.19

u/ml

0.32

469

613

Biological medicines for asthma

147

117

15.46

155.92

1.3

1.1

1.24

0.77

u/ml

0.33

Asthma-related pneumonia

576

1728

3.40

155.43

1.1

1.26

1.07

u/ml

0.27

340

655

Asthma, hospital admissions 3, pneumonia

577

1736

3.39

154.97

1.1

1.26

1.08

u/ml

0.26

340

663

Asthma-related pneumonia or sepsis

577

1736

3.39

154.97

1.1

1.26

1.08

u/ml

0.26

340

663

Abnormalities of breathing

1676

4779

2.07

145.80

1.1

0.87

1.24

u/ml

1.75

797

1986

Childhood allergy (age < 16)

684

1947

3.07

142.49

1.2

1.1

1.74

1.34

u/ml

0.57

483

890

Undetermined asthma

280

527

5.51

141.32

1.1

1.0

0.93

1.53

u/ml

0.54

147

168

Undetermined asthma, excluding more controls

280

529

5.49

140.73

1.1

1.0

0.93

1.55

u/ml

0.56

147

166

ILD medications

1970

5664

1.91

135.34

1.1

1.36

1.01

u/ml

1.09

974

2366

Symptoms and signs involving the circulatory and respiratory systems

1830

4805

1.93

127.60

1.1

0.96

1.24

u/ml

1.08

877

1999

Inflammatory bowel disease treatment related agents

1937

5849

1.87

127.08

1.1

1.31

1.02

u/ml

0.85

937

2436

Deviated nasal septum

472

1448

3.32

123.16

1.1

1.0

0.94

1.31

u/ml

0.55

209

486

First line medication for Crohn's disease

1887

5585

1.85

117.45

1.1

1.34

1.04

u/ml

0.84

926

2332

Chronic diseases of tonsils and adenoids

1234

3742

2.11

116.41

1.1

1.0

1.05

1.08

u/ml

0.04

563

1333

Adverse effects, not elsewhere classified

530

1827

3.01

114.80

1.1

1.38

1.12

u/ml

0.39

360

802

FESS (DNB20)

319

807

4.14

112.53

1.2

1.1

0.74

1.07

u/ml

0.42

172

324

Ethmoidectomy

322

836

4.02

109.53

1.2

1.1

0.73

1.09

u/ml

0.47

174

333

Dermatitis due to ingested food

256

548

5.14

108.33

1.3

1.1

2.12

1.04

u/ml

1.29

206

305

Personal history of allergy to analgesic agent

28.21

95.23

1.5

1.1

0.72

0.93

u/ml

0.14

Urticaria

679

2898

2.41

95.08

1.1

1.58

1.10

u/ml

0.71

395

1280

Urticaria and erythema

740

3396

2.23

86.99

1.1

1.54

1.17

u/ml

0.55

430

1485

Other and unspecified effects of external causes

632

2747

2.36

85.00

1.1

1.29

1.19

u/ml

0.14

407

1216

Diseases of the skin and subcutaneous tissue

1527

4374

1.77

81.49

1.1

1.51

0.76

u/ml

3.13

792

1647

Acute upper respiratory infections

1534

5499

1.73

80.52

1.1

1.20

1.11

u/ml

0.16

705

2312

Personal history of allergy to drugs, medicaments and biological substances

13.02

79.77

1.4

1.1

0.68

0.69

u/ml

0.01

Non-allergic asthma (mode)

283

826

3.46

78.96

1.1

1.0

0.37

1.67

u/ml

2.75

116

283

Non-allergic asthma (mode), excluding more controls

283

835

3.42

77.64

1.1

1.0

0.37

1.66

u/ml

2.76

116

286

Dyspnoea

1261

5240

1.80

77.37

1.1

0.81

1.12

u/ml

1.55

600

2192

Polypectomy (DHB20)

144

288

5.22

68.39

1.3

1.1

0.57

1.89

u/ml

1.23

113

Other medical care

564

2319

2.21

65.28

1.1

1.73

1.09

u/ml

1.41

383

957

Acute sinusitis

889

4451

1.87

64.93

1.1

0.96

1.14

u/ml

0.31

404

1855

Acute upper respiratory infections of multiple and unspecified sites

1198

5189

1.73

64.59

1.1

1.22

1.13

u/ml

0.14

559

2199

Any reimbursement code in KELA

1211

3500

1.76

63.02

1.1

1.43

1.03

u/ml

0.87

620

1388

Diseases of the eye and adnexa

1458

4445

1.66

62.19

1.1

1.42

1.05

u/ml

0.97

748

1788

Insomnia

1360

6046

1.66

62.17

1.1

0.78

1.20

u/ml

2.58

525

2574

Sleep apnoea, including avohilmo

1303

4835

1.68

61.73

1.1

0.87

1.11

u/ml

0.67

522

2006

Dermatitis

782

4127

1.91

61.51

1.1

1.14

0.78

u/ml

1.10

387

1580

Allergic contact dermatitis

276

956

2.97

59.35

1.1

1.94

0.90

u/ml

0.79

143

352

Sleep disorders

1359

6077

1.63

58.67

1.1

0.81

1.22

u/ml

2.36

533

2605

1563

5091

1.60

58.19

1.1

1.19

1.08

u/ml

0.22

707

2081

Other and unspecified dermatitis

655

3409

1.94

54.51

1.1

1.08

0.81

u/ml

0.72

328

1316

Other and unspecified urticaria

410

1808

2.33

53.60

1.1

1.48

1.19

u/ml

0.28

229

798

Sleep disorders (combined)

1593

5421

1.55

52.87

1.1

0.92

1.26

u/ml

1.15

634

2392

Bronchitis

1522

6209

1.56

52.72

1.1

1.17

1.11

u/ml

0.11

712

2596

Medical observation and evaluation for suspected diseases and conditions

1004

2958

1.75

52.61

1.1

0.77

1.22

u/ml

2.00

515

1166

D07AA Corticosteroids, weak (group I)

389

1692

2.37

52.53

1.2

1.1

3.04

1.15

u/ml

2.54

274

809

Behavioural syndromes associated with physiological disturbances and physical factors

1377

6306

1.56

49.56

1.1

0.81

1.22

u/ml

2.41

564

2769

Diarrhoea and gastroenteritis of presumed infectious origin

1449

6278

1.53

47.49

1.1

0.95

1.15

u/ml

0.57

633

2751

Asthma mixed form (mode)

193

5.25

47.31

1.1

1.0

0.33

2.47

u/ml

1.30

Asthma mixed form (mode), excluding more controls

193

5.24

47.31

1.1

1.0

0.33

2.51

u/ml

1.31

Sleep apnoea

1123

4586

1.60

43.97

1.1

0.89

1.05

u/ml

0.33

445

1883

Voice disturbances

359

1642

2.22

42.79

1.1

0.68

1.02

u/ml

0.90

162

657

Early onset COPD, excluding more controls

173

552

3.17

42.63

1.0

0.90

1.50

u/ml

0.54

163

Chronic laryngitis and laryngotracheitis

166

521

3.25

42.25

1.1

1.0

0.57

1.39

u/ml

1.04

176

Pain in joint

877

3349

1.69

42.24

1.1

1.11

1.12

u/ml

0.01

394

1471

Idiopathic urticaria

156

5.72

41.84

1.1

0.73

0.71

u/ml

0.02

Headache

1052

5340

1.59

41.64

1.1

1.02

1.18

u/ml

0.29

454

2302

Dentofacial anomalies [including malocclusion]

1134

5933

1.55

40.35

1.1

0.92

1.16

u/ml

0.54

517

2546

Migraine

901

4537

1.63

39.58

1.1

0.72

1.25

u/ml

2.81

394

1983

Asthma and opportunity respiratory infection

6.73

38.86

1.1

0.53

2.06

u/ml

0.57

Special screening examination for infectious and parasitic diseases

527

2093

1.88

37.73

1.1

1.0

1.38

1.34

u/ml

0.03

273

779

Examination and observation for other reasons

838

2947

1.66

37.42

1.1

0.90

1.22

u/ml

0.94

404

1159

COPD/asthma related infections

1409

4845

1.47

35.47

1.1

1.24

1.09

u/ml

0.28

637

1994

COPD/asthma/ILD related infections

1409

4845

1.47

35.47

1.1

1.24

1.09

u/ml

0.28

637

1994

Symptoms and signs involving speech and voice

391

1983

2.00

35.43

1.1

0.72

1.02

u/ml

0.82

174

813

Triptan medication for migraine, single purchase ok

1212

5559

1.49

34.92

1.1

1.03

1.21

u/ml

0.35

492

2419

Migraine, single triptan purchase ok & required. ICD-code if available is included

1212

5559

1.49

34.92

1.1

1.03

1.21

u/ml

0.35

492

2419

Recurrent or chronic depression

628

2578

1.73

34.08

1.1

0.81

1.25

u/ml

1.43

268

1102

Other special examinations and investigations of persons without complaint or reported diagnosis

923

2958

1.59

34.02

1.1

1.19

1.22

u/ml

0.05

421

1166

Other acute lower respiratory infections

715

4185

1.64

33.65

1.2

1.1

1.08

1.19

u/ml

0.23

377

1911

Bronchiectasis

142

5.09

33.64

1.0

1.1

0.38

2.15

u/ml

1.01

Depression or dysthymia

859

2978

1.60

33.34

1.1

1.10

1.22

u/ml

0.20

371

1300

Any death

2185

0.29

33.27

1.0

1.1

0.36

1.05

u/ml

3.21

905

Gastro-oesophageal reflux disease

795

4353

1.59

32.14

1.1

0.83

1.11

u/ml

0.75

317

1841

Episodal and paroxysmal disorders

1568

5700

1.41

32.05

1.1

0.96

1.21

u/ml

0.82

688

2558

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

628

1838

1.73

31.68

1.1

1.56

1.38

u/ml

0.17

274

779

Intestinal infectious diseases

1508

6168

1.40

31.12

1.1

0.92

1.18

u/ml

0.80

635

2697

Neurotic, stress-related and somatoform disorders

1288

6319

1.44

31.11

1.1

1.23

1.13

u/ml

0.15

587

2681

Dermatographic urticaria

150

538

2.89

30.69

1.1

1.53

1.02

u/ml

0.22

222

Anxiety disorders

1290

6324

1.43

30.59

1.1

1.23

1.13

u/ml

0.16

589

2680

Pain in throat and chest

1079

4403

1.48

29.88

1.1

0.90

1.26

u/ml

1.49

495

1798

Pain (limb, back, neck, head abdominally)

1034

3491

1.49

28.76

1.1

1.28

1.09

u/ml

0.30

477

1584

COPD

244

905

2.22

28.51

1.0

0.78

1.07

u/ml

0.40

311

Malignant neoplasm

481

4775

0.59

27.46

1.0

1.1

1.08

1.09

u/ml

0.01

193

1983

Speech therapy

287

1441

2.02

26.93

1.1

0.44

1.06

u/ml

2.13

112

612

Irritable bowel syndrome

394

2213

1.80

26.23

1.1

0.96

1.12

u/ml

0.14

177

921

Covid-19 suspected case

397

2247

1.80

25.89

1.1

1.03

1.30

u/ml

0.29

175

979

Temporomandibular joint disorders, including avohilmo

735

4777

1.53

25.89

1.1

0.71

1.24

u/ml

2.79

331

2012

Other chronic obstructive pulmonary disease

226

854

2.19

25.84

1.0

0.76

1.10

u/ml

0.47

291

Abnormalities of heart beat

395

2197

1.78

25.24

1.1

1.14

1.30

u/ml

0.10

162

882

Solid cancers, helper endpoint

470

4572

0.60

24.96

1.0

1.1

1.13

1.04

u/ml

0.10

185

1871

Persons encountering health services for examination and investigation

878

2958

1.50

24.89

1.1

1.03

1.22

u/ml

0.34

410

1166

Malignant neoplasm, wide definition for exclusion

541

5052

0.62

24.82

1.1

1.01

1.09

u/ml

0.11

215

2110

Low back pain

988

4950

1.44

24.75

1.1

0.96

1.13

u/ml

0.31

417

2079

Any event in cancer register

608

5543

0.64

24.53

1.1

1.17

1.06

u/ml

0.14

243

2332

Provisional assignment of new diseases of uncertain etiology

683

4506

1.53

23.78

1.1

0.87

1.09

u/ml

0.40

298

1985

Other headache syndromes

556

3510

1.60

23.68

1.1

0.98

1.27

u/ml

0.33

247

1437

Codes for special purposes

683

4516

1.52

23.53

1.1

0.87

1.08

u/ml

0.40

298

1990

Tonsillectomy and adenotomy

1070

5324

1.41

23.52

1.1

0.96

1.21

u/ml

0.70

500

2426

Anxiety disorders, excluding more controls

1136

5325

1.40

23.40

1.1

0.98

1.07

u/ml

0.19

517

2247

Acetic acid derivatives and related substances

337

930

1.90

23.35

1.1

1.05

1.28

u/ml

0.27

133

446

Dorsalgia

1337

5276

1.36

23.14

1.1

1.05

1.19

u/ml

0.28

588

2267

All anxiety disorders

999

5609

1.42

23.13

1.1

1.39

1.18

u/ml

0.28

471

2419

Other dorsopathies, not elsewhere classified

1374

5333

1.36

22.68

1.1

1.01

1.18

u/ml

0.39

598

2306

Triptan medication for migraine, min. 3 purchases

938

5062

1.43

22.27

1.1

0.80

1.21

u/ml

1.01

381

2107

Atopic conjunctivitis

102

361

2.93

21.58

1.2

1.1

1.22

1.54

u/ml

0.19

172

Anxiety (asthma-related co-morbidities)

968

5358

1.41

21.50

1.1

1.40

1.16

u/ml

0.33

459

2293

Acute bronchitis

466

2832

1.63

21.47

1.1

1.00

1.23

u/ml

0.51

223

1280

Mycoses

1077

6846

1.38

21.30

1.1

0.97

1.17

u/ml

0.55

448

2945

Soft tissue disorders

1443

5631

1.33

20.59

1.1

1.10

1.17

u/ml

0.12

638

2543

Conjunctivitis (acute, non atopic)

391

2349

1.68

20.30

1.1

1.85

0.93

u/ml

1.76

211

1035

Exposure to unspecified factor

1287

6982

1.33

20.22

1.1

1.42

1.05

u/ml

0.87

654

2985

Diseases of the musculoskeletal system and connective tissue

953

3411

1.41

19.89

1.1

1.36

1.23

u/ml

0.18

445

1618

Other specific joint derangements/joint disorders

1103

5258

1.36

19.77

1.1

1.01

1.24

u/ml

0.48

483

2318

Caries of enamel

1198

6477

1.34

19.67

1.1

0.79

1.13

u/ml

1.94

562

2761

Depression

1248

6372

1.33

19.53

1.1

0.98

1.16

u/ml

0.49

567

2680

Coxibs

330

976

1.79

19.43

1.1

1.85

1.26

u/ml

0.39

133

478

Selective serotonin reuptake inhibitors

1251

4894

1.34

19.37

1.1

1.13

1.10

u/ml

0.06

546

2104

Abnormal findings on diagnostic imaging of lung

332

1854

1.73

19.34

1.1

1.56

1.12

u/ml

0.30

133

738

Certain infectious and parasitic diseases

999

3617

1.39

19.30

1.1

1.45

1.02

u/ml

0.89

438

1572

Eosinophilic disease (BM)

7.81

19.24

1.3

1.1

0.43

5.72

u/ml

—

Other disorders of lacrimal gland

370

2241

1.67

18.88

1.1

1.03

1.15

u/ml

0.17

164

894

Myalgia

319

1866

1.73

18.62

1.1

0.53

1.23

u/ml

3.13

146

774

Lower back pain or/and sciatica

1267

6289

1.32

18.55

1.1

1.00

1.14

u/ml

0.28

532

2608

Parasetamol

1125

4231

1.35

18.52

1.1

1.18

1.19

u/ml

0.01

492

1881

Functional dyspepsia

302

1747

1.75

18.32

1.1

0.84

1.07

u/ml

0.45

127

714

Disorders of lacrimal system

441

2801

1.58

18.30

1.1

0.96

1.05

u/ml

0.16

192

1118

Dorsopathies

1408

5496

1.31

18.30

1.1

0.97

1.16

u/ml

0.46

622

2427

Other soft tissue disorders, not elsewhere classified

1232

5490

1.32

17.73

1.1

1.19

1.16

u/ml

0.04

543

2455

Mood [affective] disorders

1290

6412

1.31

17.71

1.1

0.91

1.17

u/ml

0.89

581

2701

Lichen simplex chronicus and prurigo

260

3.02

17.64

1.1

0.60

1.13

u/ml

0.51

103

Bronchitis, not specified as acute or chronic

342

2.73

17.61

1.1

1.0

1.05

1.55

u/ml

0.30

115

Neurological diseases

1283

4922

1.32

17.42

1.1

1.04

1.27

u/ml

0.61

580

2255

Codeine or tramadol medication

1359

5736

1.30

17.34

1.1

0.97

1.13

u/ml

0.38

566

2349

Mood disorders

1288

6414

1.30

17.25

1.1

0.91

1.17

u/ml

0.88

580

2702

Gastrointestinal diseases

1005

3716

1.36

17.22

1.1

1.30

1.20

u/ml

0.15

470

1682

Codeine

1214

5020

1.32

17.12

1.1

0.92

1.15

u/ml

0.64

506

2063

Other antidepressants

1221

4770

1.32

16.77

1.1

1.25

1.09

u/ml

0.24

517

2009

Opioids

1303

5211

1.30

16.75

1.1

1.11

1.14

u/ml

0.06

564

2170

Cystitis

1039

4624

1.34

16.73

1.1

1.22

1.06

u/ml

0.27

443

1972

Propionic acid derivatives

395

1227

1.63

16.44

1.1

1.70

1.25

u/ml

0.36

174

661

Other anxiety disorders

753

4709

1.40

16.38

1.1

1.58

1.14

u/ml

0.56

368

2037

Soft tissue disorders related to use, overuse and pressure

261

1497

1.76

16.36

1.1

1.05

1.14

u/ml

0.05

576

Exposure to other specified factors

983

6792

1.34

16.33

1.1

1.33

1.11

u/ml

0.38

502

2926

Other joint disorders

1321

5397

1.30

16.32

1.1

1.01

1.24

u/ml

0.54

586

2406

Candidiasis

364

2283

1.61

16.27

1.1

0.73

1.26

u/ml

1.69

158

976

Neurological diseases, wide definition

605

2073

1.48

16.25

1.1

0.93

1.33

u/ml

1.08

284

1040

Renal tubulo-interstitial diseases

539

5802

0.69

15.91

1.1

0.87

1.17

u/ml

0.74

239

2490

Viral infections characterized by skin and mucous membrane lesions

1072

7008

1.31

15.76

1.1

1.41

1.07

u/ml

0.61

478

3062

Diseases of middle ear and mastoid

871

5292

1.35

15.67

1.1

1.29

1.17

u/ml

0.15

431

2378

Diseases of oesophagus, stomach and duodenum

1243

5816

1.28

14.57

1.1

0.89

1.12

u/ml

0.76

530

2472

Migraine with aura

400

2633

1.54

14.55

1.1

0.65

1.23

u/ml

2.12

182

1122

Abdominal and pelvic pain

1271

4993

1.28

14.49

1.1

1.06

1.19

u/ml

0.28

562

2241

Diabetes, insulin treatment (Kela reimbursement)

663

5515

0.72

14.42

1.1

0.83

1.10

u/ml

0.80

267

2372

Pain and other conditions associated with female genital organs and menstrual cycle

350

2068

1.57

14.05

1.1

0.90

1.25

u/ml

0.54

135

898

COPD (mode)

139

528

2.08

14.03

1.0

0.81

1.59

u/ml

0.64

164

Migraine without aura

369

2415

1.55

13.86

1.1

0.81

1.33

u/ml

1.19

174

1067

Persons encountering health services for specific procedures and health care

1379

6593

1.26

13.86

1.1

1.28

1.09

u/ml

0.52

744

2772

Early onset COPD

173

924

1.89

13.80

1.0

1.1

0.90

1.16

u/ml

0.30

375

Allergic urticaria

146

740

2.01

13.79

1.1

2.72

1.14

u/ml

0.81

349

Pruritus

128

617

2.10

13.77

1.1

0.54

0.92

u/ml

0.68

233

Anti-inflammatory and antirheumatic products, non-steroids

382

1231

1.57

13.77

1.1

1.31

1.25

u/ml

0.04

169

664

Chronic conjunctivitis

183

3.16

13.77

1.1

2.76

2.31

u/ml

0.09

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

646

5327

0.73

13.55

1.1

0.81

1.07

u/ml

0.74

262

2305

Herpesviral [herpes simplex] infections

349

2269

1.55

13.48

1.1

1.75

1.29

u/ml

0.37

168

965

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

529

3330

1.43

13.39

1.1

1.09

1.03

u/ml

0.05

212

1379

Depression medications

624

2238

1.41

13.38

1.1

1.63

1.21

u/ml

0.49

281

1033

All kidney diseases

750

6809

0.75

13.06

1.1

1.14

1.11

u/ml

0.03

333

2936

Oxicams

205

646

1.81

13.00

1.1

1.30

1.23

u/ml

0.03

309

Mood disorders, excluding more controls

1128

5309

1.27

12.53

1.1

0.91

1.09

u/ml

0.47

507

2216

Follow-up examination after treatment for conditions other than malignant neoplasms

514

2394

1.43

12.49

1.1

1.36

1.17

u/ml

0.24

219

917

Paracetamol or NSAID medication

275

841

1.66

12.44

1.1

1.53

1.33

u/ml

0.11

131

481

Symptoms and signs involving the digestive system and abdomen

1252

4994

1.26

12.42

1.1

0.91

1.19

u/ml

1.14

554

2242

Other bacterial diseases

612

5588

0.73

12.42

1.0

1.1

1.88

1.00

u/ml

1.46

289

2419

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1358

5948

1.25

12.28

1.1

0.92

1.15

u/ml

0.87

659

2537

Injuries to the wrist and hand

1238

6875

1.25

12.24

1.1

0.80

1.18

u/ml

1.66

573

2975

Schizophrenia or delusion

161

2854

0.56

12.20

1.0

1.1

0.95

1.24

u/ml

0.43

1225

Acute pharyngitis

272

1702

1.61

12.08

1.1

2.34

1.33

u/ml

0.74

143

835

General symptoms and signs

1395

5653

1.24

12.04

1.1

1.01

1.19

u/ml

0.39

627

2440

Migraine with aura and triptan purchases

275

1747

1.60

11.90

1.1

0.68

1.25

u/ml

1.54

127

766

Haemorrhage from respiratory passages

242

1334

1.64

11.90

1.1

0.97

1.43

u/ml

0.60

108

534

Schizophrenia, schizotypal and delusional disorders

163

2859

0.57

11.90

1.0

1.1

0.95

1.24

u/ml

0.42

1229

Fenamates

158

572

1.89

11.87

1.1

0.71

1.36

u/ml

0.94

278

Symptoms and signs involving the skin and subcutaneous tissue

768

5736

1.32

11.83

1.1

1.21

1.06

u/ml

0.22

362

2396

Mouth breathing

431

3006

1.44

11.70

1.1

0.95

1.09

u/ml

0.21

192

1395

Acute bronchiolitis

186

970

1.78

11.61

1.3

1.1

1.37

1.50

u/ml

0.12

133

582

Schizophrenia

1388

0.39

11.56

1.0

1.1

0.86

1.24

u/ml

0.28

614

Diseases of the ear and mastoid process

1486

6107

1.23

11.48

1.1

1.13

1.11

u/ml

0.04

669

2616

Other nutritional deficiencies

813

5911

1.30

11.47

1.1

1.01

1.13

u/ml

0.16

359

2479

Other diseases of hard tissues of teeth

604

2277

1.38

11.46

1.1

1.31

1.29

u/ml

0.02

267

932

Malignant neoplasm of breast, HER2-negative

188

2066

0.59

11.29

1.1

1.49

0.78

u/ml

0.42

770

Suppurative and unspecified otitis media

618

4090

1.35

11.10

1.1

1.20

1.24

u/ml

0.06

311

1902

Somatoform disorder

208

1257

1.67

11.02

1.1

0.55

1.23

u/ml

1.70

506

Diabetes medication

818

6230

0.78

10.96

1.1

0.86

1.13

u/ml

0.91

338

2675

Emphysema

3.60

10.90

1.1

2.04

1.05

u/ml

0.46

Malignant neoplasm of breast

196

2102

0.60

10.82

1.1

1.51

0.78

u/ml

0.46

787

Other and unspecified tonsillitis

563

3499

1.36

10.74

1.1

1.36

1.21

u/ml

0.18

243

1600

Non-allergic asthma

393

2.21

10.68

1.0

0.24

0.95

u/ml

1.07

127

Malignant neoplasm of breast, including Hilmo

208

2176

0.62

10.67

1.1

1.44

0.80

u/ml

0.42

817

Malignant neoplasm of breast, HER2-negative, including Hilmo

208

2176

0.62

10.67

1.1

1.44

0.80

u/ml

0.42

817

Inflammatory diseases of female pelvic organs

785

4463

1.30

10.66

1.1

0.99

1.05

u/ml

0.09

339

1779

Simple and mucopurulent chronic bronchitis

105

3.48

10.58

1.1

0.32

2.61

u/ml

0.90

Other diseases of urinary system

1159

5257

1.24

10.51

1.1

1.42

1.08

u/ml

0.62

494

2280

Unspecified threat to breathing

4.16

10.51

1.2

1.1

1.09

0.72

u/ml

0.25

Eosinophilia

4.30

10.46

1.3

1.1

0.43

0.48

u/ml

0.07

Arthropathies

1320

5468

1.23

10.43

1.1

1.00

1.22

u/ml

0.50

584

2462

Migraine without aura and triptan purchases

283

1870

1.53

10.34

1.1

0.75

1.20

u/ml

0.75

120

819

Heartburn

127

678

1.90

10.34

1.1

0.60

1.22

u/ml

0.98

288

Other enthesopathies

300

2004

1.51

10.30

1.2

1.1

1.09

1.04

u/ml

0.04

126

783

Allergic colitis

446

2.17

10.23

1.2

2.03

1.20

u/ml

0.53

279

Other and unspecified vaccines and biological substances

5.16

10.22

1.2

1.1

0.35

0.50

u/ml

0.16

Other menopausal disorders

278

1010

1.56

10.20

1.1

1.0

0.84

0.80

u/ml

0.03

382

Persons encountering health services in other circumstances, wide

1401

5949

1.22

10.16

1.1

0.97

1.15

u/ml

0.57

660

2537

Diabetes mellitus

839

6216

0.79

10.10

1.1

1.12

1.10

u/ml

0.02

348

2679

Other viral diseases

591

4425

1.33

10.09

1.1

0.85

1.24

u/ml

1.68

282

2071

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

256

1664

1.56

10.09

1.1

1.14

1.08

u/ml

0.06

105

693

Diabetes, varying definitions

832

6180

0.79

9.99

1.1

1.12

1.10

u/ml

0.03

346

2659

ILD, hospital admissions 1, main diag only

372

2.19

9.95

1.1

0.46

1.46

u/ml

1.36

159

Kela-code for severe mental illness

202

3203

0.63

9.90

1.1

0.88

1.21

u/ml

0.62

1375

Other and unspecified nonorganic psychotic disorders

113

2074

0.54

9.84

1.0

1.1

1.07

1.31

u/ml

0.22

924

Other bacterial diseases

781

6306

0.78

9.84

1.1

1.93

0.99

u/ml

1.87

368

2727

Other chronic obstructive pulmonary disease, including avohilmo

308

1715

1.49

9.82

1.0

1.1

0.62

1.23

u/ml

1.62

130

674

Allergic contact dermatitis due to drugs in contact with skin

101

3.47

9.82

1.0

1.1

0.56

0.68

u/ml

0.14

Accidents

1053

4241

1.25

9.73

1.1

1.41

1.02

u/ml

0.70

490

1733

Intestinal infectious diseases

1127

6982

1.23

9.66

1.1

0.91

1.16

u/ml

0.90

516

3050

Benign neoplasm: Colon

319

2084

1.47

9.63

1.1

0.71

1.09

u/ml

1.02

123

800

Pain in thoracic spine

177

1066

1.68

9.56

1.1

0.88

1.55

u/ml

1.05

433

Benign neoplasm: Colon, unspecified

142

805

1.77

9.49

1.1

0.88

1.03

u/ml

0.17

325

Vocal cord dysfunction

176

948

1.68

9.47

1.1

0.55

1.09

u/ml

1.10

400

Disorders of eyelid, lacrimal system and orbit

857

5174

1.26

9.38

1.1

1.20

1.09

u/ml

0.14

377

2172

Enthesopathies of lower limb, excluding foot

239

1555

1.55

9.36

1.1

2.01

1.26

u/ml

0.44

103

619

Schizophrenia or delusion, excluding more controls

161

2627

0.60

9.35

1.0

1.1

0.95

1.07

u/ml

0.16

1122

Prurigo nodularis

3.89

9.28

1.0

0.25

2.83

u/ml

0.68

Dysphagia

188

1161

1.63

9.18

1.1

0.90

1.21

u/ml

0.45

485

Other external causes of accidental injury

1046

4241

1.24

9.14

1.1

1.42

1.02

u/ml

0.72

495

1733

Other noninfective gastroenteritis and colitis

293

2001

1.47

9.07

1.2

1.1

1.36

u/ml

0.00

163

952

Obesity

752

5728

1.27

9.07

1.1

0.72

1.17

u/ml

1.65

330

2386

Obesity and other hyperalimentation

754

5737

1.27

9.06

1.1

0.71

1.17

u/ml

1.68

332

2390

Disorders of skin appendages

610

4690

1.31

9.05

1.1

1.06

1.21

u/ml

0.34

279

2051

Nummular dermatitis

317

2.23

8.97

1.1

1.38

1.10

u/ml

0.10

118

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

111

598

1.88

8.88

1.1

0.87

1.04

u/ml

0.14

260

Rotator cuff syndrome

500

2673

1.35

8.86

1.1

0.93

1.05

u/ml

0.16

195

1014

Trochanteric bursitis

121

669

1.82

8.86

1.1

0.32

1.10

u/ml

2.43

255

Injury, poisoning and certain other consequences of external causes

757

2970

1.28

8.85

1.1

1.23

1.04

u/ml

0.26

339

1249

Alcohol use disorder, Swedish definition

281

3733

0.69

8.83

1.1

1.20

u/ml

0.00

127

1552

Mental and behavioural disorders due to alcohol, excluding acute intoxication

206

3154

0.65

8.83

1.1

1.46

1.17

u/ml

0.24

1315

External causes of morbidity and mortality

895

3589

1.25

8.70

1.1

1.44

1.03

u/ml

0.71

408

1487

Disturbances of skin sensation

339

2401

1.42

8.69

1.1

1.61

1.04

u/ml

0.48

162

978

Lichen simplex chronicus

142

2.87

8.59

1.1

0.33

1.80

u/ml

0.90

Dermatophytosis

640

4987

1.29

8.57

1.1

0.99

1.16

u/ml

0.40

262

2129

Pain in limb

955

5190

1.23

8.52

1.1

1.20

1.14

u/ml

0.09

413

2301

COPD, hospital admissions

225

1241

1.54

8.47

1.0

1.1

0.76

1.10

u/ml

0.55

499

Oedema, not elsewhere classified

270

1816

1.47

8.44

1.1

0.78

0.99

u/ml

0.40

129

745

Acute suppurative otitis media

491

3461

1.33

8.40

1.1

1.00

1.25

u/ml

0.65

250

1652

COPD, early/later onset

226

1250

1.53

8.29

1.0

1.1

0.76

1.09

u/ml

0.55

502

357

4323

0.72

8.26

1.1

1.14

u/ml

0.00

164

1822

Disease of hard tissues of teeth, NOS

551

2189

1.32

8.18

1.1

1.47

1.37

u/ml

0.08

227

866

ILD, hospital admissions

431

1.99

8.12

1.1

0.46

1.27

u/ml

1.24

188

Transport accidents

577

3843

1.30

8.08

1.1

1.07

1.08

u/ml

0.02

261

1558

Other interstitial pulmonary diseases

432

1.98

8.07

1.1

0.46

1.27

u/ml

1.24

189

Interstitial lung disease

433

1.98

8.02

1.1

0.46

1.27

u/ml

1.24

189

Interstitial lung disease endpoints

433

1.98

8.02

1.1

0.46

1.27

u/ml

1.24

189

Sciatica+with lumbago

505

3541

1.32

8.01

1.1

0.87

1.13

u/ml

0.44

213

1429

Alcohol use disorder, ICD-based

192

2931

0.65

7.99

1.1

1.46

1.16

u/ml

0.23

1227

Other and unspecified rosacea

519

1.89

7.97

1.1

1.30

1.10

u/ml

0.14

197

Later onset COPD, excluding more controls

164

2.46

7.97

1.0

0.15

1.48

u/ml

0.86

GASTRO-related operations

1187

4958

1.20

7.92

1.1

1.15

1.17

u/ml

0.05

549

2217

Any gastric operation

1187

4958

1.20

7.92

1.1

1.15

1.17

u/ml

0.05

549

2217

Cervicobrachial syndrome

223

1486

1.51

7.89

1.1

0.42

1.29

u/ml

3.45

576

Other diseases of lip and oral mucosa

389

2867

1.36

7.87

1.1

0.80

1.18

u/ml

1.22

177

1195

Other respiratory diseases principally affecting the interstitium

528

1.87

7.83

1.1

0.47

1.10

u/ml

1.15

235

332

4128

0.72

7.76

1.1

1.18

1.16

u/ml

0.02

154

1744

All chronic kidney diseases

256

3013

0.69

7.76

1.0

1.1

1.65

1.19

u/ml

0.41

106

1376

Alcohol dependence

1614

0.54

7.71

1.1

0.89

1.05

u/ml

0.23

682

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

317

1.96

7.51

1.1

0.51

1.47

u/ml

1.29

145

Psychiatric diseases

1149

4802

1.20

7.50

1.1

1.29

1.13

u/ml

0.25

497

2116

Other (not insulin) diabetes medications

669

4975

0.80

7.48

1.1

0.87

1.09

u/ml

0.59

260

2022

Dislocation, sprain and strain of joints and ligaments of knee

742

5526

1.24

7.36

1.1

1.21

1.10

u/ml

0.15

308

2312

Female infertility

420

1903

1.35

7.34

1.1

1.22

1.19

u/ml

0.03

153

796

Type 2 diabetes

735

5316

0.81

7.33

1.1

0.93

1.06

u/ml

0.33

291

2174

Hyperkinetic disorders, excluding more controls

272

1835

1.44

7.31

1.1

1.57

1.17

u/ml

0.33

158

953

Insulin medication

341

3892

0.73

7.28

1.0

1.1

0.79

1.14

u/ml

0.90

143

1765

Other intervertebral disc disorders

841

4124

1.23

7.28

1.0

1.1

0.98

1.10

u/ml

0.17

343

1673

Other disorders of patella

212

1425

1.50

7.26

1.1

0.53

1.26

u/ml

2.47

570

Female infertility, cervical, vaginal, other or unspecified origin

382

1835

1.36

7.24

1.1

1.20

u/ml

0.00

144

758

Chronic gastritis

153

956

1.61

7.22

1.1

1.0

0.33

0.88

u/ml

2.02

374

Mental and behavioural disorders due to psychoactive substance use

380

4685

0.75

7.16

1.1

1.18

1.14

u/ml

0.05

178

1968

Other viral diseases, not elsewhere classified

402

3015

1.34

7.08

1.1

0.69

1.30

u/ml

2.68

188

1446

Injuries to the ankle and foot

929

6853

1.21

7.08

1.1

1.22

1.13

u/ml

0.14

449

3011

Shoulder lesions

691

3349

1.25

7.07

1.1

0.78

1.04

u/ml

0.55

266

1325

Peritonsillar abscess

211

1425

1.49

7.05

1.1

1.0

0.47

1.31

u/ml

2.70

506

Malignant neoplasm of digestive organs

1174

0.54

7.05

1.0

1.1

1.66

1.18

u/ml

0.30

463

Substance abuse

362

4546

0.75

7.05

1.1

1.19

1.14

u/ml

0.06

172

1913

Restless leg syndrome

126

756

1.68

7.05

1.1

1.08

1.16

u/ml

0.05

309

Dental pulpitis, including avohilmo

1167

6396

1.19

7.03

1.1

0.96

1.15

u/ml

0.44

499

2704

Lumbar disc prolapse

624

3804

1.26

7.02

1.1

0.85

1.11

u/ml

0.82

264

1542

Dermatitis due to substances taken internally

324

2.07

7.02

1.1

1.0

2.91

1.02

u/ml

0.88

130

Other inflammation of eyelid

136

834

1.65

6.99

1.1

1.57

1.21

u/ml

0.34

365

Disorders of synovium and tendon

558

3844

1.28

6.99

1.0

1.1

0.45

1.06

u/ml

6.43

198

1592

Other general symptoms and signs

101

568

1.80

6.97

1.1

0.58

1.04

u/ml

0.90

328

Malignant neoplasm of breast, HER-positive

129

1623

0.62

6.89

1.1

1.44

0.77

u/ml

0.28

585

Biguanides

634

4821

0.80

6.87

1.1

0.93

1.07

u/ml

0.32

246

1941

Acute laryngitis and tracheitis

222

1501

1.47

6.86

1.2

1.1

1.16

1.29

u/ml

0.12

112

765

Factors influencing health status and contact with health services

346

1263

1.38

6.86

1.1

1.53

1.26

u/ml

0.21

160

470

Organic, including symptomatic, mental disorders

1180

0.57

6.85

1.0

1.1

0.81

0.88

u/ml

0.06

481

Malignant neoplasm of breast, ER-positive, including Hilmo

135

1659

0.62

6.83

1.1

1.39

0.77

u/ml

0.27

599

Hypertrophy of breast in women and men

226

1559

1.46

6.82

1.1

1.05

1.04

u/ml

0.02

606

Diaphragmatic hernia

232

1606

1.45

6.82

1.1

0.90

0.95

u/ml

0.07

105

615

Unspecified mental disorder

268

3723

0.72

6.80

1.1

0.90

1.17

u/ml

0.59

112

1587

Cervicocranial syndrome

106

613

1.75

6.80

1.1

1.55

u/ml

0.00

250

Renal failure

119

1720

0.61

6.76

1.0

1.1

0.93

1.05

u/ml

0.11

760

Oesophagitis

211

2.30

6.71

1.2

1.1

0.53

1.00

u/ml

0.99

Disorders of breast

545

3906

1.27

6.69

1.1

1.11

0.98

u/ml

0.19

223

1533

Cerebrovascular diseases

288

2786

0.72

6.68

1.1

0.74

0.99

u/ml

0.52

110

1118

Fibromyalgia

114

680

1.70

6.57

1.1

0.86

1.21

u/ml

0.37

257

Oter anti-inflammatory and antirheumatic agents, non-steroids

133

442

1.67

6.57

1.1

0.13

1.15

u/ml

2.83

197

Genitourinary diseases

803

3296

1.23

6.50

1.1

1.41

1.13

u/ml

0.41

382

1607

COPD, hospital admissions 1, only main diagnosis

155

850

1.57

6.48

1.0

1.1

0.62

0.99

u/ml

0.63

348

Injuries to the knee and lower leg

1393

6658

1.16

6.45

1.1

1.05

1.15

u/ml

0.17

605

2892

Generalized anxiety disorder

262

1879

1.41

6.44

1.1

1.12

1.25

u/ml

0.19

133

815

Other diseases of oesophagus

341

1.98

6.44

1.1

0.59

1.38

u/ml

1.00

144

Disorders of the thyroid gland

1026

5628

1.19

6.40

1.1

0.77

1.18

u/ml

1.79

400

2394

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

450

3114

1.30

6.35

1.1

1.91

1.17

u/ml

0.78

248

1563

Rosacea

124

763

1.64

6.35

1.1

1.17

1.22

u/ml

0.03

298

Liquid cancers, helper endpoint

128

1764

0.63

6.31

1.1

0.52

1.14

u/ml

1.47

742

ILD, hospital admission 2, with pulmonary infections

236

2.17

6.30

1.1

0.52

1.12

u/ml

0.50

Mental and behavioural disorders due to alcohol

295

3833

0.74

6.28

1.1

1.28

1.18

u/ml

0.10

141

1611

Olecranon bursitis

224

2.21

6.26

1.0

1.1

3.31

1.68

u/ml

0.29

Internal derangement of knee

377

2855

1.32

6.25

1.1

1.00

1.27

u/ml

0.34

159

1163

Disorders of thyroid, IBD co-morbidities

231

1134

1.44

6.22

1.0

1.1

0.60

1.13

u/ml

1.64

506

Other disorders of urethra and urinary system

708

4175

1.23

6.21

1.1

1.40

0.95

u/ml

0.62

284

1716

Noninflammatory disorders of female genital tract

588

2351

1.26

6.16

1.1

1.15

1.19

u/ml

0.06

238

1047

Diarrhoea and gastroenteritis of presumed infectious origin

838

6294

1.20

6.15

1.1

0.79

1.18

u/ml

1.91

406

2788

Type 2 diabetes, definitions combined, including avohilmo

690

4909

0.82

6.15

1.1

0.90

1.07

u/ml

0.43

276

2000

Other specified disorders of external ear

116

2.71

6.11

1.0

1.1

2.51

0.96

u/ml

0.60

Diseases of external ear

329

2468

1.34

6.06

1.1

2.00

1.27

u/ml

0.52

161

1112

Congenital malformations, deformations and chromosomal abnormalities

853

6578

1.20

6.05

1.1

1.42

1.11

u/ml

0.51

381

2924

Disturbance of activity and attention

273

1959

1.38

6.00

1.1

1.47

1.24

u/ml

0.17

162

1052

Hypertrophy of breast

205

1426

1.45

5.99

1.1

1.11

0.95

u/ml

0.20

551

Postviral fatigue syndrome

3.10

5.98

1.2

1.1

0.91

0.59

u/ml

0.18

Dislocation, sprain and strain of joints and ligaments at neck level

216

1519

1.44

5.97

1.1

0.98

1.28

u/ml

0.50

656

Obesity, other/unspecified

404

3127

1.30

5.96

1.1

0.52

1.14

u/ml

3.40

189

1293

Unspecified privation

114

699

1.65

5.95

1.1

1.06

1.23

u/ml

0.11

286

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

883

0.47

5.93

1.0

0.16

0.79

u/ml

3.73

344

Other and unspecified drugs and medicaments

526

1.75

5.92

1.1

0.98

1.02

u/ml

0.02

221

Vasomotor rhinitis (mode)

374

1.89

5.89

1.1

0.50

1.59

u/ml

1.29

160

Excessive, frequent and irregular menstruation

518

2247

1.27

5.84

1.1

1.12

1.22

u/ml

0.11

213

985

Epiphora

3.13

5.80

1.0

0.73

2.43

u/ml

—

948

4845

1.19

5.76

1.1

1.17

1.09

u/ml

0.14

467

1994

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

948

4845

1.19

5.76

1.1

1.17

1.09

u/ml

0.14

467

1994

Diseases of oral cavity, salivary glands and jaws

555

2278

1.26

5.75

1.1

1.22

1.29

u/ml

0.06

251

933

General examination and investigation of persons without complaint and reported diagnosis

693

2958

1.23

5.75

1.1

0.80

1.22

u/ml

1.53

282

1166

Type 2 diabetes, strict (exclude DM1)

680

4848

0.82

5.73

1.1

0.90

1.06

u/ml

0.39

271

1964

Continuous positive airway pressure

188

1088

1.46

5.72

1.1

0.71

0.97

u/ml

0.35

530

Acute and transient psychotic disorders

946

0.49

5.72

1.0

1.1

0.98

1.43

u/ml

0.38

400

Septicaemia

166

2272

0.68

5.71

1.1

1.65

0.99

u/ml

0.69

1042

COPD related to multimorbidity

164

925

1.50

5.71

1.0

0.79

1.03

u/ml

0.29

357

Infections with a predominantly sexual mode of transmission

608

4625

1.23

5.65

1.1

1.43

1.19

u/ml

0.28

267

1994

Hyperkinetic disorders

287

2095

1.36

5.64

1.1

1.49

1.29

u/ml

0.15

172

1120

Type 2 diabetes, definitions combined

680

4838

0.82

5.63

1.1

0.91

1.02

u/ml

0.27

271

1963

Excessive attrition of teeth

666

5495

1.22

5.62

1.1

1.30

1.14

u/ml

0.20

289

2344

Substance abuse, excluding more controls

362

3988

0.77

5.58

1.1

1.19

1.09

u/ml

0.13

172

1654

Other disorders of eyelid

248

1716

1.38

5.57

1.1

2.07

0.93

u/ml

0.59

658

Inflammatory diseases of prostate (prostatitis)

476

1.75

5.55

1.1

0.42

1.47

u/ml

1.43

205

Benign neoplasm: Liver/bile ducts

153

2.40

5.53

1.0

1.1

0.34

0.84

u/ml

1.46

Benign neoplasm of other and ill-defined parts of digestive system

121

767

1.59

5.51

1.1

0.64

0.89

u/ml

0.49

316

Irregular menses

663

4316

1.22

5.50

1.1

0.79

1.10

u/ml

0.84

278

1758

Otalgia

108

669

1.63

5.48

1.2

1.1

0.94

1.20

u/ml

0.36

343

Dementia, including avohilmo

729

0.53

5.46

1.1

1.0

0.33

0.87

u/ml

1.32

301

Subjective visual disturbances

243

1771

1.38

5.46

1.1

1.26

1.21

u/ml

0.02

117

748

Benign neoplasm: Liver

136

2.48

5.43

1.0

1.1

0.27

0.89

u/ml

1.81

Hypothyreosis and Thyroxine purchase for inclusion criteria

988

5527

1.18

5.42

1.1

0.79

1.12

u/ml

1.26

383

2346

Hypothyroidism, other/unspecified

957

5357

1.18

5.38

1.1

0.80

1.13

u/ml

1.15

369

2280

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

207

2.17

5.34

1.0

1.1

2.02

1.03

u/ml

0.34

Other disorders of breast

141

934

1.52

5.33

1.1

1.39

0.99

u/ml

0.26

374

Unspecified chronic bronchitis

3.20

5.32

1.1

1.0

1.10

3.36

u/ml

—

Cervicalgia

177

1228

1.45

5.28

1.1

0.63

1.33

u/ml

1.67

495

Visual disturbances

460

3676

1.26

5.27

1.1

1.11

1.17

u/ml

0.05

220

1627

Striking against or struck by other objects

415

3277

1.27

5.25

1.1

1.36

1.28

u/ml

0.07

202

1574

Heart failure, not strict

350

3066

0.77

5.23

1.0

1.1

0.79

1.07

u/ml

0.72

131

1286

Stroke, including SAH

208

2095

0.72

5.22

1.1

0.58

1.01

u/ml

1.20

855

Ovarian cyst

437

1987

1.27

5.21

1.1

0.85

1.15

u/ml

0.45

173

835

Ganglion

230

1677

1.38

5.18

1.1

0.45

1.21

u/ml

3.25

676

Erysipelas

402

3880

0.79

5.16

1.0

1.1

2.38

0.91

u/ml

1.69

183

1551

Other septicaemia

140

1991

0.67

5.15

1.1

1.70

0.99

u/ml

0.65

924

Other contact dermatitis

473

1.73

5.14

1.1

0.27

0.87

u/ml

1.22

170

Panic disorder

229

1674

1.38

5.12

1.1

0.82

1.25

u/ml

1.18

114

712

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

354

2753

1.29

5.12

1.1

0.92

1.26

u/ml

0.69

170

1222

Other diseases of intestines

1318

6554

1.15

5.09

1.1

1.22

1.11

u/ml

0.17

562

2929

Herpesviral [herpes simplex] infections

128

840

1.54

5.07

1.1

2.74

1.19

u/ml

0.65

362

Other enthesopathy of foot (+metatarsalgia)

103

643

1.62

5.07

1.1

0.91

1.38

u/ml

0.34

254

Mental retardation, wide definition

594

0.41

4.99

1.2

0.21

1.22

u/ml

3.31

374

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

766

0.48

4.98

1.1

0.84

1.45

u/ml

0.41

336

Other degenerative diseases of the nervous system

1013

0.60

4.97

1.0

0.27

1.21

u/ml

3.04

395

Condition for Implicit Sepsis (Organ dysfunction codes)

604

5145

0.83

4.96

1.1

0.79

1.07

u/ml

1.03

261

2217

Insulin, combination of fast acting with intermediate-acting or long-acting

341

3989

0.78

4.96

1.0

1.1

0.79

1.12

u/ml

0.83

143

1794

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

659

4346

1.20

4.94

1.0

1.1

1.13

0.98

u/ml

0.23

229

1754

Viral and other specified intestinal infections

447

3465

1.25

4.93

1.1

1.06

1.30

u/ml

0.39

203

1707

Noninfective enteritis and colitis

506

4115

1.23

4.92

1.1

1.56

1.10

u/ml

0.53

241

1874

Hypothyroidism, levothyroxine purchases

455

2054

1.26

4.90

1.1

1.01

1.21

u/ml

0.29

196

950

Hypothyroidism and >3 levothyroxin purchases

455

2054

1.26

4.90

1.1

1.01

1.21

u/ml

0.29

196

950

Disorders of tooth development and eruption

228

1353

1.37

4.87

1.1

0.56

1.41

u/ml

2.54

109

615

Schizoaffective disorder

663

0.45

4.84

1.0

1.1

0.36

1.23

u/ml

1.97

284

Selective deficiency of immunoglobulin G [IgG] subclasses

4.62

4.83

1.1

0.64

0.61

u/ml

—

Disorders of other endocrine glands

479

3822

1.24

4.83

1.1

1.16

1.18

u/ml

0.01

207

1807

Stroke, excluding SAH

183

1867

0.71

4.82

1.1

0.59

1.07

u/ml

1.20

749

Polyarthropathies

504

4031

0.81

4.78

1.1

0.60

1.18

u/ml

3.05

212

1714

Infections of the skin and subcutaneous tissue

656

5442

1.20

4.77

1.1

1.54

1.13

u/ml

0.46

336

2435

Hypothyroidism, strict autoimmune

815

4554

1.18

4.76

1.1

0.71

1.14

u/ml

1.83

305

1924

Cervical disc disorders

264

1993

1.33

4.75

1.1

0.59

1.21

u/ml

1.94

106

758

253

0.24

4.75

1.0

1.1

—

1.61

—

Viral warts

279

2126

1.32

4.75

1.1

1.07

1.43

u/ml

0.55

105

995

Other extrapyramidal and movement disorders in other diseases

176

1246

1.42

4.75

1.1

0.85

1.19

u/ml

0.37

516

Mental retardation

580

0.42

4.74

1.2

0.21

1.23

u/ml

3.30

369

Other/unspecified dorsalgia

348

2704

1.28

4.74

1.1

1.40

1.20

u/ml

0.14

172

1130

Acute tubulo-interstitial nephritis

399

4303

0.80

4.73

1.1

0.85

1.13

u/ml

0.53

183

1855

Other diseases of the respiratory system

109

701

1.56

4.72

1.1

0.55

1.17

u/ml

1.27

328

Other respiratory disorders and diseases

109

701

1.56

4.72

1.1

0.55

1.17

u/ml

1.27

328

Exposure to other and unspecified forces of nature

3.67

4.70

1.1

1.04

0.69

u/ml

—

Flat foot [pes planus] (acquired)

547

1.64

4.69

1.1

0.72

1.43

u/ml

0.98

230

Chondrocostal junction syndrome [Tietze]

198

2.10

4.68

1.2

1.1

0.78

1.41

u/ml

0.42

Otitis externa

241

1802

1.35

4.67

1.0

1.1

2.38

1.40

u/ml

0.51

114

812

Myotonic disorders

3.62

4.67

1.3

1.0

0.50

0.94

u/ml

—

COPD, hospital admission 2, with asthma infections

138

799

1.48

4.65

1.1

0.97

1.07

u/ml

0.09

326

Fissure and fistula of anal and rectal regions

218

1606

1.36

4.65

1.1

0.62

1.01

u/ml

0.97

685

Viral pneumonia

125

833

1.51

4.64

1.1

1.10

1.07

u/ml

0.03

378

STROKE

303

2660

0.77

4.64

1.1

0.64

1.02

u/ml

1.06

120

1063

Metatarsalgia

588

1.61

4.62

1.1

0.92

1.40

u/ml

0.32

237

Hypothyroidism (congenital or acquired)

457

2081

1.25

4.56

1.1

1.00

1.20

u/ml

0.29

199

967

Seborrhoeic dermatitis

460

1.69

4.54

1.1

0.93

0.84

u/ml

0.08

177

Mental and behavioural disorders due to opioids

386

0.31

4.53

1.0

1.1

0.15

1.52

u/ml

—

167

Explicit Sepsis

207

2609

0.74

4.51

1.1

2.52

1.09

u/ml

0.94

100

1182

Hypermobility syndrome

563

1.62

4.49

1.1

0.18

0.88

u/ml

2.28

242

Postmenopausal atrophic vaginitis

179

697

1.42

4.48

1.1

1.0

1.37

0.86

u/ml

0.33

254

Injury of muscle and tendon at shoulder and upper arm level

224

1669

1.35

4.44

1.1

0.63

1.23

u/ml

1.06

668

COPD-related respiratory insufficiency

250

1.93

4.43

1.0

1.1

0.16

1.59

u/ml

1.95

Other systemic involvement of connective tissue

211

1560

1.36

4.41

1.1

0.33

1.06

u/ml

3.17

636

Candidiasis

135

925

1.47

4.40

1.1

0.73

1.21

u/ml

0.78

403

Tinnitus

186

1349

1.39

4.40

1.1

0.64

1.25

u/ml

1.37

542

Erysipelas

253

2925

0.76

4.37

1.0

1.1

2.94

0.95

u/ml

1.43

116

1189

Infective dermatitis

550

1.61

4.36

1.1

0.83

0.79

u/ml

0.03

193

Visual disturbances and blindness

477

3913

1.22

4.35

1.1

1.10

1.15

u/ml

0.05

229

1739

Other and unspecified polyneuropathies, also in other diseases

103

668

1.55

4.34

1.1

1.23

1.00

u/ml

0.22

272

Nonsuppurative otitis media

383

2657

1.25

4.33

1.1

1.59

1.28

u/ml

0.25

215

1302

Inflammatory disease of uterus

185

1347

1.38

4.31

1.1

1.15

0.97

u/ml

0.14

533

Ocular pain

102

663

1.55

4.31

1.0

1.1

0.79

1.14

u/ml

0.39

292

Fall on same level involving ice and snow

533

4428

1.21

4.30

1.1

1.26

1.12

u/ml

0.17

238

1882

Care involving use of rehabilitation procedures

620

4797

1.19

4.29

1.1

0.88

1.01

u/ml

0.23

287

2019

Pain, not elsewhere classified

291

2262

1.29

4.29

1.1

0.94

1.14

u/ml

0.37

129

986

Anomalies of dental arch relationship, including avohilmo

315

2229

1.28

4.29

1.1

1.17

1.22

u/ml

0.05

165

1089

Disorders of muscles

632

1.56

4.27

1.1

1.04

1.37

u/ml

0.29

257

Vulvovaginal ulceration/inflammation in other diseases

602

1.58

4.26

1.1

0.62

1.00

u/ml

0.61

256

Unspecified acute lower respiratory infection

152

1072

1.43

4.26

1.1

0.90

1.38

u/ml

0.70

471

Other symptoms and signs involving the circulatory and respiratory systems

319

1.80

4.24

1.1

1.0

0.18

1.77

u/ml

2.11

138

Mental retardation, excluding more controls

541

0.44

4.23

1.2

0.21

1.24

u/ml

3.26

343

Other reaction to severe stress, and adjustment disorders

482

3976

1.22

4.22

1.1

1.17

1.18

u/ml

0.01

217

1672

Unspecific neurodegenerative disorder

534

0.52

4.19

1.0

0.45

0.85

u/ml

0.59

223

Benign neoplasm of colon, rectum, anus and anal canal

364

2525

1.25

4.19

1.1

0.67

1.05

u/ml

1.23

140

959

Uterine polyps

502

1.63

4.17

1.0

2.04

0.97

u/ml

0.35

196

Benign neoplasm: Transverse colon

321

1.79

4.16

1.1

1.0

0.71

1.26

u/ml

0.62

127

Benign neoplasm: Sigmoid colon

628

1.55

4.14

1.0

0.89

0.95

u/ml

0.06

257

All influenza

246

1880

1.31

4.13

1.1

0.92

1.10

u/ml

0.29

118

885

Other systemic involvement of connective tissue (FG)

208

1531

1.35

4.13

1.1

0.34

0.95

u/ml

2.80

607

Immunodeficiency with predominantly antibody defects

195

2.04

4.12

1.1

0.31

0.76

u/ml

1.74

102

Occupational exposure to risk-factors

148

2.19

4.11

1.1

0.31

1.02

u/ml

1.42

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

794

6347

0.86

4.10

1.1

0.89

1.12

u/ml

0.45

379

2731

Type 2 diabetes, wide definition

436

3407

0.82

4.08

1.1

0.96

1.09

u/ml

0.19

163

1335

Mycoses

236

1798

1.32

4.07

1.1

0.75

1.26

u/ml

1.20

103

781

Any dementia

537

0.53

4.07

1.0

0.30

1.04

u/ml

1.55

218

Other infestations

2.99

4.04

1.0

1.1

1.12

0.93

u/ml

—

Polyuria

142

999

1.43

4.03

1.1

1.06

1.04

u/ml

0.02

413

Dementia

646

0.57

4.03

1.1

1.0

0.34

0.90

u/ml

1.29

268

Any dementia, excluding more controls

520

0.53

4.00

1.1

1.0

0.32

0.89

u/ml

1.27

208

Impingement syndrome of shoulder

164

1188

1.39

3.95

1.0

0.33

1.20

u/ml

2.94

453

Embedded and impacted teeth

490

3360

1.21

3.94

1.1

0.94

1.38

u/ml

1.40

231

1598

Other deformities of toe(s)

131

2.24

3.94

1.0

1.1

0.38

0.90

u/ml

—

Any operation in hilmo

210

1.72

3.94

1.1

1.0

2.36

1.00

u/ml

0.35

Endocrine, nutritional and metabolic diseases

1154

5161

1.13

3.90

1.1

1.42

1.17

u/ml

0.40

507

2348

Transplanted organ and tissue status

715

0.53

3.89

1.1

0.18

1.61

u/ml

3.41

356

Subacute thyroiditis

206

1.97

3.89

1.0

1.1

0.54

1.51

u/ml

0.75

Chronic periodontitis, including avohilmo

681

5328

0.85

3.88

1.1

1.36

1.06

u/ml

0.35

301

2140

Diseases of male genital organs

487

2027

1.22

3.87

1.1

1.22

1.30

u/ml

0.09

245

1016

Immunodeficiencies

352

1.73

3.87

1.1

0.44

1.13

u/ml

1.09

179

Radiculopathy

104

695

1.50

3.87

1.2

1.1

0.64

1.32

u/ml

0.98

265

Degenerative diseases of the nervous system

490

0.51

3.86

1.1

0.38

1.07

u/ml

1.15

199

Crossbite

162

1091

1.39

3.84

1.1

1.25

1.40

u/ml

0.10

109

638

Blepharochalasis

145

1034

1.41

3.83

1.1

0.75

0.99

u/ml

0.26

396

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

872

6502

0.87

3.82

1.1

0.76

1.16

u/ml

2.14

397

2832

Other gastritis (incl. Duodenitis)

139

985

1.42

3.82

1.2

1.1

1.50

1.02

u/ml

0.31

393

Obsessive-compulsive disorder

124

864

1.45

3.81

1.1

0.59

1.39

u/ml

2.09

399

Peripheral artery disease

1037

0.65

3.80

1.1

1.0

1.35

1.04

u/ml

0.21

423

Contracture of joint

3.24

3.80

1.0

1.1

2.71

1.21

u/ml

—

Dysplasia of cervi uteri

301

1723

1.27

3.78

1.1

1.45

1.14

u/ml

0.24

113

707

Spondylolisthesis/Spondylolysis

140

996

1.41

3.77

1.1

0.53

1.41

u/ml

1.81

394

Polyp of the female genital tract

284

1275

1.28

3.76

1.1

0.94

0.83

u/ml

0.12

112

500

Disorders of choroid and retina

426

3666

0.82

3.75

1.1

1.17

1.02

u/ml

0.12

178

1469

Disorders of sclera, cornea, iris and ciliary body

524

4409

1.19

3.74

1.1

2.04

1.08

u/ml

1.06

248

1871

Keratitis

343

2769

1.24

3.74

1.1

2.75

1.10

u/ml

1.37

169

1177

Implicit Sepsis

463

4192

0.83

3.74

1.1

0.86

1.07

u/ml

0.53

198

1804

Disorders of ocular muscles, binocular movement, accommodation and refraction

573

4817

1.18

3.74

1.1

1.00

1.16

u/ml

0.25

257

2228

Congenital malformations, deformations and chromosomal abnormalities

769

6352

1.16

3.73

1.1

1.23

1.13

u/ml

0.18

337

2859

Periodontitis

686

5334

0.86

3.73

1.1

1.35

1.05

u/ml

0.34

302

2144

Other and unspecified nerve root and plexus disorders, also in other diseases

179

1330

1.35

3.71

1.1

0.67

1.33

u/ml

1.65

540

Tramadol

770

4087

1.16

3.71

1.1

0.92

1.15

u/ml

0.44

341

1659

Other disorders of eye and adnexa

158

1153

1.38

3.69

1.1

0.65

1.09

u/ml

0.95

515

Ischaemic Stroke, excluding all haemorrhages

166

1672

0.74

3.69

1.0

1.1

0.65

1.11

u/ml

0.93

675

Urethritis and urethral syndrome

103

2.37

3.69

1.1

0.32

0.98

u/ml

1.26

Thyroiditis

496

1.59

3.68

1.0

1.1

0.37

0.98

u/ml

1.26

210

Impacted teeth

377

2740

1.23

3.68

1.1

0.97

1.39

u/ml

1.01

173

1337

Pleural plaque

122

2.22

3.66

1.0

0.96

0.76

u/ml

—

Dialysis, with operation codes

688

0.53

3.65

1.1

0.46

1.31

u/ml

1.42

330

Bacterial Sepsis

180

2048

0.75

3.63

1.0

1.1

1.20

1.15

u/ml

0.05

894

Acute appendicitis, no complications

627

5345

1.17

3.63

1.1

1.35

1.08

u/ml

0.29

246

2230

Certain infectious and parasitic diseases

1204

5368

1.13

3.59

1.1

1.44

1.04

u/ml

0.87

533

2330

Bruxism

144

2.13

3.58

1.0

1.1

0.20

1.65

u/ml

0.93

Cholinergic urticaria

4.43

3.57

1.2

1.0

1.23

1.17

u/ml

—

Benign neoplasm: Choroid

220

1.88

3.55

1.1

0.76

1.51

u/ml

0.49

Sub-endpoint used in defining T1D endpoints

200

2566

0.76

3.54

1.0

1.1

0.82

1.22

u/ml

0.71

1226

Appendicitis, broad definition

783

6174

1.15

3.53

1.1

1.44

1.04

u/ml

0.47

307

2563

Haemorrhoids and perianal venous thrombosis

210

1607

1.31

3.50

1.0

1.1

1.17

1.01

u/ml

0.11

657

ILD-related respiratory insufficiency

2.72

3.50

1.1

0.92

1.03

u/ml

—

Insulin, intermediate and long-acting

301

3628

0.80

3.50

1.0

1.1

0.64

1.18

u/ml

1.97

126

1627

Other/unspecified enthesopathies, not elsewhere classified

386

1.64

3.46

1.3

1.1

0.46

1.01

u/ml

1.09

152

Complications predominantly related to the puerperium

323

2619

1.24

3.44

1.1

0.97

1.04

u/ml

0.10

136

1047

Malaise and fatigue

445

2989

1.20

3.42

1.1

1.32

1.10

u/ml

0.23

208

1309

Adenomyosis (Endometriosis of uterus)

110

765

1.45

3.40

1.1

1.0

0.58

0.94

u/ml

0.52

294

Diseases of appendix

785

6188

1.15

3.40

1.1

1.44

1.04

u/ml

0.47

307

2568

Substance use, excluding alcohol

136

1861

0.73

3.40

1.1

1.13

1.30

u/ml

0.13

807

Other complications of surgical and medical care, not elsewhere classified

643

1.49

3.39

1.1

1.31

0.88

u/ml

0.29

270

Autoimmune diseases excluding thyroid diseases, strict definition

981

6063

0.88

3.39

1.1

1.10

1.18

u/ml

0.12

432

2720

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.89

3.39

1.3

1.1

2.67

0.76

u/ml

—

All influenza (not pneumonia)

164

1223

1.35

3.37

1.1

1.09

1.12

u/ml

0.02

583

Other and unspecified acute skin changes due to ultraviolet radiation

2.86

3.37

1.0

0.24

3.76

u/ml

—

Recurrent aphthous stomatitis , including avohilmo

148

1087

1.37

3.36

1.1

0.86

1.09

u/ml

0.22

507

Obesity due to excess calories

513

4357

1.18

3.35

1.1

0.82

1.16

u/ml

0.65

213

1831

Postpartum care and examination

170

1426

0.75

3.32

1.1

1.23

0.97

u/ml

0.27

599

Acute appendicitis

743

6064

1.15

3.32

1.1

1.47

1.04

u/ml

0.49

297

2519

Pulmonary eosinophilia, not elsewhere classified

3.71

3.31

1.3

1.0

0.50

1.01

u/ml

—

Extrapyramidal and movement disorders

234

1836

1.28

3.30

1.1

0.81

1.09

u/ml

0.42

752

Autoimmune diseases excluding thyroid diseases

1005

6167

0.89

3.29

1.1

1.13

1.18

u/ml

0.07

446

2765

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

664

0.56

3.27

1.0

1.90

0.86

u/ml

—

256

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

571

3102

1.17

3.26

1.1

0.89

1.05

u/ml

0.39

261

1266

Gluteal tendinitis

184

1.92

3.25

1.0

1.1

1.56

1.86

u/ml

0.10

Malignant neoplasm of skin

183

1642

0.76

3.25

1.0

1.1

0.93

0.86

u/ml

0.08

619

Other diseases of intestine

551

1.51

3.25

1.1

0.91

1.16

u/ml

0.17

240

Other/unspecified enthesopathies of lower limb, excluding foot

472

1.56

3.25

1.1

0.90

1.43

u/ml

0.47

190

Primary hyperparathyroidism

393

1.61

3.24

1.0

1.1

0.22

1.11

u/ml

1.72

160

Other abnormal products of conception

499

2797

1.19

3.23

1.1

1.17

0.97

u/ml

0.32

201

1124

Abnormal findings in secretions and smears from cervix uteri vagina vulva

613

3992

1.16

3.23

1.0

1.1

1.16

1.00

u/ml

0.25

219

1596

Dyshidrosis [pompholyx]

2.31

3.23

1.0

1.1

0.18

0.77

u/ml

—

Nonalcoholic fatty liver disease

634

1.48

3.23

1.1

1.22

1.28

u/ml

0.04

250

Inhalation and ingestion of food causing obstruction of respiratory tract

2.93

3.22

1.4

1.2

1.58

0.70

u/ml

—

Nonorganic sleeping disorders, excluding more controls

240

1898

1.27

3.22

1.1

1.12

1.11

u/ml

0.01

110

818

Alzheimer disease, including avohilmo

423

0.53

3.22

1.1

1.0

0.44

0.97

u/ml

0.66

166

Redundant prepuce, phimosis and paraphimosis

194

1478

1.31

3.21

1.1

1.34

1.44

u/ml

0.08

104

715

L04AD Calcineurin inhibitors

920

0.63

3.20

1.1

1.19

1.39

u/ml

0.09

467

Other disorders of white blood cells

259

1.75

3.15

1.2

1.1

0.30

1.23

u/ml

1.39

122

Other arthrosis

405

2337

1.20

3.14

1.1

0.69

1.12

u/ml

0.65

161

887

N06DA Anticholinesterases

437

0.52

3.12

1.1

1.0

0.27

0.95

u/ml

—

169

Use of anticholinesterases

437

0.52

3.12

1.1

1.0

0.27

0.95

u/ml

—

169

Lateral epicondylitis

117

838

1.40

3.12

1.2

1.1

1.58

1.33

u/ml

0.08

314

Other disorders of penis

647

1.46

3.11

1.1

2.60

1.62

u/ml

0.29

348

Open wound of wrist and hand

475

3943

1.18

3.11

1.0

1.1

0.69

1.24

u/ml

2.46

216

1726

Suppurative otitis media, unspecified

209

1.85

3.11

1.0

1.1

0.40

1.81

u/ml

1.26

105

Alcohol withdrawal state with delirium

288

0.34

3.11

1.1

0.68

1.87

u/ml

—

113

Other diseases of stomach and duodenum

223

1.81

3.11

1.1

0.72

1.27

u/ml

0.63

Presence of other functional implants

214

1891

0.78

3.09

1.1

0.97

1.14

u/ml

0.16

755

Galactorrhea

2.50

3.09

1.1

6.35

0.81

u/ml

—

Persistent delusional disorders

401

0.45

3.09

1.1

0.30

1.54

u/ml

—

164

Other predominantly sexually transmitted diseases, not elsewhere classified

313

2564

1.23

3.09

1.1

2.15

1.30

u/ml

0.64

133

1121

Polyneuropathies and other disorders of the peripheral nervous system

123

890

1.39

3.08

1.1

1.15

1.01

u/ml

0.13

378

Endometriosis

379

1841

1.21

3.07

1.1

0.83

1.06

u/ml

0.43

145

761

Type 1 diabetes, wide definition

179

2315

0.77

3.07

1.1

1.69

1.12

u/ml

0.26

1123

Appendectomy

713

5977

1.14

3.05

1.1

1.38

1.06

u/ml

0.40

297

2476

Peroneal tendinitis

2.34

3.03

1.0

1.1

0.76

4.48

u/ml

—

Single spontaneous delivery

316

2043

0.82

3.03

1.1

1.67

1.09

u/ml

0.46

133

890

Ehlers-Danlos syndrome

2.31

3.02

1.1

1.0

0.88

0.55

u/ml

0.20

Hard cardiovascular diseases

566

3913

0.86

3.01

1.1

0.91

1.07

u/ml

0.30

220

1697

Haemangioma, any site

554

1.49

3.00

1.1

0.78

1.38

u/ml

0.48

255

Menorrhagia

347

1584

1.22

3.00

1.1

0.88

0.93

u/ml

0.05

131

646

Other acquired deformities of musculoskeletal system and connective tissue

241

1.76

2.99

1.1

0.23

1.83

u/ml

1.46

103

Endometriosis of pelvic peritoneum

186

1371

1.30

2.99

1.1

0.93

0.99

u/ml

0.07

560

Falls/tendency to fall

1342

6088

1.11

2.99

1.1

1.00

1.12

u/ml

0.32

616

2622

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

302

1.68

2.98

1.1

0.65

1.29

u/ml

0.58

139

Testicular hypofunction

183

1.88

2.98

1.1

1.67

1.57

u/ml

0.02

Nephropathy related operations

682

0.58

2.98

1.1

0.63

1.32

u/ml

0.92

325

Dental operations

537

2358

1.17

2.97

1.1

1.42

1.11

u/ml

0.32

236

958

Other/unspecified soft tissue disorders related to use, overuse and pressure

162

1.94

2.97

1.1

1.0

0.62

1.09

u/ml

0.65

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

631

0.57

2.96

1.1

0.35

1.10

u/ml

1.24

257

Otitis media, unspecified

203

1465

1.29

2.96

1.2

1.1

1.57

1.42

u/ml

0.10

119

774

Acute renal failure

757

0.61

2.96

1.0

1.1

1.26

1.17

u/ml

0.04

324

Other and unspecified mental retardation

330

0.41

2.95

1.1

1.2

0.27

1.15

u/ml

—

243

Spondylosis

361

2447

1.20

2.95

1.1

0.96

1.15

u/ml

0.20

143

938

Benign neoplasm of eye and adnexa

451

1.54

2.95

1.1

0.71

1.04

u/ml

0.31

189

Separation of retinal layers (serosa)

198

1.84

2.95

1.1

1.02

1.46

u/ml

0.20

Other obstetric conditions, not elsewhere classified

574

3153

1.16

2.95

1.1

0.90

1.06

u/ml

0.39

262

1279

Sexual dysfunction

2.36

2.94

1.0

1.1

0.37

0.86

u/ml

—

Sequelae of other external causes

303

1.66

2.93

1.1

0.40

1.23

u/ml

1.13

130

Injuries to the neck

257

2074

1.24

2.93

1.1

1.07

1.41

u/ml

0.63

114

904

Atherosclerosis, excluding cerebral and coronary sclerosis

841

0.67

2.92

1.1

1.0

1.53

0.90

u/ml

0.45

335

Other neurological diseases

379

3547

0.84

2.92

1.1

0.62

1.06

u/ml

1.76

164

1457

Erosion of teeth , including avohilmo

310

2555

1.22

2.89

1.1

0.66

1.27

u/ml

1.95

144

1140

Infections with a predominantly sexual mode of transmission

416

3517

1.19

2.89

1.1

1.67

1.17

u/ml

0.46

179

1486

Fibroblastic disorders

132

977

1.36

2.89

1.1

0.54

1.26

u/ml

1.65

373

Mental and behavioural disorders due to cannabinoids

374

0.45

2.89

1.1

0.93

1.72

u/ml

0.60

169

Implicit bacterial Sepsis

140

1648

0.75

2.88

1.0

1.1

1.18

0.90

u/ml

0.34

698

Diseases of arteries, arterioles and capillaries

266

2418

0.81

2.88

1.1

0.78

1.00

u/ml

0.44

105

980

Polyarthrosis

107

710

1.40

2.87

1.1

1.0

0.31

1.15

u/ml

2.72

260

Suicide or other Intentional self-harm

185

2362

0.78

2.87

1.1

1.11

1.31

u/ml

0.12

1013

Sacrococcygeal disorders, not elsewhere classified

186

1.85

2.85

1.1

0.27

1.97

u/ml

1.62

Other mycoses, not elsewhere classified/unspecified

2.38

2.84

1.0

1.1

1.59

0.69

u/ml

—

Colonic or urogenital fistula

221

1760

1.26

2.83

1.1

0.65

1.17

u/ml

1.33

744

Implicit Sepsis

579

4864

0.87

2.83

1.1

0.80

1.06

u/ml

0.93

248

2094

Fracture of femur

779

0.64

2.82

1.0

1.1

0.34

1.09

u/ml

2.42

345

Other and unspecified disorders of vitreous body

224

1761

1.26

2.82

1.0

1.1

0.72

0.87

u/ml

0.25

649

Disorders of refraction and accommodation

349

2906

1.20

2.82

1.1

0.81

1.24

u/ml

0.82

159

1411

malignant neoplasm of male genital organs

630

0.67

2.82

1.0

1.1

0.55

1.09

u/ml

0.57

245

Benign neoplasm of middle ear and respiratory system

314

1.63

2.82

1.1

0.39

1.21

u/ml

1.22

139

Oligomenorrhoea

315

1.64

2.81

1.0

1.1

0.41

1.10

u/ml

0.89

134

Thyroiditis, ILD-related definition

131

975

1.35

2.81

1.1

0.49

0.94

u/ml

1.18

414

Rheumatism, unspecified

695

1.42

2.80

1.1

1.0

0.74

1.03

u/ml

0.37

269

Atypical facial pain

292

1.66

2.79

1.0

1.1

0.73

1.42

u/ml

0.60

122

Benign neoplasm: Ascending colon

417

1.54

2.78

1.1

0.88

1.10

u/ml

0.15

167

Use of disulfiram, acamprosate or naltrexone

618

0.58

2.78

1.1

0.33

1.62

u/ml

2.06

248

Coronary artery bypass grafting

445

0.57

2.78

1.0

1.07

1.26

u/ml

0.10

183

ILD, hospital admissions 3, with pneumonia sepsis

209

1.78

2.78

1.1

0.46

1.83

u/ml

0.85

Other otitis externa (chronic)

426

1.54

2.78

1.0

1.1

1.19

1.60

u/ml

0.21

200

Certain disorders involving the immune mechanism

168

1298

1.30

2.76

1.1

1.38

1.13

u/ml

0.10

566

Other acute skin changes due to ultraviolet radiation

131

2.00

2.76

1.1

1.0

0.19

1.79

u/ml

0.85

Condition for Implicit Sepsis (Organ dysfunction codes)

738

5747

0.88

2.76

1.1

0.90

1.09

u/ml

0.43

319

2499

Nontoxic goitre/thyroid nodule

187

1465

1.28

2.75

1.1

0.91

0.93

u/ml

0.02

567

Type 1 diabetes, wide definition, subgroup 1

175

2233

0.78

2.75

1.0

1.1

0.59

1.13

u/ml

1.62

1080

Urticaria due to cold and heat

2.57

2.74

1.1

0.67

0.61

u/ml

—

Other specified/unspecified soft tissue disorders

181

1.84

2.74

1.1

1.0

0.22

1.23

u/ml

1.63

Disorders of parathyroid gland

107

764

1.39

2.73

1.1

0.50

1.18

u/ml

1.33

313

Contraceptive management

516

3122

1.16

2.73

1.1

1.02

1.12

u/ml

0.13

213

1286

Haemangioma and lymphangioma, any site

633

1.43

2.72

1.1

0.72

1.24

u/ml

0.47

292

Short Achilles tendon (acquired)

132

1.99

2.72

1.0

1.1

0.41

0.99

u/ml

0.82

Noninfectious colitis NAS

137

1032

1.33

2.71

1.1

0.92

1.23

u/ml

0.40

467

Alzheimer disease

349

0.52

2.71

1.0

0.40

1.09

u/ml

—

140

Insulin, fast-acting (human)

1332

0.72

2.71

1.0

1.1

0.41

1.36

u/ml

3.44

598

Type 1 diabetes

202

2529

0.79

2.71

1.0

1.1

0.81

1.22

u/ml

0.76

1229

Systemic connective tissue disorders

257

2093

1.23

2.71

1.1

0.39

1.12

u/ml

3.61

109

853

Budesonide

133

998

1.34

2.70

1.1

2.35

1.11

u/ml

0.36

397

Inflammation of lacrimal passages (acute and unspecified)

2.31

2.69

1.2

1.1

0.40

1.98

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

148

1128

1.32

2.69

1.1

0.51

1.10

u/ml

1.95

521

Other and unspecified follicular disorders

257

1.69

2.69

1.1

0.13

1.83

u/ml

1.79

110

Other immunodeficiencies

2.27

2.68

1.1

0.67

0.80

u/ml

0.08

Deep bite

196

1360

1.27

2.67

1.1

1.31

1.27

u/ml

0.02

110

764

Acute alcohol intoxication

138

1811

0.76

2.67

1.1

1.70

1.16

u/ml

0.30

780

Superficial injury of wrist and hand

255

2081

1.23

2.66

1.1

0.63

1.40

u/ml

2.95

120

963

Other and unspecified local infections of skin and subcutaneous tissue

636

1.42

2.65

1.1

0.80

0.99

u/ml

0.19

280

Exclusions for E4_PCOS_CONSORTIUM

737

5202

0.89

2.65

1.1

1.30

1.08

u/ml

0.40

289

2264

Sulfonylureas

655

0.64

2.65

1.0

1.1

0.49

0.86

u/ml

0.47

273

Delirium, not induced by alcohol and other psychoactive substances

293

0.41

2.64

1.1

0.29

1.86

u/ml

—

112

Other noninflammatory disorders of vulva and perineum

679

1.41

2.63

1.0

1.1

0.78

1.00

u/ml

0.21

280

Fracture at wrist and hand level

355

2986

1.19

2.63

1.1

1.18

1.28

u/ml

0.09

176

1353

Pre-eclampsia or poor fetal growth

287

3445

0.83

2.63

1.1

1.36

1.10

u/ml

0.12

107

1375

Injury of muscle and tendon at lower leg level

122

908

1.35

2.63

1.1

0.44

0.94

u/ml

1.65

388

Cerebrovascular diseases (FINNGEN)

204

1807

0.80

2.63

1.1

0.71

1.09

u/ml

0.66

734

L04AA Selective immunosuppressants

139

1817

0.76

2.63

1.0

1.1

0.23

1.29

u/ml

7.24

815

Persons encountering health services in circumstances related to reproduction

742

4431

1.13

2.63

1.1

1.27

1.17

u/ml

0.13

333

2041

Meniscus derangement

457

2638

1.17

2.62

1.1

0.91

1.15

u/ml

0.34

180

1020

L02BG Aromatase inhibitors

108

1462

0.74

2.62

1.0

1.1

1.76

0.91

u/ml

0.32

546

Benign neoplasm: Small intestine

113

2.05

2.62

1.2

1.1

0.39

1.98

u/ml

0.80

Other specified/unspecified bacterial intestinal infections

321

1.60

2.61

1.1

0.43

1.15

u/ml

1.02

140

Other and unspecified trigeminal disorders

2.33

2.60

1.0

0.13

2.93

u/ml

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

145

1095

1.32

2.58

1.2

1.1

1.22

1.20

u/ml

0.02

612

Acute alcohol intoxication, ICD10

121

1608

0.75

2.58

1.1

1.86

1.18

u/ml

0.35

704

Autonomic disorders

114

2.04

2.58

1.0

1.1

0.59

1.64

u/ml

0.45

Stomatitis and related lesions

206

1649

1.25

2.57

1.1

1.76

1.17

u/ml

0.40

740

Hyperparathyroidism

615

1.42

2.57

1.1

1.0

0.53

1.36

u/ml

1.32

247

Other viral hepatitis

578

0.58

2.57

1.2

1.1

0.37

1.03

u/ml

1.43

240

Acute otitis externa, noninfective

2.39

2.57

1.1

1.0

9.82

0.74

u/ml

—

Alcoholic liver disease

372

0.48

2.57

1.1

0.32

1.16

u/ml

—

152

Other disorders of bone

205

1641

1.25

2.56

1.1

0.73

1.37

u/ml

1.71

706

Arthropod-borne viral fevers and viral haemorrhagic fevers

161

1252

1.29

2.54

1.1

0.49

1.24

u/ml

2.45

576

Implicit viral Sepsis

218

1758

1.24

2.53

1.1

0.99

1.06

u/ml

0.08

103

789

Gingivitis and periodontal diseases

1084

5063

1.11

2.53

1.1

1.10

1.15

u/ml

0.10

491

2154

Secondary uncertain malignant neoplasm

475

0.55

2.53

1.1

0.47

1.30

u/ml

—

204

Pericarditis

143

1.90

2.52

1.1

0.83

0.97

u/ml

0.11

Disorders of eyelid in diseases classified elsewhere

172

1.82

2.51

1.1

7.20

1.01

u/ml

0.80

Persons encountering health services in other circumstances

427

3651

1.17

2.51

1.1

1.55

1.15

u/ml

0.37

177

1605

Kidney transplant status

381

0.49

2.51

1.2

1.1

0.09

1.62

u/ml

—

203

Other maternal disorders predominantly related to pregnancy

700

3888

1.13

2.51

1.1

0.96

1.10

u/ml

0.24

262

1567

Hypothyroidism, strict autoimmune, 3 medication purchases required

851

5151

1.12

2.50

1.1

0.70

1.10

u/ml

1.71

313

2153

Other local infections of skin and subcutaneous tissue

669

1.40

2.50

1.1

0.82

0.96

u/ml

0.15

293

Ehlers-Danlos syndrome

123

2.00

2.50

1.1

1.0

0.88

0.66

u/ml

0.13

Sicca syndrome [Sjögren]

437

1.50

2.50

1.1

0.58

1.06

u/ml

0.47

179

Mixed conductive and sensorineural hearing loss

453

1.49

2.49

1.0

1.1

0.14

1.18

u/ml

2.93

196

Benign neoplasm: Duodenum

2.34

2.49

1.3

1.1

0.35

0.79

u/ml

—

Benign paroxysmal vertigo

186

1478

1.26

2.48

1.0

1.1

0.45

1.03

u/ml

2.45

587

Retained placenta and membranes, without haemorrhage

122

918

1.34

2.48

1.1

0.42

0.82

u/ml

1.05

363

Excessive earwax

410

3431

1.17

2.47

1.1

0.82

1.19

u/ml

1.09

176

1528

Idiopathic pulmonary fibrosis

151

1.86

2.47

1.0

1.1

0.74

0.80

u/ml

0.06

Synovial cyst of popliteal space [Baker]

271

1.63

2.46

1.0

0.34

1.70

u/ml

1.61

109

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

699

5034

0.89

2.46

1.1

1.12

1.05

u/ml

0.08

273

2013

Metabolic disorders

748

5114

0.89

2.45

1.1

1.11

u/ml

0.01

324

2191

Other sleep disorders

705

1.38

2.45

1.1

1.32

1.17

u/ml

0.08

296

Cholecystectomy

557

4213

1.14

2.43

1.1

0.54

0.97

u/ml

2.56

217

1644

Primary_lymphoid and hematopoietic malignant neoplasms

1040

0.70

2.43

1.1

0.73

1.07

u/ml

0.35

472

Deforming dorsopathies

254

2095

1.22

2.41

1.1

0.55

1.27

u/ml

3.09

113

919

Other infective otitis externa

352

1.55

2.41

1.0

1.1

2.00

1.32

u/ml

0.18

154

Non-selective monoamine reuptake inhibitors

253

2009

1.22

2.41

1.1

0.45

0.91

u/ml

2.54

124

747

Antihypertensive medication - note that there are other indications

1006

4827

1.11

2.41

1.1

1.00

1.25

u/ml

0.64

434

2248

Pulmonary embolism

154

1200

1.29

2.41

1.0

1.1

0.99

1.16

u/ml

0.19

478

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.38

2.40

1.1

1.0

0.22

1.14

u/ml

—

Impetigo

533

1.44

2.40

1.2

1.1

1.74

1.03

u/ml

0.33

283

Malignant neoplasm of brain, including Hilmo

280

0.43

2.40

1.3

1.1

1.68

1.60

u/ml

—

135

Malignant neoplasm of respiratory system and intrathoracic organs

453

0.59

2.39

1.1

0.49

0.62

u/ml

0.21

177

Spinal osteochondrosis

2.46

2.39

1.1

0.42

3.45

u/ml

—

Major anomalies of jaw size

213

1.71

2.38

1.0

1.1

0.65

1.23

u/ml

0.36

102

Viral hepatitis

627

0.62

2.38

1.2

1.1

0.35

1.14

u/ml

1.65

263

Pulmonary heart disease

154

1202

1.28

2.38

1.0

1.1

0.99

1.15

u/ml

0.19

480

Atrial septal defect, secundum type

408

0.53

2.36

1.0

1.2

1.53

1.11

u/ml

0.12

276

Other and specified injuries of hip and thigh

2.17

2.36

1.1

0.16

1.82

u/ml

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

505

4399

1.15

2.35

1.1

1.33

1.19

u/ml

0.15

246

1976

Medicines for HER+ breast cancer

168

2001

0.79

2.34

1.1

1.29

0.89

u/ml

0.21

724

Other protozoal intestinal diseases

162

1.82

2.33

1.1

1.87

1.49

u/ml

0.14

Other bursopathies

610

1.40

2.33

1.0

1.1

0.62

1.33

u/ml

0.83

232

Viral infections characterized by skin and mucous membrane lesions

411

3544

1.16

2.32

1.1

2.06

1.13

u/ml

0.83

201

1650

Other inflammation of vagina/vulva

348

1.54

2.32

1.1

1.0

0.39

0.70

u/ml

0.66

146

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

162

1.81

2.32

1.0

0.48

1.80

u/ml

0.96

Benign mammary dysplasia

704

1.37

2.32

1.1

0.42

0.92

u/ml

0.98

284

Other and unspecified visual disturbances

586

1.41

2.31

1.1

0.64

1.19

u/ml

0.81

248

Superficial injury of lower leg

257

2133

1.21

2.31

1.1

1.24

u/ml

0.00

112

956

Thyroiditis, unspecified

2.15

2.31

1.0

1.1

0.22

0.93

u/ml

—

Other superficial mycoses

129

991

1.31

2.30

1.1

1.89

1.10

u/ml

0.36

440

Toxic effect of contact with venomous animals

293

1.59

2.29

1.1

0.79

1.20

u/ml

0.32

135

Complications of medical and surgical care

636

5197

1.13

2.29

1.1

0.90

1.08

u/ml

0.32

281

2131

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

238

1.65

2.28

1.0

1.1

0.44

1.31

u/ml

0.83

Drug-induced adrenocortical insufficiency

106

2.01

2.28

1.1

0.08

1.73

u/ml

—

Other puerperal infections

127

977

1.31

2.26

1.1

0.98

1.13

u/ml

0.14

408

Other viral diseases

393

3380

1.16

2.26

1.1

0.95

1.26

u/ml

0.79

187

1620

Complications associated with artificial fertilization

179

1.76

2.26

1.0

1.1

1.14

0.96

u/ml

0.06

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

263

1.62

2.26

1.0

1.1

0.30

1.63

u/ml

1.63

133

Anogenital herpesviral [herpes simplex] infection

156

1232

1.27

2.25

1.1

0.79

1.22

u/ml

0.81

546

Carpal tunnel syndrome

497

3837

1.14

2.25

1.1

0.36

1.02

u/ml

6.74

168

1512

Premenstrual syndrome

100

2.04

2.24

1.0

1.1

0.38

0.44

u/ml

—

Convergence insufficiency and excess

114

1.97

2.23

1.2

1.1

0.20

1.61

u/ml

0.89

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

258

2150

1.20

2.23

1.1

0.38

1.24

u/ml

5.66

936

Other prurigo

2.90

2.22

1.1

1.33

0.83

u/ml

—

Type 1 diabetes, strict (exclude DM2)

109

1427

0.76

2.22

1.1

0.67

1.33

u/ml

1.10

756

Speech and linguistic disorders, excluding more controls

156

1162

1.27

2.21

1.1

1.74

1.29

u/ml

0.30

679

Atrial septal defect

511

0.59

2.21

1.0

1.2

1.41

0.98

u/ml

0.15

333

Dipeptidyl peptidase 4 (DPP-4) inhibitors

197

1938

0.81

2.21

1.0

1.1

1.16

1.17

u/ml

0.00

759

Testicular dysfunction

210

1.68

2.21

1.1

1.67

2.31

u/ml

0.16

Certain conditions originating in the perinatal period

196

1414

1.24

2.20

1.2

1.1

0.85

1.57

u/ml

1.56

111

803

Bacterial infection, other or unspecified

264

2732

0.84

2.19

1.0

1.1

0.91

0.98

u/ml

0.14

121

1193

Reimbursement for rheumatic diseases

386

4441

0.86

2.19

1.1

0.54

1.12

u/ml

2.42

142

1898

Other specified disorders of muscle

136

1.86

2.19

1.0

1.1

1.55

1.16

u/ml

0.18

Other skin changes

122

937

1.31

2.18

1.1

2.31

0.96

u/ml

0.35

405

Dislocation, sprain and strain of joint and ligaments of hip

129

1.88

2.17

1.2

1.1

0.73

2.95

u/ml

0.91

Impacted maxillary canine

145

1.86

2.17

1.0

1.1

1.58

1.32

u/ml

0.07

Abnormal findings on diagnostic imaging of other body structures

670

1.36

2.16

1.1

0.19

1.32

u/ml

2.86

276

Benign neoplasm: Stomach

337

1.52

2.16

1.1

0.76

1.33

u/ml

0.58

135

Polyarthritis, unspecified

181

1.73

2.16

1.1

0.38

1.01

u/ml

1.40

Other predominantly sexually transmitted diseases, not elsewhere classified

233

1934

1.21

2.14

1.1

2.38

1.29

u/ml

0.63

100

830

Concussion

585

4240

1.13

2.14

1.1

1.13

1.32

u/ml

0.36

279

1937

Other specified/unspecified hearing loss

314

1.54

2.13

1.1

0.38

1.76

u/ml

1.68

141

Other disorders of adrenal gland

347

1.51

2.13

1.1

0.63

1.23

u/ml

0.53

178

Any mental disorder

1196

5498

1.09

2.13

1.1

1.36

1.05

u/ml

0.58

543

2368

Diseases of salivary glands

281

2372

1.19

2.13

1.1

0.57

1.21

u/ml

2.50

120

1000

Malignant neoplasm of breast, ER-negative, including Hilmo

1086

0.73

2.13

1.1

1.32

0.80

u/ml

0.38

408

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

323

1.53

2.12

1.0

1.1

0.78

1.42

u/ml

—

135

Use of pramipexole

125

967

1.30

2.12

1.1

1.06

1.11

u/ml

0.03

390

Localized swelling, mass and lump of skin and subcutaneous tissue

263

2208

1.19

2.12

1.1

0.97

1.04

u/ml

0.11

129

941

Unspecified event, undetermined intent

175

1.74

2.11

1.3

1.1

1.12

1.57

u/ml

0.23

Viral pneumonia (unknown virus, not influenza)

446

1.44

2.11

1.1

1.62

1.63

u/ml

0.01

189

Emotional disorders starting during childhood or adolecense, excluding more controls

110

819

1.33

2.11

1.1

1.52

1.41

u/ml

0.08

476

Colorectal adenocarcinoma

546

0.62

2.10

1.0

1.18

0.80

u/ml

0.33

213

Delivery

334

2061

0.85

2.10

1.1

1.74

1.09

u/ml

0.55

137

898

Insulin, fast-acting or short human

240

2868

0.83

2.10

1.1

0.89

1.18

u/ml

0.46

1344

Palmar fascial fibromatosis [Dupuytren]

388

1.47

2.10

1.0

1.1

0.28

1.03

u/ml

2.50

150

Other factor of the environment

2.30

2.09

1.0

1.94

0.75

u/ml

—

Oxycodone

141

1612

0.79

2.09

1.0

0.87

1.14

u/ml

0.41

633

Dementia in Alzheimer disease

176

0.43

2.09

1.0

—

1.52

—

Muscle strain

206

1.67

2.09

1.1

0.55

0.88

u/ml

0.42

Special screening examination for neoplasms

198

1.68

2.08

1.1

1.0

0.17

1.35

u/ml

0.91

Sequelae of cerebrovascular disease

1031

0.74

2.08

1.1

0.58

0.86

u/ml

0.43

407

Other diseases of anus and rectum

198

1617

1.22

2.08

1.1

0.67

1.02

u/ml

0.93

700

Familial hypercholesterolemia

431

1.44

2.06

1.0

1.1

0.93

1.26

u/ml

0.16

201

Insulin, fast-acting

240

2861

0.84

2.05

1.0

1.1

0.89

1.18

u/ml

0.46

1340

LeFortI or BSSO operation

375

1.48

2.05

1.0

1.1

0.29

1.57

u/ml

1.61

151

All-cause Heart Failure

166

1454

0.80

2.05

1.0

1.1

0.87

1.16

u/ml

0.38

616

Patellar tendinitis

125

1.87

2.04

1.1

1.90

1.03

u/ml

—

Chronic kidney disease

1088

0.74

2.04

1.0

1.1

1.22

1.23

u/ml

0.00

495

Perforation of tympanic membrane

669

1.35

2.04

1.1

1.23

1.43

u/ml

0.07

298

Poor fetal growth

126

1604

0.78

2.04

1.1

0.38

1.01

u/ml

3.15

672

Lichen ruber planus, wide definition including periferal and oral lichen planus

141

1114

1.27

2.04

1.0

1.1

1.22

1.08

u/ml

0.09

432

Neuralgia and neuritis, unspecified

262

1.58

2.04

1.1

3.09

1.12

u/ml

0.37

106

Heart failure, strict

170

1483

0.81

2.04

1.0

1.1

0.86

1.15

u/ml

0.38

630

Nonorganic sleeping disorders

240

2008

1.20

2.04

1.1

1.12

1.41

u/ml

0.43

110

875

Other bacterial intestinal infections

172

1391

1.24

2.04

1.1

0.44

1.23

u/ml

2.94

601

Type 1 diabetes, definitions combined

111

1430

0.77

2.03

1.1

1.92

1.24

u/ml

0.22

756

Type 1 diabetes, strict definition

1294

0.76

2.03

1.1

2.08

1.17

u/ml

0.28

705

Chronic apical periodontitis

1035

6427

0.92

2.03

1.1

1.13

1.09

u/ml

0.06

447

2681

Implicit bacterial Sepsis

171

1820

0.81

2.03

1.0

1.1

1.06

0.92

u/ml

0.17

781

Type1 diabetes, definitions combined, early onset

1132

0.74

2.02

1.1

2.25

1.25

u/ml

0.28

630

Pain associated with micturition

722

1.34

2.02

1.1

1.00

1.37

u/ml

0.33

328

Acne

184

1501

1.23

2.02

1.1

0.98

1.43

u/ml

0.71

100

732

Contact with and exposure to communicable diseases

383

4374

0.87

2.02

1.1

0.91

1.20

u/ml

0.64

175

2040

Ulcer of vagina/vulva

193

1.68

2.02

1.1

0.66

0.64

u/ml

0.03

Bleeding

525

4208

0.89

2.01

1.1

1.02

1.12

u/ml

0.19

233

1792

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

138

1735

0.79

2.01

1.1

0.58

1.43

u/ml

2.24

755

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

418

3617

1.15

2.00

1.1

1.02

1.21

u/ml

0.29

209

1678

Mental and behavioural disorders due to sedatives or hypnotics

562

0.64

1.99

1.0

1.1

0.64

1.18

u/ml

0.45

245

Single delivery by caesarean section

230

1580

0.83

1.98

1.1

0.86

1.04

u/ml

0.30

699

Hyperlipidaemia, other/unspecified

183

1375

1.23

1.97

1.1

0.63

1.11

u/ml

0.75

565

Bacterial infection, other or unspecified

315

3097

0.86

1.96

1.0

1.1

0.89

1.02

u/ml

0.30

142

1348

Type 1 diabetes, strict definition, subgroup 1

1231

0.76

1.96

1.1

0.40

1.21

u/ml

3.52

665

Procedures for purposes other than remedying health state

127

1.83

1.95

1.0

1.1

0.23

1.65

u/ml

0.78

Diseases of tongue

273

1.55

1.95

1.1

2.06

1.01

u/ml

0.31

101

Malignant neoplasm of breast, HER-negative

932

0.72

1.94

1.1

1.33

0.81

u/ml

0.29

349

Other spirochaetal diseases

233

1953

1.20

1.94

1.1

0.76

1.16

u/ml

1.01

104

816

Struck by thrown, projected or falling objec

388

1.46

1.93

1.1

0.82

1.15

u/ml

0.22

170

Other retinal artery occlusion

2.46

1.93

1.0

1.1

0.07

0.96

u/ml

—

Severe mental retardation

0.00

1.93

0.0

1.2

—

1.54

—

Other spirochaetal diseases

238

2001

1.19

1.92

1.1

0.76

1.14

u/ml

1.00

106

835

Presence of cardiac and vascular implants and grafts

127

1196

0.79

1.92

1.0

1.1

0.67

1.16

u/ml

0.85

503

Demyelinating diseases of the central nervous system

783

0.70

1.92

1.0

1.1

0.13

1.14

u/ml

3.52

335

Nausea and vomiting

244

2014

1.19

1.92

1.1

0.81

1.32

u/ml

1.19

115

987

Family history of malignant neoplasm

946

0.73

1.92

1.1

0.15

1.34

u/ml

4.67

379

Melanocytic naevi

284

2426

1.17

1.91

1.1

0.83

1.23

u/ml

0.94

116

1053

Kyphosis

0.00

1.89

0.0

1.1

—

1.36

—

Basal cell carcinoma, including avohilmo

156

1329

0.81

1.89

1.1

0.63

0.90

u/ml

0.70

501

Abnormal findings on diagnostic imaging of central nervous system

316

1.50

1.89

1.0

1.1

0.47

1.46

u/ml

1.13

142

Other retinal disorders

300

2720

0.86

1.89

1.0

1.1

0.83

1.09

u/ml

0.55

124

1135

Heart failure,strict

166

1438

0.81

1.88

1.0

1.1

0.82

1.15

u/ml

0.44

613

Adhesive capsulitis of shoulder

101

774

1.31

1.88

1.1

1.0

0.96

1.11

u/ml

0.12

287

Persistent mood disorders

171

1397

1.23

1.87

1.1

0.52

1.26

u/ml

2.71

570

Iron deficiency

293

1.52

1.87

1.0

1.1

0.71

0.94

u/ml

0.18

135

Use of biperiden

265

0.49

1.87

1.0

1.1

2.01

1.29

u/ml

—

113

MS-disease / Multiple Sclerosis

672

0.68

1.86

1.0

1.1

0.18

1.19

u/ml

—

290

Pulmonary heart disease, diseases of pulmonary circulation

164

1334

1.23

1.86

1.0

1.1

0.98

1.21

u/ml

0.28

552

Benign neoplasms

1156

5887

1.08

1.85

1.1

0.86

1.23

u/ml

1.74

480

2589

Other disorders of the musculoskeletal system and connective tissue

715

1.32

1.85

1.1

0.89

1.17

u/ml

0.28

284

Retinal breaks without detachment

689

1.33

1.85

1.1

0.53

1.21

u/ml

1.42

282

Abrasion of teeth

283

2424

1.17

1.85

1.0

1.1

0.83

1.10

u/ml

0.55

123

964

Chondropathies

157

1274

1.24

1.85

1.1

0.75

1.14

u/ml

0.83

546

Tic disorders

207

1.63

1.85

1.1

1.2

0.72

1.29

u/ml

0.43

129

Tic and related disorders

215

1.62

1.84

1.1

1.2

0.69

1.75

u/ml

0.89

138

Benign neoplasm of mouth and pharynx

535

1.37

1.84

1.0

1.1

1.32

1.34

u/ml

0.01

221

Diabetic nephropathy, excluding more controls

504

0.67

1.83

1.0

1.1

2.55

0.59

u/ml

0.73

201

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

276

0.51

1.82

1.0

1.1

1.79

0.82

u/ml

—

108

Disorders of orbit

254

1.55

1.82

1.0

1.1

0.68

1.97

u/ml

1.05

112

Hypersomnia

2.09

1.82

1.2

1.1

0.28

0.82

u/ml

—

Otitis externa, unspecified

117

920

1.28

1.81

1.1

2.44

1.22

u/ml

0.40

429

Rash and other nonspecific skin eruption

614

1.34

1.81

1.1

0.67

1.25

u/ml

0.70

288

Congenital absence, atresia and stenosis of large intestine

0.00

1.81

0.0

1.3

—

0.50

—

Female genital prolapse

219

1032

1.20

1.81

1.1

0.51

0.89

u/ml

1.21

392

Other and/or unspecified nontoxic goitre

377

1.44

1.80

1.0

1.1

1.09

1.08

u/ml

0.01

144

Disorder of lipoprotein metabolism, unspecified

385

1.43

1.80

1.0

1.1

0.54

0.85

u/ml

0.45

172

Hallux rigidus

520

1.37

1.80

1.1

0.47

1.20

u/ml

1.50

209

Lifestyle-related condition

2.20

1.79

1.0

1.1

1.94

0.89

u/ml

—

Ischemic heart diseases

540

3623

0.89

1.79

1.1

0.97

1.07

u/ml

0.16

207

1553

Pedestrian injured in other and unspecified transport accidents

2.37

1.79

1.2

1.1

0.05

3.28

u/ml

—

Other protozoal intestinal diseases

102

1.89

1.78

1.1

1.52

0.67

u/ml

0.59

Adrenocortical insufficiency

232

1.57

1.77

1.1

0.76

1.59

u/ml

0.46

117

Coronary atherosclerosis

268

1982

0.85

1.77

1.0

1.17

1.16

u/ml

0.01

776

Other diseases of liver

142

1146

1.24

1.77

1.1

0.89

1.45

u/ml

0.81

467

Injury of muscle and tendon at ankle and foot level

162

1.69

1.76

1.0

1.1

0.92

2.02

u/ml

0.53

Valvular heart disease excluding rheumatic fever

223

1907

0.84

1.76

1.0

1.1

0.99

1.09

u/ml

0.13

865

Varicose veins

303

2644

0.86

1.75

1.1

1.42

0.94

u/ml

0.35

998

Lichen planus, including avohilmo

116

915

1.27

1.75

1.0

1.1

1.47

1.12

u/ml

0.21

358

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

162

1.68

1.75

1.0

1.1

0.91

1.50

u/ml

0.30

Other diseases of peritoneum

201

1.60

1.74

1.0

1.1

0.35

1.36

u/ml

—

Other demyelinating diseases of the central nervous system

334

0.56

1.73

1.1

0.04

1.38

u/ml

—

139

Anosmia

107

1.83

1.72

1.1

0.27

0.45

u/ml

—

Malignant neoplasm of bronchus and lung, including Hilmo

466

0.66

1.72

1.1

0.44

0.64

u/ml

0.40

185

Benign neoplasm of other and unspecified female genital organs

210

1.58

1.71

1.1

1.26

1.29

u/ml

0.01

Malignant neoplasm of bronchus and lung

361

0.62

1.71

1.0

0.52

0.72

u/ml

0.27

143

Generalized epilepsy, strict definition

243

1.54

1.70

1.1

1.2

0.28

1.58

u/ml

1.52

131

Melanocytic naevi of other and unspecified parts of face

399

1.41

1.70

1.2

1.1

0.89

1.45

u/ml

0.38

169

Chronic viral hepatitis

492

0.65

1.70

1.2

1.1

0.35

1.14

u/ml

1.52

202

Drug-induced cataract

111

1.82

1.70

1.3

1.1

1.55

1.69

u/ml

—

malignant neoplasm of female genital organs

632

0.69

1.69

1.1

0.71

0.84

u/ml

0.15

246

Poisoning by drugs, medicaments and biological substances

209

2471

0.84

1.69

1.1

0.77

1.30

u/ml

1.31

1088

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

442

3929

1.13

1.68

1.1

0.96

1.04

u/ml

0.10

194

1579

Lichen planus

527

1.35

1.68

1.0

1.1

1.91

1.33

u/ml

0.26

213

Other disorders of cornea

493

1.37

1.68

1.0

1.1

6.22

1.40

u/ml

0.76

198

Residual foreign body in soft tissue

350

1.44

1.67

1.1

0.31

1.32

u/ml

1.62

156

Other functional intestinal disorders

388

3178

1.13

1.67

1.1

1.35

1.08

u/ml

0.19

175

1470

Other noninflammatory disorders of vagina

502

1.36

1.67

1.0

1.1

0.30

1.04

u/ml

1.67

199

Viral pneumonia (known virus, not influenza)

134

1.73

1.67

1.2

1.1

0.57

2.20

u/ml

0.96

Calculus of kidney and ureter

187

1562

1.20

1.67

1.1

1.91

1.08

u/ml

0.41

659

Covid-19 confirmed case

279

2410

1.16

1.66

1.1

0.67

1.25

u/ml

1.92

124

1061

Ulcerative colitis (strict definition, all Crohn cases excluded)

101

1283

0.78

1.66

1.1

0.49

1.44

u/ml

3.03

568

Other disorders starting during childhood or adolecense, excluding more controls

116

885

1.27

1.66

1.1

2.17

1.35

u/ml

0.39

536

Chronic periodontitis, complicated

274

3139

0.86

1.66

1.1

1.75

1.04

u/ml

0.58

128

1194

Horner syndrome

2.47

1.65

1.1

1.0

0.10

4.47

u/ml

—

Panniculitis affecting regions of neck and back

189

1.60

1.63

1.2

1.1

0.70

1.76

u/ml

0.75

Exposure to other and unspecified man-made environmental factors

1.86

1.63

1.1

0.60

2.10

u/ml

0.57

Postpartum hemorraghe, parous women as controls

338

2523

1.14

1.63

1.1

1.44

1.05

u/ml

0.24

130

984

Endometriosis of ovary

157

1262

1.22

1.63

1.0

1.1

0.61

0.95

u/ml

0.70

505

Biomechanical lesions, not elsewhere classified

213

1.56

1.62

1.2

1.1

1.37

2.21

u/ml

0.32

Leiomyoma of uterus

469

2973

0.89

1.62

1.1

0.82

0.85

u/ml

0.05

160

1138

Lyme disease

225

1917

1.18

1.62

1.1

0.77

1.14

u/ml

0.91

102

792

Spirochaetal infections, other/unspecified

227

1936

1.18

1.61

1.1

0.77

1.17

u/ml

1.02

104

802

Unspecified fall

446

3925

1.12

1.61

1.1

1.03

1.18

u/ml

0.33

234

1836

Contusion of toe(s) with damage to nail

1.98

1.61

1.1

0.39

0.60

u/ml

—

Single ventricle heart

0.00

1.61

0.0

1.3

—

2.12

—

Other and unspecified erythematous conditions

151

1.67

1.60

1.1

1.27

2.50

u/ml

0.44

Coeliac disease

123

990

1.25

1.60

1.1

1.55

1.24

u/ml

0.18

468

Adenocarcinoma and papilloma adenocarcinoma of rectum

263

0.53

1.60

1.0

1.79

0.71

u/ml

—

101

Campylobacter enteritis

136

1.71

1.59

1.1

0.72

0.74

u/ml

—

Cardiovascular diseases

1023

5095

1.08

1.59

1.1

1.28

1.17

u/ml

0.17

450

2370

Major coronary heart disease event

517

3466

0.90

1.59

1.1

0.94

1.06

u/ml

0.22

190

1487

Other shoulder lesions

637

1.31

1.59

1.1

0.23

1.13

u/ml

2.62

252

Major coronary heart disease event excluding revascularizations

223

1743

0.85

1.59

1.1

1.0

1.19

1.04

u/ml

0.11

703

Benign neoplasm: Spinal meninges

2.72

1.58

1.0

1.1

—

1.43

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

379

1.40

1.58

1.1

0.81

1.43

u/ml

0.53

157

Hordeolum and other deep inflammation of eyelid

456

1.37

1.58

1.1

0.29

1.40

u/ml

1.87

219

Benign neoplasm: Scapula and long bones of upper limb

2.24

1.58

1.1

1.51

4.88

u/ml

—

Burn and corrosion confined to eye and adnexa

152

1.66

1.58

1.1

0.87

0.91

u/ml

0.02

Other malignant neoplasms of skin (=non-melanoma skin cancer)

158

1308

0.83

1.57

1.1

0.81

0.89

u/ml

0.10

497

Atrial fibrillation and flutter

193

1484

0.84

1.57

1.0

1.1

0.74

1.19

u/ml

1.01

587

Congenital malformations of trachea and bronchus

2.01

1.56

1.2

0.82

1.47

u/ml

—

Cholecystitis

508

1.34

1.56

1.1

0.75

1.10

u/ml

0.29

204

Other follicular disorders

596

1.32

1.55

1.1

1.49

1.28

u/ml

0.08

250

Glucosamine medication

179

1195

1.20

1.55

1.1

1.0

0.45

0.90

u/ml

0.99

447

Background retinopathy and retinal vascular changes

1.99

1.54

1.0

1.1

2.06

0.95

u/ml

—

Dialysis

246

0.52

1.54

1.3

1.1

0.12

1.64

u/ml

—

133

Mucosal proctocolitis

1124

0.78

1.54

1.1

0.48

1.31

u/ml

2.27

487

Scleritis and episcleritis

407

1.38

1.54

1.1

0.76

1.51

u/ml

0.56

166

Drug-induced neutropenia

310

0.58

1.54

1.1

1.18

1.77

u/ml

—

126

Congenital ichthyosis

2.70

1.54

1.1

1.0

3.27

0.96

u/ml

—

Aplastic and other anaemias

176

1951

0.84

1.54

1.1

0.60

1.15

u/ml

1.72

825

Post-traumatic stress disorder

127

1033

1.24

1.53

1.1

0.77

1.23

u/ml

0.73

463

132

985

1.23

1.53

1.0

1.98

1.08

u/ml

0.27

390

Other erythematous conditions

161

1.63

1.53

1.1

1.27

2.46

u/ml

0.44

Hypertensive diseases

707

4358

0.91

1.53

1.1

1.01

1.13

u/ml

0.20

293

1843

Haemorrhage in early pregnancy

321

2747

1.14

1.53

1.1

0.71

1.14

u/ml

1.27

113

1112

Burns and corrosions confined to eye and internal organs

177

1.60

1.53

1.1

0.75

1.50

u/ml

0.45

Helminthiases

1.85

1.53

1.1

0.67

0.58

u/ml

—

Agranulocytosis

633

0.71

1.52

1.2

1.1

0.85

1.29

u/ml

0.40

285

Complications of procedures, not elsewhere classified

741

5631

1.09

1.52

1.1

0.95

1.07

u/ml

0.20

308

2299

Nontoxic multinodular goitre

109

871

1.25

1.52

1.1

0.86

0.96

u/ml

0.10

327

Other specified and unspecified disorders of eye and adnexa

185

1.58

1.52

1.1

0.25

1.10

u/ml

1.47

Dental caries, including avohilmo

706

3300

1.10

1.52

1.1

1.20

1.00

u/ml

0.28

313

1390

Disturbances of smell and taste

185

1.58

1.52

1.0

1.1

0.35

1.75

u/ml

—

Spinal instabilities

146

1.66

1.51

1.0

0.03

2.20

u/ml

—

Basal cell carcinoma

145

1216

0.82

1.51

1.1

0.67

0.91

u/ml

0.52

459

Artrosis, including avohilmo

784

3942

1.09

1.51

1.1

0.76

1.12

u/ml

1.08

307

1603

Intermittent heterotropia

779

0.74

1.51

1.1

0.74

1.25

u/ml

0.78

442

Contact with machinery

546

1.32

1.51

1.1

1.00

1.43

u/ml

0.37

234

Sequelae of external causes of morbidity and mortality

172

1443

1.19

1.50

1.0

1.1

0.48

1.12

u/ml

2.71

619

Impacted cerumen

486

1.34

1.50

1.1

0.89

1.65

u/ml

0.64

245

Other/unspecified synovitis and tenosynovitis

696

1.28

1.49

1.0

1.1

0.36

1.18

u/ml

2.10

278

Examination and encounter for administrative purposes

170

1.60

1.49

1.0

1.1

0.54

1.00

u/ml

0.59

Other disorders of prostate

2.01

1.49

1.1

1.0

0.21

0.64

u/ml

—

Bicipital tendinitis

194

1.55

1.48

1.1

0.15

1.16

u/ml

3.32

Puerperal sepsis

103

821

1.26

1.48

1.1

1.03

1.07

u/ml

0.03

322

Acute generalized exanthematous pustulosis

284

1.45

1.48

1.1

0.62

1.56

u/ml

0.92

134

Tic and related disorders

228

1.52

1.48

1.1

1.2

0.69

1.18

u/ml

0.40

148

Inflammatory disorders of breast

610

1.30

1.48

1.1

0.50

1.01

u/ml

0.96

258

Benign neoplasm: Bones of skull and face

2.26

1.47

1.0

6.29

1.19

u/ml

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

284

3240

0.87

1.47

1.1

0.90

1.25

u/ml

0.35

116

1391

Hypertension

707

4348

0.92

1.47

1.1

1.01

1.13

u/ml

0.20

293

1838

ILD medications: immunosuppressive drugs

575

4862

1.10

1.47

1.1

1.95

1.04

u/ml

1.03

246

2023

Myopia

165

1384

1.20

1.47

1.1

0.91

1.41

u/ml

0.48

615

Congenital malformations of the musculoskeletal system, not elsewhere classified

156

1.63

1.46

1.1

0.75

0.64

u/ml

0.08

Other hammer toe(s) (acquired)

538

1.31

1.45

1.1

1.79

1.11

u/ml

0.21

202

Other congenital malformations of tongue, mouth and pharynx

369

1.40

1.45

1.2

2.81

1.09

u/ml

0.29

251

Myocarditis

310

1.43

1.45

1.1

1.34

1.20

u/ml

0.08

127

Benign neoplasm: Larynx

102

1.78

1.45

1.1

0.22

1.10

u/ml

—

Chronic mastoiditis

1.89

1.45

1.0

1.1

0.47

0.79

u/ml

—

Osteopathies and chondropathies

437

3657

1.11

1.45

1.1

1.08

1.20

u/ml

0.14

199

1566

Gastric ulcer

506

1.33

1.45

1.1

0.30

1.04

u/ml

1.72

213

Umbilical hernia

201

1716

1.17

1.44

1.1

1.61

1.11

u/ml

0.43

100

716

Poisoning by medicine

191

2239

0.85

1.44

1.1

0.69

1.31

u/ml

1.65

985

Polyarteritis nodosa and related conditions

1.99

1.44

1.3

1.1

0.46

2.02

u/ml

—

Spirochaetal infections, other/unspecified

438

1.35

1.44

1.1

0.87

1.63

u/ml

0.77

197

Ptosis of eyelid

378

1.38

1.44

1.1

0.84

1.57

u/ml

0.50

160

Invasive ventilation

425

0.66

1.43

1.1

0.29

1.45

u/ml

2.20

237

Autoimmune thyroiditis

141

1.65

1.43

1.0

1.1

0.16

1.50

u/ml

—

Diagnoses used for exclusion with ILD

147

1222

1.21

1.43

1.1

1.78

1.07

u/ml

0.22

517

Unspecified kidney failure

265

0.56

1.42

1.1

1.10

2.34

u/ml

—

112

Early lumbar disc prolapse, operated

126

1034

1.22

1.41

1.1

1.03

1.29

u/ml

0.26

422

Benign intracranial hypertension

111

1.75

1.41

1.1

1.32

0.68

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

124

1047

0.82

1.41

1.1

1.0

1.06

1.25

u/ml

0.17

421

Ulcerative colitis (strict definition, require KELA)

125

1518

0.82

1.41

1.1

0.44

1.40

u/ml

4.01

675

Other diseases of pleura

213

1602

1.17

1.41

1.0

1.1

0.43

1.08

u/ml

2.67

693

Amblyopia ex anopsia

441

1.35

1.40

1.1

0.70

1.57

u/ml

1.13

254

Chronic iridocyclitis

313

0.60

1.40

1.1

0.38

1.49

u/ml

—

147

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

434

3045

0.90

1.40

1.1

1.18

1.05

u/ml

0.13

159

1228

Fever of other and unknown origin

530

4289

1.10

1.40

1.1

0.72

1.18

u/ml

1.75

252

1885

Disorders of lacrimal system and orbit in diseases classified elsewhere

134

1.66

1.40

1.0

1.1

0.46

1.74

u/ml

0.73

Other bursitis of hip

1.91

1.39

1.1

0.16

1.37

u/ml

—

Other and unspecified mononeuropathies, also in other diseases

111

1.72

1.39

1.1

1.0

0.26

2.30

u/ml

—

Congenital malformations of the respiratory system

198

1.54

1.39

1.1

1.2

0.85

0.93

u/ml

0.05

129

Alzheimer disease, excluding more controls

208

0.60

1.39

1.1

1.0

0.53

1.07

u/ml

—

Non-rheumatic valve diseases

220

1839

0.86

1.39

1.0

1.1

1.01

1.09

u/ml

0.09

819

Dermatitis herpetiformis

1.96

1.39

1.1

1.0

0.47

0.75

u/ml

—

Malignant neoplasm of prostate

512

0.76

1.39

1.0

1.1

0.57

0.95

u/ml

0.37

197

Vascular disorders of the intestines

134

1.65

1.38

1.0

0.16

1.99

u/ml

—

Crohn's disease of large intestine

433

1.35

1.38

1.1

3.98

1.21

u/ml

0.37

189

Urolithiasis

193

1649

1.17

1.38

1.1

1.88

1.11

u/ml

0.38

692

L04AC Interleukin inhibitors

492

0.69

1.38

1.1

0.23

1.28

u/ml

2.05

212

Female infertility, tubal origin

390

1.37

1.38

1.0

1.24

1.18

u/ml

0.02

155

Faecal incontinence

330

1.40

1.38

1.1

1.0

0.49

1.24

u/ml

1.00

139

Disorders of gallbladder, biliary tract and pancreas

751

5127

0.92

1.38

1.1

0.56

1.14

u/ml

4.31

293

2090

Secondary and unspecified malignant neoplasm of lymph nodes

349

0.63

1.38

1.1

0.52

1.45

u/ml

—

156

Acute lymphadenitis

555

1.31

1.38

1.1

2.86

1.32

u/ml

0.25

251

Non-Hodgkin lymphoma, all, including Hilmo

457

0.68

1.38

1.0

1.1

1.57

1.37

u/ml

—

201

Stenosis and insufficiency of lacrimal passages

459

1.33

1.37

1.1

0.77

1.34

u/ml

0.62

202

Colorectal cancer

708

0.74

1.37

1.0

1.67

1.05

u/ml

0.34

271

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

135

1622

0.83

1.37

1.1

0.61

1.38

u/ml

1.96

724

Congenital malformations of breast

207

1.52

1.37

1.1

1.18

0.79

u/ml

0.32

Nerve, nerve root and plexus disorders

989

5646

1.07

1.37

1.1

0.65

1.16

u/ml

3.89

362

2339

Right bundle-branch block

1.81

1.37

1.1

0.26

2.23

u/ml

—

Malignant neoplasm of prostate, including Hilmo

548

0.77

1.37

1.0

0.51

0.92

u/ml

0.47

210

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

399

1.36

1.37

1.1

0.73

1.53

u/ml

0.80

170

Anogenital herpesviral [herpes simplex] infection

653

1.28

1.37

1.1

1.05

0.86

u/ml

0.20

283

Malignant neoplasm of corpus uteri, including Hilmo

299

0.60

1.37

1.2

1.1

0.62

0.86

u/ml

—

120

Streptococcal septicaemia

444

0.67

1.37

1.0

1.1

1.05

1.35

u/ml

0.18

219

Congenital malformations of the musculoskeletal system, not elsewhere classified

191

1.54

1.37

1.1

0.75

0.71

u/ml

0.03

Generalized skin eruption due to drugs and medicaments

256

1.46

1.36

1.1

0.67

1.64

u/ml

0.85

123

Focal epilepsy

138

1653

0.83

1.36

1.1

0.54

1.25

u/ml

2.85

800

Syncope and collapse

334

2540

1.13

1.36

1.1

0.81

1.15

u/ml

0.87

142

1097

Intracranial injury

548

4730

1.10

1.36

1.1

1.17

1.13

u/ml

0.07

270

2120

Vitiligo

1.89

1.36

1.0

1.1

1.27

0.81

u/ml

—

Other/unspecified rheumatoid arthritis

467

0.68

1.35

1.1

0.37

1.17

u/ml

1.39

185

Biological medication for rheuma

144

1717

0.84

1.35

1.1

0.63

1.32

u/ml

1.56

756

Bilateral sagittal split ramus osteotomy operation

307

1.41

1.35

1.0

1.1

0.36

1.88

u/ml

1.45

121

Symptoms and signs involving emotional state

257

1.45

1.35

1.2

1.1

1.17

1.63

u/ml

0.20

121

Secondary malignant neoplasm of other and unspecified sites

0.00

1.34

0.0

1.1

—

1.27

—

Hernia of abdominal wall

316

2803

1.13

1.34

1.1

2.09

1.03

u/ml

0.92

142

1147

Disorders of vestibular function (Vertigo)

291

2525

1.13

1.34

1.1

0.61

0.99

u/ml

1.73

119

980

Seborrhoeic keratosis

103

832

1.24

1.34

1.1

1.23

1.20

u/ml

0.02

327

Inflammatory disease of cervix uteri

307

1.41

1.34

1.1

0.22

0.85

u/ml

1.49

118

Cysts of oral region, not elsewhere classified

341

1.39

1.34

1.0

1.1

0.36

1.70

u/ml

1.76

151

Delayed milestone in childhood

518

0.71

1.34

1.2

2.67

1.00

u/ml

0.42

389

Otorrhagia

0.00

1.34

0.0

1.2

—

0.51

—

Erythema intertrigo

1.93

1.34

1.0

1.1

0.14

0.67

u/ml

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

122

1475

0.82

1.34

1.1

0.45

1.41

u/ml

3.90

660

Disorders of vitreous body

265

2245

1.14

1.33

1.0

1.1

0.85

0.94

u/ml

0.14

113

835

Superficial injury of hip and thigh

761

1.25

1.33

1.1

0.87

1.15

u/ml

0.30

317

Calcific aortic valvular stenosis, diagnosis (helper)

608

1.28

1.33

1.0

1.1

0.70

1.31

u/ml

0.72

263

Operations 2 for CAVS

608

1.28

1.33

1.0

1.1

0.70

1.31

u/ml

0.72

263

Monoamine oxidase A inhibitors

593

1.29

1.33

1.0

1.84

1.21

u/ml

0.33

233

Other and unspecified myopathies

333

0.63

1.33

1.0

1.1

0.22

1.21

u/ml

1.83

138

Other neurotic disorders

200

1.51

1.32

1.3

1.1

0.87

1.91

u/ml

0.52

Alcohol abuse, main dg

101

1243

0.81

1.32

1.1

1.92

1.27

u/ml

0.30

545

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

581

0.72

1.32

1.1

0.87

0.94

u/ml

0.06

248

Bulimia nervosa (incl. atypical)

429

1.34

1.31

1.1

0.95

1.29

u/ml

0.23

192

Cellulitis

196

1687

1.16

1.31

1.1

1.42

1.12

u/ml

0.19

763

Tooth agenesis EXCLUDE clefts and syndromes

623

1.28

1.30

1.1

0.79

1.42

u/ml

0.81

340

Achilles tendinitis

551

1.29

1.30

1.1

3.62

1.60

u/ml

0.41

211

Hypogonadotropic hypogonadism

185

1.53

1.30

1.1

1.0

2.21

1.53

u/ml

0.15

Benign neoplasm: Skin of eyelid, including canthus

675

1.26

1.30

1.0

1.1

1.36

1.21

u/ml

0.08

265

Meralgia paraesthetica

177

1.54

1.29

1.1

0.39

2.15

u/ml

1.43

Pacemaker

838

0.78

1.29

1.0

1.1

0.66

0.96

u/ml

0.40

370

Hydronephrosis

555

0.72

1.29

1.0

1.1

0.32

1.27

u/ml

2.05

236

Congenital malformations of great arteries

438

0.68

1.29

1.0

1.2

1.48

1.05

u/ml

0.24

313

Isolated growth hormone deficiency

214

0.54

1.28

1.1

1.3

1.85

0.92

u/ml

—

163

Calcific aortic valvular stenosis, including rheumatic fever

611

1.27

1.28

1.0

1.1

0.70

1.30

u/ml

0.71

265

Other diseases caused by chlamydiae

130

1.64

1.28

1.1

1.0

0.39

0.59

u/ml

—

Amputation

256

0.58

1.28

1.0

1.1

2.79

1.38

u/ml

—

100

Nontoxic single thyroid nodule

387

1.35

1.28

1.1

1.27

1.06

u/ml

0.15

157

Crohn disease (strict definition, all UC cases excluded)

457

1.32

1.27

1.1

4.97

1.41

u/ml

0.46

191

Dental caries

212

1768

1.15

1.27

1.1

0.75

1.37

u/ml

1.58

115

763

Unspecified/other endometriosis

117

966

1.22

1.27

1.1

1.06

1.07

u/ml

0.01

410

Tongue abnormality

260

1.43

1.27

1.1

0.59

1.26

u/ml

0.67

108

Care involving dialysis

389

0.67

1.27

1.2

1.1

0.51

1.60

u/ml

1.06

181

Other superficial mycoses

146

1.59

1.27

1.1

0.36

1.68

u/ml

—

Tobacco use

345

1.37

1.27

1.0

1.1

0.67

1.69

u/ml

1.01

130

Other disorders of Eustachian tube

162

1.56

1.26

1.1

0.63

2.69

u/ml

1.05

Zoster [herpes zoster]

322

2827

1.12

1.26

1.0

1.1

1.78

1.02

u/ml

0.57

145

1143

Pilonidal cyst

914

0.78

1.26

1.1

0.61

1.15

u/ml

1.27

384

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

184

1453

0.86

1.26

1.1

0.91

0.85

u/ml

0.08

551

Convergent concomitant strabismus

620

0.74

1.26

1.0

1.1

3.53

1.28

u/ml

0.33

307

Extracorporeal dialysis

279

0.61

1.25

1.2

1.1

0.71

1.42

u/ml

—

127

Carcinoma in situ of other and unspecified digestive organs

1.83

1.25

1.1

1.0

0.41

2.45

u/ml

—

Other congenital malformations of the digestive system

666

1.26

1.25

1.1

1.2

2.39

1.28

u/ml

0.25

413

Dizziness and giddiness

624

4557

1.09

1.24

1.1

0.69

1.09

u/ml

2.25

266

1888

Tumor necrosis factor alpha inhibitors

132

1571

0.84

1.24

1.1

0.70

1.11

u/ml

0.71

692

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

220

1.47

1.24

1.1

0.38

0.80

u/ml

0.57

Disorders of vitreous body and globe

272

2309

1.13

1.24

1.0

1.1

0.85

1.03

u/ml

0.31

115

866

Emotional disorders and disorders of social functioning with onset specific to childhood

121

990

1.21

1.24

1.1

1.37

1.31

u/ml

0.05

555

Benign neoplasm: Tongue

100

1.71

1.24

1.0

1.1

0.46

2.52

u/ml

—

Need for other prophylactic measures

407

1.33

1.24

1.1

0.81

1.71

u/ml

0.69

216

Alopecia areata

204

1.48

1.23

1.0

1.1

0.75

1.33

u/ml

0.41

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

299

2662

1.13

1.23

1.0

1.1

1.12

1.11

u/ml

0.00

126

1183

Fall on and from ladder

304

1.39

1.23

1.1

1.23

1.74

u/ml

0.28

127

Exposure to other and unspecified inanimate mechanical forces

619

1.27

1.22

1.1

0.45

1.48

u/ml

2.01

287

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

655

1.26

1.22

1.1

3.53

1.17

u/ml

0.41

289

DVT of lower extremities and pulmonary embolism

216

1876

1.15

1.21

1.0

1.1

0.91

1.09

u/ml

0.30

756

Other congenital malformations of ear

189

1.51

1.21

1.1

0.96

0.57

u/ml

0.43

105

Graves ophthalmopathy

132

1.60

1.21

1.0

1.1

0.46

1.82

u/ml

0.70

Calcific aortic valvular stenosis

617

1.26

1.21

1.0

1.1

0.70

1.32

u/ml

0.74

269

Calcific aortic valvular stenosis, operated

617

1.26

1.21

1.0

1.1

0.70

1.32

u/ml

0.74

269

Endometriosis of rectovaginal septum and vagina

461

1.31

1.20

1.1

0.43

1.02

u/ml

0.79

190

Overexertion and strenuous or repetitive movements

728

1.24

1.20

1.1

0.48

1.28

u/ml

1.61

307

Postpartum haemorrhage due to anatomy

151

1285

1.18

1.20

1.1

2.33

1.02

u/ml

0.39

514

Abnormal involuntary movements

102

836

1.22

1.20

1.1

0.65

1.01

u/ml

0.71

362

Other congenital malformations of skin

375

1.34

1.20

1.1

0.89

1.54

u/ml

0.55

195

Mixed specific developmental disorders

533

0.73

1.20

1.1

1.2

0.26

1.11

u/ml

2.58

373

Misadventures to patients during surgical and medical care

809

1.23

1.20

1.1

0.52

0.92

u/ml

0.89

342

Retinal haemorrhage

1.84

1.20

1.1

0.50

0.58

u/ml

—

Enlarged lymph nodes

135

1137

1.19

1.1

2.37

1.21

u/ml

0.41

517

Benign neoplasm: Vulva

1.76

1.19

1.1

1.33

0.72

u/ml

—

Other disorders of conjunctiva

532

1.28

1.19

1.0

1.1

0.47

1.38

u/ml

1.25

202

Diseases caused by chlamydiae

125

1.62

1.19

1.1

1.0

0.39

0.59

u/ml

—

Malignant neoplasm of rectum

274

0.62

1.18

1.1

1.77

0.83

u/ml

—

106

Dislocation, sprain and strain of joints and ligaments of thorax

198

1.47

1.17

1.0

1.1

1.07

0.97

u/ml

0.06

Conotruncal defects

271

0.61

1.17

1.0

1.2

2.03

1.24

u/ml

0.19

193

Oesophageal obstruction

1.78

1.17

1.1

0.86

0.81

u/ml

—

181

1.49

1.16

1.0

1.1

1.54

1.51

u/ml

0.01

Intentional self-harm by jumping from a high place

0.00

1.16

0.0

1.1

—

0.60

—

Crohn's disease of small intestine

615

1.26

1.16

1.1

3.69

1.27

u/ml

0.41

260

Emergency coronary revascularization (for ACS)

511

3387

0.92

1.16

1.1

0.97

1.08

u/ml

0.16

181

1460

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

466

4206

1.09

1.16

1.1

0.92

1.05

u/ml

0.18

206

1700

Maternal care for other known or suspected fetal problems

327

2304

0.90

1.15

1.1

0.58

0.96

u/ml

1.45

125

974

Cardiomyopathy (excluding other)

497

0.72

1.15

1.1

1.15

1.19

u/ml

0.02

223

Symptoms and signs concerning food and fluid intake

713

1.24

1.15

1.1

0.87

1.05

u/ml

0.15

381

Astigmatism

669

1.25

1.15

1.1

1.14

1.40

u/ml

0.14

378

Fasciculation

1.87

1.14

1.0

0.70

0.65

u/ml

—

Injury of muscle and tendon at hip and thigh level

607

1.26

1.14

1.2

1.1

1.61

1.21

u/ml

0.13

248

Benign lipomatous neoplasm

190

1652

1.15

1.14

1.0

1.1

0.48

1.09

u/ml

2.17

681

Peripheral arterial reconstruction

332

0.66

1.14

1.2

1.0

0.29

1.36

u/ml

—

124

Other disorders of breast and lactation associated with childbirth

200

1.47

1.14

1.0

1.1

1.28

0.91

u/ml

0.21

Crohn disease (strict definition, require KELA)

617

1.26

1.14

1.1

3.88

1.21

u/ml

0.43

272

Alzheimer’s disease, strict definition

274

0.66

1.13

1.0

0.21

1.30

u/ml

—

Single delivery by forceps and vacuum extractor

208

1431

0.87

1.13

1.1

0.41

1.02

u/ml

2.67

641

Other arrhythmias

586

4083

1.08

1.13

1.1

1.04

u/ml

0.01

240

1687

Fall on and from stairs and steps

201

1757

1.15

1.13

1.1

0.79

1.22

u/ml

0.59

759

Congenital malformations of breast

184

1.49

1.12

1.1

1.49

0.85

u/ml

0.46

Pregnancy, childbirth and the puerperium

262

1542

0.89

1.12

1.0

1.1

1.68

1.05

u/ml

0.42

102

686

Pre-eclampsia

166

1919

0.86

1.12

1.1

2.22

1.02

u/ml

0.37

777

Seropositive rheumatoid arthritis, strict definition

788

0.78

1.12

1.0

1.1

0.56

1.11

u/ml

1.03

315

Infective bursitis

119

1.61

1.12

1.1

2.19

1.18

u/ml

—

Other peripheral vertigo

379

1.32

1.12

1.1

0.39

1.27

u/ml

1.58

159

Cardiac murmurs and other cardiac sounds

104

852

1.21

1.12

1.1

0.90

1.53

u/ml

0.86

421

Glomerular diseases

1097

0.82

1.11

1.1

1.23

1.25

u/ml

0.01

513

Unknown and unspecified causes of morbidity

423

1.31

1.11

1.1

0.58

1.16

u/ml

0.74

180

Other congenital malformations

127

1073

1.19

1.11

1.1

1.32

1.18

u/ml

0.11

570

Crohn disease (strict definition, require KELA, min 2 HDR)

610

1.25

1.11

1.1

3.88

1.22

u/ml

0.43

270

Congenital malformations of the urinary system

572

0.75

1.11

1.0

1.1

3.23

1.47

u/ml

0.50

307

Explicit bacterial Sepsis

595

0.75

1.10

1.0

1.1

1.12

1.33

u/ml

0.13

278

Other specified/unspecified systemic involvement of connective tissue

337

1.34

1.10

1.1

0.19

1.30

u/ml

1.84

135

Speech and linguistic disorders

169

1405

1.16

1.10

1.1

1.60

1.25

u/ml

0.25

811

Other and unspecified injuries of ankle and foot

416

1.31

1.10

1.1

1.07

1.22

u/ml

0.08

194

Carcinoma in situ of breast, intraductal

364

0.68

1.10

1.0

1.1

1.77

1.14

u/ml

—

137

Other congenital malformations

170

1473

1.16

1.09

1.1

1.24

1.26

u/ml

0.02

736

Collagenous colitis

513

1.27

1.09

1.1

0.52

1.27

u/ml

1.17

219

Abnormalities of forces of labour

117

984

1.19

1.09

1.1

0.67

0.86

u/ml

0.32

379

Postprocedural disorders of nervous system

739

0.78

1.09

1.1

0.21

1.18

u/ml

3.20

323

Other complications of labour and delivery, not elsewhere classified

150

1598

0.86

1.08

1.0

1.1

1.40

1.08

u/ml

0.15

670

Heart failure and coronary heart disease

109

924

0.83

1.08

1.0

0.87

1.11

u/ml

0.20

405

Focal epilepsy, mode (most common among epilepsy diagnosis)

118

1397

0.84

1.08

1.1

0.54

1.13

u/ml

2.11

679

Diabetic maculopathy, excluding more controls

661

0.77

1.08

1.0

1.1

1.31

1.35

u/ml

0.02

287

Acute gastritis

286

1.37

1.08

1.1

0.69

1.33

u/ml

0.64

115

Myocardial infarction, unclassifiable

377

0.71

1.08

1.0

1.1

3.18

1.22

u/ml

—

153

Hyperhidrosis

244

1.40

1.08

1.1

0.27

1.61

u/ml

1.56

102

Cerebral cysts

461

1.29

1.08

1.1

0.78

1.48

u/ml

0.67

205

Spinal stenosis

237

1592

1.13

1.08

1.1

0.78

1.22

u/ml

0.75

589

Cerebral palsy

217

0.59

1.07

1.2

0.41

1.56

u/ml

—

133

Myocardial infarction

167

1356

0.87

1.07

1.1

1.0

1.30

1.14

u/ml

0.09

548

Maternal care for other conditions predominantly related to pregnancy

291

2563

1.12

1.07

1.1

0.55

1.19

u/ml

2.49

117

1051

Heterophoria

785

1.22

1.07

1.1

0.93

1.12

u/ml

0.11

396

Other papulosquamous disorders

1.95

1.07

1.3

1.1

0.87

2.21

u/ml

—

Pure hypercholesterolaemia

412

2945

0.91

1.07

1.1

1.18

1.04

u/ml

0.15

179

1174

False labour

459

2623

1.09

1.07

1.1

1.46

1.02

u/ml

0.43

195

1079

Caries of dentine, including avohilmo

785

3748

1.07

1.06

1.1

1.40

1.04

u/ml

0.59

364

1612

Alcohol abuse, main dg, excluding more controls

101

1210

0.83

1.06

1.1

1.92

1.19

u/ml

0.35

536

Diffuse brain injury

217

0.60

1.06

1.0

0.84

1.39

u/ml

—

Oral lichen planus, including avohilmo , including avohilmo

296

1.36

1.06

1.0

1.1

0.25

1.38

u/ml

1.64

121

Malignant melanoma, including Hilmo

670

0.77

1.06

1.0

1.1

1.21

0.72

u/ml

0.38

258

Non-follicular lymphoma

302

0.66

1.06

1.0

1.1

2.70

2.10

u/ml

—

134

KRA_PSY_EATING, excluding more controls

137

1166

1.17

1.06

1.1

0.96

1.17

u/ml

0.28

555

Finngen Rheumatological endpoints

989

5963

0.94

1.05

1.1

0.75

1.19

u/ml

1.91

427

2532

Laparoscopic right hemicolectomy

129

1.56

1.05

1.0

1.1

0.33

2.15

u/ml

—

Benign neoplasm of major salivary glands

392

1.30

1.05

1.1

0.12

1.41

u/ml

2.22

168

Influenza and pneumonia

1158

6973

1.06

1.05

1.1

1.13

1.09

u/ml

0.09

577

3002

Keratoconus

162

1.49

1.05

1.1

9.62

1.80

u/ml

0.61

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

130

1.57

1.04

1.0

1.2

4.17

0.60

u/ml

0.44

Cardiomyopathies, Primary/intrinsic

476

0.73

1.04

1.1

1.15

1.23

u/ml

0.03

219

Postmenopausal bleeding

134

606

1.18

1.04

1.1

1.0

1.16

0.91

u/ml

0.10

222

Congenital malformations of cardiac septa

913

0.81

1.04

1.0

1.2

1.31

1.16

u/ml

0.10

557

Congenital malformations of the urinary system

599

0.76

1.03

1.0

1.1

3.10

1.43

u/ml

0.49

318

Malignant melanoma of skin, including Hilmo

554

0.76

1.02

1.0

1.1

1.25

0.80

u/ml

0.28

214

Coronary revascularization (ANGIO or CABG)

499

3311

0.92

1.02

1.1

0.95

1.09

u/ml

0.23

178

1423

Prominent ears

139

1.54

1.02

1.0

1.1

1.21

0.51

u/ml

—

Delivery, wide proxy

299

1763

0.90

1.02

1.1

1.92

1.11

u/ml

0.59

116

774

Other female pelvic inflammatory diseases

127

1084

1.17

1.01

1.1

0.64

0.86

u/ml

0.35

417

Lesion of ulnar nerve

100

836

1.20

1.00

1.1

0.28

1.62

u/ml

3.02

325

Wide developmental disorders

671

0.78

1.00

1.1

1.2

0.50

1.06

u/ml

0.91

403

Familial hypercholesterolemia, with ischemic heart disease

180

1.45

1.00

1.1

1.0

3.87

1.73

u/ml

—

Other orthopaedic follow-up care

282

1.35

1.00

1.1

0.21

1.74

u/ml

1.59

114

Heart failure and antihypertensive medication

113

874

0.84

1.00

1.0

1.1

0.96

1.52

u/ml

0.56

371

Supernumerary ureter

0.00

1.00

0.0

1.1

—

0.49

—

Rheumatoid arthritis

168

1724

0.87

1.00

1.1

0.51

1.14

u/ml

1.77

652

Pre-eclampsia or eclampsia

177

2016

0.88

1.00

1.1

2.03

1.02

u/ml

0.34

813

Episcleritis

352

1.31

0.99

1.1

0.91

1.64

u/ml

0.43

144

Ingrowing nail

396

1.29

0.99

1.1

0.40

1.65

u/ml

1.68

180

Other specified/unspecified dorsopathies

164

1.47

0.99

1.2

1.1

1.27

2.21

u/ml

0.40

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.99

0.0

1.0

—

0.60

—

Focal epilepsy, strict definition

124

1447

0.85

0.98

1.1

0.51

1.14

u/ml

2.52

709

Ovarian hyperstimulation (induction)

207

1.42

0.98

1.0

1.1

1.14

0.81

u/ml

0.12

Percutaneous Coronary Intervention

499

3307

0.92

0.98

1.1

0.95

1.09

u/ml

0.22

178

1422

Other noninflammatory disorders of uterus, except cervix

116

661

1.18

0.98

1.1

1.0

0.39

0.94

u/ml

1.15

249

Benign neoplasm: Parotid gland

318

1.33

0.97

1.1

0.10

1.65

u/ml

2.10

133

Lymphoid leukaemia

236

0.63

0.97

1.2

0.12

1.52

u/ml

—

138

Other congenital malformations of skin

730

1.21

0.97

1.1

1.00

1.21

u/ml

0.20

343

Other benign neoplasms of skin

234

2090

1.12

0.97

1.1

0.76

1.14

u/ml

0.70

859

Scleritis

1.76

0.97

1.0

1.1

2.23

2.70

u/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

521

3481

0.93

0.97

1.1

1.07

1.09

u/ml

0.02

222

1399

Congenital malformations and deformations of the musculoskeletal system

172

1501

1.14

0.96

1.1

0.68

1.33

u/ml

1.67

809

Plantar fascial fibromatosis

559

1.24

0.96

1.1

0.77

1.16

u/ml

0.49

213

Exclusions for E4_PCOS_BROAD

186

1640

1.14

0.95

1.1

1.38

1.16

u/ml

0.17

826

Barrett oesophagus

149

1.48

0.95

1.0

1.1

0.20

1.18

u/ml

—

Mumps

141

1.50

0.95

1.1

1.0

0.25

1.00

u/ml

—

Open wound of lower leg

125

1072

1.17

0.95

1.1

0.57

1.24

u/ml

1.45

498

Retinal detachments and breaks

168

1472

1.14

0.95

1.1

1.81

1.06

u/ml

0.29

568

Benign neoplasm of other and unspecified sites

141

1.50

0.95

1.0

0.14

2.71

u/ml

—

Benign neoplasm: salivary glands, exclude unknown (D119)

355

1.30

0.94

1.1

0.13

1.55

u/ml

2.20

152

Viral conjunctivitis

338

1.31

0.94

1.1

1.10

1.29

u/ml

0.12

157

Osteoporosis

105

829

1.19

0.94

1.1

2.09

1.22

u/ml

0.27

358

Graves ophthalmopathy, strict

117

1.55

0.94

1.0

0.49

2.08

u/ml

0.71

Oral lichen planus

1.62

0.94

1.0

0.33

2.13

u/ml

—

Other congenital malformations of tongue, mouth and pharynx

303

1.34

0.94

1.2

0.30

1.10

u/ml

1.51

213

Other and unspecified iridocyclitis

277

1.34

0.94

1.1

3.02

1.95

u/ml

0.19

124

Cystic kidney disease

209

0.62

0.94

1.0

1.1

9.27

1.12

u/ml

—

111

Hypoplasia of dental enamel, prenatal , including avohilmo

155

0.56

0.94

1.1

1.3

0.55

0.94

u/ml

—

119

Phobic anxiety disorders

188

1661

1.13

0.93

1.1

0.42

1.39

u/ml

5.00

759

Fracture of neck

209

0.62

0.93

1.1

1.42

1.06

u/ml

—

Juvenile osteochondrosis

339

1.31

0.93

1.0

1.1

0.49

1.23

u/ml

1.01

157

Chalazion

780

1.20

0.92

1.1

0.62

1.13

u/ml

0.61

325

Acute nasopharyngitis (common cold)

104

876

1.18

0.91

1.1

2.54

1.17

u/ml

0.40

404

Emotional disorders starting during childhood or adolescence

111

941

1.18

0.91

1.1

1.49

1.47

u/ml

0.02

527

Erythema nodosum

151

1.47

0.91

1.1

0.25

0.71

u/ml

1.35

Small fibre neuropathy

102

1.58

0.90

1.2

1.0

1.02

0.67

u/ml

—

Sequelae of injuries of upper limb

645

1.21

0.90

1.1

0.51

1.31

u/ml

1.43

265

Congenital malformations and deformations of the musculoskeletal system

145

1258

1.15

0.90

1.1

0.72

1.30

u/ml

1.27

694

597

0.78

0.90

1.1

1.2

0.42

1.11

u/ml

2.09

413

Carcinoma in situ of skin of other and unspecified parts of face

110

1.55

0.90

1.1

1.0

0.88

0.85

u/ml

—

Diabetic nephropathy

535

0.77

0.90

1.0

1.1

2.55

1.03

u/ml

0.50

207

5-aminosalicylic acid

194

1724

1.13

0.90

1.1

0.87

1.11

u/ml

0.37

705

Ulcer of oesophagus

185

1.41

0.89

1.2

1.1

0.64

1.07

u/ml

0.44

Other diseases of gallbladder

160

1.44

0.89

1.2

1.1

0.30

1.58

u/ml

—

Other symptoms and signs involving the digestive system and abdomen

122

1052

1.16

0.88

1.1

1.27

1.24

u/ml

0.02

471

Later onset COPD

334

1.26

0.88

1.0

0.15

1.23

u/ml

2.20

137

Diseases of pulp and periapical tissues and dental caries

625

2995

1.07

0.88

1.1

1.24

1.02

u/ml

0.29

282

1257

Benign neoplasm: Conjunctiva

144

1.47

0.87

1.0

1.1

0.69

1.83

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

298

1.31

0.87

1.1

0.41

1.21

u/ml

1.04

122

Septal defects

871

0.83

0.87

1.0

1.2

1.40

1.14

u/ml

0.18

541

Viral conjunctivitis

161

1.44

0.87

1.0

1.1

1.37

1.33

u/ml

—

Pterygium

1.73

0.86

1.0

0.80

0.67

u/ml

—

Pervasive developmental disorders excl. Autism + Asperger

316

0.71

0.86

1.0

1.3

0.63

0.75

u/ml

0.06

230

COPD, hospital admissions 3, with asthma pneumonia sepsis

561

1.20

0.86

1.0

1.1

0.89

1.23

u/ml

0.25

237

Trigger finger

796

1.18

0.85

1.0

1.1

0.43

1.21

u/ml

2.42

296

Juvenile arthritis (FINNGEN)

625

0.80

0.85

1.1

0.17

1.46

u/ml

4.23

315

Fitting and adjustment of other devices

158

1256

1.14

0.85

1.1

0.74

0.91

u/ml

0.26

494

Oral leukoplakia, including avohilmo

1.57

0.84

1.1

0.29

2.16

u/ml

—

Other congenital malformations of circulatory system

137

1.47

0.84

1.1

1.59

1.87

u/ml

—

Overjet

477

1.24

0.84

1.2

3.03

1.05

u/ml

0.63

299

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

477

0.77

0.84

1.1

1.2

2.97

1.24

u/ml

0.64

290

Lesion of radial nerve

162

1.43

0.84

1.1

1.0

0.71

1.85

u/ml

0.60

Enterocolitis due to Clostridium difficile

401

0.75

0.84

1.1

0.86

1.52

u/ml

0.48

173

Colon adenocarcinoma

286

0.70

0.84

1.0

1.1

0.58

0.87

u/ml

—

117

Pneumonia due to Streptococcus pneumoniae

196

1.38

0.84

1.0

1.1

0.76

1.82

u/ml

—

Myocardial infarction, strict

155

1252

0.88

0.83

1.1

1.0

1.44

1.20

u/ml

0.13

502

Cystic kidney disease

226

0.66

0.83

1.0

1.1

7.95

1.21

u/ml

—

119

Injuries to the abdomen, lower back, lumbar spine and pelvis

303

2742

1.09

0.83

1.1

1.15

1.20

u/ml

0.07

140

1204

Polycystic ovarian syndrome, consortium definition

806

4516

1.06

0.83

1.1

0.91

1.08

u/ml

0.33

320

1839

Other, unspecified and serous retinal detachments

113

1.51

0.82

1.1

1.0

11.90

1.71

u/ml

—

Alzheimer’s disease (Late onset)

230

0.69

0.82

1.1

1.0

0.03

1.33

u/ml

—

Crushed, pushed or stepped on by crowd or human stampede

847

1.17

0.82

1.1

0.55

1.33

u/ml

1.98

403

Failed attempted abortion

130

1.48

0.82

1.1

0.15

1.28

u/ml

—

Loose body in joint

105

1.53

0.82

1.2

0.58

2.54

u/ml

—

Exposure to other and unspecified animate mechanical forces

302

1.30

0.82

1.1

0.47

1.64

u/ml

1.24

140

Abnormal results of function studies

571

1.21

0.82

1.0

1.1

0.31

1.41

u/ml

2.24

263

Maxillary retrognathism

215

1.36

0.82

1.0

1.1

0.19

0.78

u/ml

2.90

123

Glaucoma

219

2089

0.90

0.82

1.0

1.1

0.80

1.06

u/ml

0.41

824

Other abnormal immunological findings in serum

155

1.43

0.82

1.1

0.49

0.53

u/ml

—

Caries of dentine

180

1561

1.12

0.81

1.1

0.76

1.45

u/ml

1.53

684

Chondromalacia

155

1.43

0.81

1.1

1.0

0.20

1.72

u/ml

—

Other keratitis

102

875

1.17

0.81

1.0

1.1

3.99

1.28

u/ml

0.80

367

Gonococcal infection

189

1.38

0.81

1.0

1.1

0.95

1.45

u/ml

0.26

severe traumatic brain injury, does not include concussion

884

0.84

0.81

1.1

0.76

1.41

u/ml

0.99

374

Macular pucker

346

1.27

0.81

1.0

1.1

0.23

1.17

u/ml

1.72

140

Other anaemias

168

1795

0.89

0.81

1.1

0.63

0.94

u/ml

0.85

761

Erectile dysfunction

201

0.65

0.81

1.0

1.1

0.54

1.38

u/ml

—

Thyrotoxicosis, other and/or unspecified

161

1427

1.13

0.81

1.1

0.51

0.98

u/ml

1.82

576

Diabetic retinopathy, excluding more controls

110

715

0.86

0.80

1.0

1.1

2.53

0.60

u/ml

0.58

273

Marasmic kwashiorkor

0.00

0.80

0.0

1.1

—

1.08

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

321

1.29

0.80

1.1

0.57

1.44

u/ml

1.04

164

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.80

0.0

1.1

—

0.68

—

Mixed disorders of conduct and emotions

429

0.76

0.80

1.0

1.1

0.98

1.23

u/ml

0.18

229

Spondylopathies

600

3366

1.07

0.79

1.1

0.93

1.16

u/ml

0.37

228

1348

Benign neoplasm: Bladder

0.00

0.79

0.0

1.1

—

0.94

—

Other disorders of veins

285

2593

1.09

0.79

1.1

0.91

0.93

u/ml

0.02

125

987

Intestinal malabsorption

277

1.31

0.79

1.1

3.22

1.64

u/ml

0.49

131

Acquired absence of limb

0.00

0.78

0.0

1.0

—

0.87

—

Primary open-angle glaucoma

757

0.83

0.78

1.0

0.41

0.86

u/ml

1.11

311

Other specified and unspecified retinal disorders

131

1.46

0.78

1.0

1.1

0.39

1.74

u/ml

—

142

1253

1.14

0.78

1.1

1.04

0.98

u/ml

0.04

503

Crowding of teeth, including avohilmo

189

1402

1.12

0.78

1.1

1.27

1.35

u/ml

0.06

123

782

Use of hypnotics and sedatives

935

5636

0.95

0.78

1.1

0.96

1.08

u/ml

0.24

378

2350

Left bundle-branch block

225

1.34

0.78

1.1

1.0

0.67

1.40

u/ml

0.49

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.78

0.0

1.0

—

1.15

—

Lung cancer and mesothelioma

252

1.29

0.77

1.1

1.0

0.41

2.11

u/ml

1.13

Viral agents as the cause of diseases classified to other chapters

191

1.37

0.77

1.1

0.88

1.40

u/ml

0.34

Supplementary factors related to causes of morbidity and mortality classified elsewhere

283

2593

1.09

0.77

1.1

1.36

1.26

u/ml

0.10

136

1173

Thyrotoxicosis

191

1716

1.11

0.77

1.0

1.1

0.66

1.03

u/ml

0.93

691

Malignant melanoma

540

0.79

0.77

1.0

1.1

1.39

0.67

u/ml

0.45

207

Disorders of lens

347

2346

0.92

0.77

1.1

1.36

1.08

u/ml

0.20

153

882

Endometriosis ASRM stages 1,2

188

1689

1.12

0.77

1.1

0.92

1.00

u/ml

0.11

681

Allergic purpura

226

1.34

0.77

1.1

2.08

1.73

u/ml

0.07

104

Other disorders of electrolyte and fluid balance, not elsewhere classified

0.00

0.76

0.0

1.1

—

1.28

—

Thrombocytopenia, unspecified

371

0.75

0.76

1.1

0.41

1.62

u/ml

—

183

Sequelae of injuries of lower limb

631

1.19

0.76

1.1

0.51

1.24

u/ml

1.23

249

Early syphilis

1.71

0.76

1.1

11.43

0.92

u/ml

—

Contact with other hot fluids

279

1.30

0.76

1.1

1.44

1.09

u/ml

0.21

138

Open wound of abdomen, lower back and pelvis

235

1.33

0.76

1.2

1.1

0.81

1.28

u/ml

0.36

114

Other specified and unspecified strabismus

1.56

0.76

1.1

1.2

1.88

0.83

u/ml

—

Other abnormal uterine and vaginal bleeding

164

1045

1.13

0.76

1.1

0.85

1.12

u/ml

0.40

418

Other and unspecified anaemias

167

1780

0.89

0.76

1.1

0.63

0.94

u/ml

0.85

755

Striae atrophicae

1.58

0.75

1.1

1.0

0.17

0.78

u/ml

—

Retinal detachment with retinal break

458

1.22

0.75

1.1

3.61

1.04

u/ml

0.36

184

Congenital malformations of the nervous system

301

0.72

0.75

1.1

1.2

0.98

0.79

u/ml

—

185

Haemolytic anaemias

192

1.36

0.75

1.2

1.1

0.96

1.25

u/ml

0.15

105

Other and unspecified mononeuropathies of lower limb

124

1.46

0.75

1.0

0.16

2.18

u/ml

—

Complications of labour and delivery

668

3507

1.06

0.75

1.1

1.30

0.93

u/ml

0.62

258

1408

Congenital hydrocephalus

2.12

0.75

1.0

1.1

—

0.18

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

658

0.82

0.75

1.1

1.20

0.93

u/ml

0.16

268

Congenital malformations of the respiratory system

184

1.37

0.74

1.2

0.99

0.95

u/ml

0.02

122

Medial epicondylitis

201

1.35

0.74

1.3

1.0

0.20

1.30

u/ml

2.13

Other and unspecified injuries of lower leg

633

1.19

0.74

1.0

1.1

1.06

1.07

u/ml

0.01

290

Personality disorders, excluding more controls

292

2685

1.09

0.74

1.1

0.84

1.10

u/ml

0.52

131

1125

Viral meningitis

298

1.28

0.74

1.1

1.23

1.39

u/ml

0.08

124

SLE, ICD10

196

0.66

0.74

1.2

1.1

0.13

1.50

u/ml

—

SLE, strict definition

196

0.66

0.74

1.2

1.1

0.13

1.50

u/ml

—

675

0.82

0.74

1.1

1.2

0.37

1.06

u/ml

2.54

465

Actinic keratosis

782

1.16

0.74

1.0

2.67

0.88

u/ml

0.44

318

Combinations of oral blood glucose lowering drugs

103

1186

0.87

0.74

1.0

1.1

1.25

1.21

u/ml

0.02

480

Pedestrian injured in collision with pedal cycle

167

1.38

0.74

1.1

0.19

2.38

u/ml

1.44

Congenital malformations of heart and great arteries

130

1426

0.88

0.73

1.0

1.1

1.16

1.21

u/ml

0.04

796

Fentanyl

300

0.73

1.0

0.63

0.83

u/ml

—

125

Prepatellar bursitis

219

1.33

0.73

1.0

1.1

1.01

1.00

u/ml

—

Abnormal findings on examination of blood, without diagnosis

280

2360

1.09

0.73

1.1

0.51

1.23

u/ml

3.22

102

1036

Dilated cardiomyopathy

402

0.77

0.73

1.1

1.22

1.42

u/ml

0.07

174

Viral infections of the central nervous system

570

1.20

0.73

1.1

0.79

1.41

u/ml

0.76

255

Varicose veins of other sites

361

1.25

0.73

1.1

0.58

1.43

u/ml

1.06

149

Peripheral artery operations in Hilmo

300

0.73

1.2

1.1

1.75

1.38

u/ml

0.12

117

Personal history of malignant neoplasm

424

0.78

0.73

1.1

0.59

1.57

u/ml

1.13

188

Status post-ami

501

0.82

0.72

1.0

0.54

1.03

u/ml

0.45

196

Abnormal blood-pressure reading, without diagnosis

237

1.31

0.72

1.1

1.31

2.44

u/ml

0.38

113

Ulcer of lower limb, not elsewhere classified

446

0.78

0.72

1.0

1.1

1.71

1.46

u/ml

0.10

183

Seronegative juvenile rheumatoid arthritis

241

0.70

0.72

1.0

1.1

0.16

1.44

u/ml

—

127

Other abnormal auditory perceptions

1.63

0.72

1.1

0.99

2.18

u/ml

—

6-mercaptopurine

344

0.75

0.72

1.0

1.1

0.45

1.13

u/ml

—

157

Acne vulgaris

135

1196

1.13

0.72

1.1

1.08

1.58

u/ml

0.59

566

Postpartum haemorrhage

338

2636

1.08

0.72

1.1

1.44

1.00

u/ml

0.29

130

1059

Skin changes due to chronic exposure to nonionizing radiation

106

850

1.15

0.72

1.0

2.54

0.96

u/ml

0.40

346

Other conjunctival vascular disorders and cysts

1.59

0.72

1.2

1.1

0.13

1.16

u/ml

—

Sequelae of injuries, of poisoning and of other consequences of external causes

193

1745

1.11

0.71

1.1

0.61

1.23

u/ml

2.01

736

Vitamin B12 deficiency anaemia

310

0.74

0.71

1.1

0.15

1.18

u/ml

—

120

Parkinson's disease, including avohilmo

344

0.75

0.71

1.0

0.70

1.08

u/ml

—

142

Use of memantine

295

0.76

0.71

1.0

0.69

1.21

u/ml

—

115

Use of other anti-dementia drugs

295

0.76

0.71

1.0

0.69

1.21

u/ml

—

115

Other congenital malformations of the digestive system

578

1.19

0.71

1.1

1.2

0.63

1.37

u/ml

1.21

360

Hypertrichosis

221

1.32

0.70

1.0

1.84

0.72

u/ml

—

Parkinson's disease

332

0.75

0.70

1.0

0.70

1.10

u/ml

—

137

Sarcoidosis

748

1.17

0.70

1.1

2.57

0.98

u/ml

0.33

292

Burn and corrosion of trunk

195

1.34

0.70

1.1

0.55

1.24

u/ml

0.64

100

Secondary hypertension

525

0.81

0.70

1.0

1.1

0.85

1.47

u/ml

0.52

255

Benign neoplasm: Long bones of lower limb

230

1.31

0.70

1.0

1.1

0.55

1.87

u/ml

0.94

105

Superficial injury of shoulder and upper arm

814

1.16

0.69

1.1

0.52

1.22

u/ml

1.52

351

IgA nephropathy (IgA glomerulonephritis)

118

1.45

0.69

1.0

0.71

1.83

u/ml

—

Burn and corrosion of wrist and hand

353

0.76

0.69

1.1

1.62

1.38

u/ml

0.13

175

Other (seronegative) rheumatoid arthritis, wide

922

0.86

0.69

1.1

0.27

1.22

u/ml

3.20

376

Acute peritonitis

251

0.72

0.69

1.2

1.1

0.10

1.77

u/ml

—

112

Chronic tubulo-interstitial nephritis

152

1.39

0.69

1.1

0.38

1.92

u/ml

—

Lesion of plantar nerve

257

1.29

0.68

1.1

0.16

1.52

u/ml

1.65

Gonococcal infection

222

1.31

0.68

1.0

1.1

0.85

1.65

u/ml

0.49

Cyst of kidney

213

1.32

0.68

1.1

1.0

0.09

1.79

u/ml

—

Other specified/unspecified disorders of bone/cartilage

127

1.42

0.68

1.1

1.25

0.78

u/ml

—

Other disorders of bone density and structure

168

0.65

0.68

1.0

1.1

0.36

2.43

u/ml

—

SLE (Finngen)

215

0.69

0.68

1.1

0.13

1.53

u/ml

—

Sulfasalazine

209

1904

1.10

0.67

1.0

1.1

0.68

1.04

u/ml

0.47

732

330

1.26

0.67

1.1

1.67

1.48

u/ml

0.06

185

Excessive vomiting in pregnancy

826

1.15

0.67

1.1

0.24

1.37

u/ml

3.55

340

Delayed puberty

145

1.40

0.67

1.1

4.03

1.17

u/ml

0.80

Congenital deformities of hip

285

1.27

0.67

1.2

0.30

1.43

u/ml

1.51

160

Bitten or struck by other mammals

123

1089

1.13

0.67

1.1

1.09

1.27

u/ml

0.14

469

Atrophic disorders of skin

106

929

1.14

0.67

1.1

0.82

1.20

u/ml

0.41

384

Ankyloglossia

384

1.24

0.67

1.2

2.98

1.10

u/ml

0.31

254

Malignant neoplasm of bladder

102

1.47

0.67

1.1

1.0

1.11

0.96

u/ml

—

Habitual aborter

223

1.31

0.67

1.1

1.46

0.93

u/ml

0.27

Diseases of the digestive system

307

2831

1.08

0.67

1.1

1.50

1.15

u/ml

0.41

132

1279

Transient ischemic attack

187

1669

0.91

0.67

1.1

0.62

1.14

u/ml

1.01

649

Symptoms and signs involving the nervous and musculoskeletal systems

480

4517

1.06

0.67

1.1

0.67

1.10

u/ml

2.12

213

1979

Presbyopia

375

1.23

0.66

1.1

0.53

1.26

u/ml

0.89

146

Foreign body in alimentary tract

339

1.24

0.66

1.1

0.46

1.70

u/ml

1.50

172

Cicatricial alopecia [scarring hair loss]

1.80

0.66

1.0

—

0.97

—

Other or ill-defined heart diseases

285

1.27

0.66

1.2

1.1

1.45

1.53

u/ml

0.03

130

Female infertility, associated with anovulation

112

987

1.14

0.66

1.0

1.1

0.69

1.28

u/ml

0.92

418

Viral encephalitis, not elsewhere classified/unspecified

1.52

0.66

1.1

1.2

0.40

2.37

u/ml

—

Atrial fibrillation and flutter with reimbursement

127

910

0.89

0.65

1.0

0.87

1.33

u/ml

0.59

356

Contact with other sharp object(s)

679

0.84

0.65

1.0

1.1

0.60

1.48

u/ml

1.55

292

Right ventricular outflow tract obstruction

177

0.66

0.65

1.0

1.2

3.17

1.44

u/ml

—

131

Benign neoplasm: other/unspecified salivary gland

1.58

0.65

1.1

1.0

0.20

3.23

u/ml

—

Injuries to unspecified part of trunk, limb or body region

698

1.16

0.65

1.0

1.1

2.54

1.35

u/ml

0.35

314

Diseases of inner ear

337

3035

1.07

0.65

1.1

0.58

0.95

u/ml

2.09

136

1182

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

115

1299

0.88

0.65

1.0

1.1

0.61

1.12

u/ml

0.90

512

Bullous disorders

215

1.31

0.65

1.1

0.76

1.43

u/ml

0.50

Unstable angina pectoris

883

0.87

0.64

1.1

1.0

1.03

0.97

u/ml

0.06

354

Non-ischemic cardiomyopathy

858

0.87

0.64

1.0

1.1

0.68

1.06

u/ml

0.54

377

Algoneurodystrophy

251

1.28

0.64

1.1

0.34

1.50

u/ml

1.35

107

Benzodiazepine use

904

6495

0.96

0.64

1.1

0.66

1.16

u/ml

3.60

361

2726

Other and unspecified mood [affective] disorders

802

1.15

0.64

1.0

1.1

1.10

1.39

u/ml

0.18

348

Sequelae with surgical and medical care as external cause

117

1036

1.13

0.64

1.0

1.1

0.50

1.01

u/ml

1.37

436

Corneal ulcer

161

1453

1.11

0.64

1.1

1.79

1.25

u/ml

0.34

613

Benign neoplasm: Descending colon

198

1.32

0.64

1.0

1.1

0.82

1.55

u/ml

0.44

Coxarthrosis [arthrosis of hip](FG)

257

1961

0.92

0.64

1.1

0.66

1.17

u/ml

1.43

719

Hypertensive diseases (excluding secondary)

581

3561

0.95

0.63

1.1

1.08

1.15

u/ml

0.09

254

1543

Follicular cysts of skin and subcutaneous tissue

136

1217

1.12

0.63

1.1

1.16

1.33

u/ml

0.11

506

Pectus excavatum

1.58

0.63

1.2

1.1

1.09

1.98

u/ml

—

Gastroduodenal ulcer

791

1.15

0.63

1.1

1.0

0.52

0.87

u/ml

0.60

315

Other/unspecified seropositive rheumatoid arthritis

116

1306

0.89

0.63

1.0

1.1

0.61

1.12

u/ml

0.90

513

Adalimumab

912

0.86

0.63

1.1

0.48

1.11

u/ml

1.28

398

Other congenital malformations of integument

0.00

0.62

0.0

1.0

—

3.69

—

Obstructed labour due to maternal pelvic abnormality

108

954

1.13

0.62

1.1

1.99

0.77

u/ml

0.58

349

Ulcerative ileocolitis

302

0.76

0.62

1.1

1.06

1.61

u/ml

0.32

124

Other Crohn's disease

655

1.16

0.62

1.1

0.90

1.19

u/ml

0.21

280

Dextrocardia

0.00

0.62

0.0

1.3

—

0.45

—

Implicit fungal Sepsis

279

1.26

0.62

1.1

1.76

1.26

u/ml

0.21

111

Benign neoplasm: Caecum

306

1.24

0.62

1.0

1.1

0.63

1.32

u/ml

0.79

117

Mandibular retrognathia AND surgery (BSSO)

226

1.29

0.62

1.0

1.1

0.50

1.25

u/ml

—

Diverticular disease of intestine

433

2598

1.06

0.62

1.1

0.51

0.98

u/ml

2.66

144

1002

Hirsprung

0.00

0.62

0.0

1.1

—

0.86

—

Other juvenile arthritis

533

0.82

0.62

1.1

0.18

1.27

u/ml

3.18

282

Diplopia

702

1.16

0.61

1.1

1.23

1.21

u/ml

0.01

287

Congenital malformations of aortic and mitral valves

368

0.78

0.61

1.0

1.2

1.16

1.20

u/ml

0.02

212

Malignant neoplasm of urinary organs

279

0.75

0.61

1.0

1.1

0.93

0.78

u/ml

—

117

Rheumatoid arthritis, including avohilmo

203

2215

0.92

0.61

1.1

0.44

1.01

u/ml

2.38

873

Noonan syndrome

0.00

0.61

0.0

1.0

—

3.43

—

Multiple congenital exostoses

0.00

0.61

0.0

1.0

—

0.90

—

Systemic lupus erythematosus

210

0.71

0.61

1.1

0.13

1.41

u/ml

—

Spontaneous abortion

499

3179

1.06

0.61

1.1

0.62

0.95

u/ml

1.40

188

1273

Seropositive rheumatoid arthritis

119

1329

0.89

0.61

1.0

1.1

0.60

1.04

u/ml

0.80

501

Alport

0.00

0.61

0.0

1.2

—

0.18

—

Benign neoplasm of bone and articular cartilage

610

1.17

0.61

1.0

1.1

1.98

1.35

u/ml

0.24

262

Neuromyelitis optica

0.00

0.61

0.0

1.0

—

0.93

—

Typhoid and paratyphoid fevers

0.00

0.60

0.0

1.1

—

0.87

—

Undescended testicle

242

0.73

0.60

1.1

1.2

3.37

1.60

u/ml

0.34

183

Other disorders of bladder

423

0.80

0.60

1.1

0.40

0.92

u/ml

1.10

179

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.60

0.0

1.0

—

0.91

—

Cardiac arrest

209

0.73

0.60

1.0

1.1

1.03

1.54

u/ml

—

Other viral diseases, not elsewhere classified

219

2009

1.09

0.60

1.1

0.76

1.31

u/ml

1.39

103

1001

Autoimmune diseases related-to ILD

821

6726

1.04

0.60

1.1

0.96

1.16

u/ml

0.30

327

2881

Unattended death

0.00

0.60

0.0

1.1

—

0.84

—

Spina bifida

0.00

0.60

0.0

1.0

—

0.18

—

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.60

0.0

1.0

—

1.63

—

Event of undetermined intent

546

1.18

0.60

1.1

0.96

1.08

u/ml

0.12

234

Placental disorders

1.46

0.60

1.1

1.0

0.72

1.35

u/ml

—

Trigeminal neuralgia

308

1.24

0.59

1.1

1.34

1.47

u/ml

0.05

121

Lichen sclerosus et atrophicus

500

1.18

0.59

1.1

0.52

1.31

u/ml

1.16

203

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

281

1.25

0.59

1.1

0.33

1.43

u/ml

1.51

113

Premature rupture of membranes

278

2140

0.93

0.59

1.0

1.1

1.11

1.05

u/ml

0.04

104

901

Intracerebral haemorrhage

322

0.78

0.59

1.2

1.1

0.26

1.58

u/ml

1.69

137

Perineal laceration during delivery

223

2022

0.92

0.59

1.1

1.41

1.06

u/ml

0.39

839

Ulcerative colitis

192

2095

0.92

0.59

1.1

0.58

1.32

u/ml

2.60

919

Persons with potential health hazards related to communicable diseases

473

4951

0.95

0.58

1.1

1.39

1.20

u/ml

0.23

233

2298

Rheumatic fever with heart involvement

0.00

0.58

0.0

1.0

—

1.19

—

Injury of unspecified body region

501

1.18

0.58

1.0

1.1

3.25

1.48

u/ml

0.39

232

Lactose intolerance

237

1.27

0.58

1.1

0.63

1.68

u/ml

0.89

123

Seropositive rheumatoid arthritis, wide

119

1330

0.89

0.58

1.0

1.1

0.60

1.11

u/ml

0.96

523

Other and unspecified corneal deformities and disorders

175

1.32

0.58

1.0

1.1

6.19

1.56

u/ml

0.34

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

119

1046

1.12

0.58

1.1

2.08

1.28

u/ml

0.39

602

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

219

0.73

0.58

1.0

1.1

0.86

0.87

u/ml

—

Viral hepatitis, IBD co-morbidity

453

0.81

0.58

1.2

1.1

0.35

1.62

u/ml

2.62

205

Abnormal serum enzyme levels

135

1184

1.11

0.58

1.1

0.53

1.05

u/ml

1.03

518

Contusion of other and unspecified parts of foot

539

1.17

0.58

1.1

2.10

1.60

u/ml

0.14

255

Rheumatic fever incl heart disease

1.47

0.58

1.1

0.53

0.61

u/ml

—

Degenerative macular diseases

291

1.24

0.58

1.0

1.1

1.14

1.20

u/ml

0.03

117

Pediculosis, acariasis and other infestations

194

1780

1.09

0.57

1.1

2.09

1.30

u/ml

0.48

810

Maternal care for known or suspected disproportion

447

1.19

0.57

1.0

1.1

1.38

0.86

u/ml

0.49

172

Precocious puberty

0.56

0.57

1.2

0.89

0.65

u/ml

—

Ascites

253

0.75

0.57

1.1

0.96

1.52

u/ml

—

108

Glomerulonephritis

615

0.84

0.57

1.1

0.35

1.37

u/ml

2.20

298

Malignant neoplasm of ovary, including Hilmo

264

0.76

0.57

1.0

1.1

0.38

0.87

u/ml

—

115

Valvular operations

561

0.84

0.57

1.0

1.1

0.25

1.31

u/ml

2.55

280

Anterior Iridocyclitis

123

1369

0.90

0.57

1.1

0.98

1.11

u/ml

0.10

581

Other and unspecified nail disorders

1.44

0.56

1.1

0.36

0.82

u/ml

—

Early syphilis

1.52

0.56

1.1

10.06

0.80

u/ml

—

Papulosquamous disorders

279

2600

1.07

0.56

1.1

0.80

1.08

u/ml

0.51

128

1077

Hypoparathyroidism

141

1.35

0.56

1.2

1.1

0.30

2.38

u/ml

—

Carcinoma in situ of other and unspecified genital organs

0.56

1.0

—

0.70

—

Glomerular disorders in diseases classified elsewhere

614

0.85

0.56

1.0

1.1

1.77

1.40

u/ml

0.11

265

Hyperprolactinaemia

329

1.22

0.56

1.1

2.10

1.28

u/ml

0.19

136

Other and unspecified injuries of wrist and hand

329

1.22

0.56

1.2

1.1

2.03

1.76

u/ml

0.08

157

Sacroiliitis, not elsewhere classified

439

1.19

0.56

1.0

1.1

0.84

1.44

u/ml

0.68

190

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

308

0.78

0.56

1.0

1.1

0.84

1.15

u/ml

—

133

Malignant neoplasm of kidney, except renal pelvis

263

0.76

0.56

1.1

0.93

0.81

u/ml

—

111

Varicella [chickenpox]

421

1.19

0.55

1.1

1.04

1.23

u/ml

0.14

221

Acute pancreatitis

1008

0.88

0.55

1.1

0.93

1.20

u/ml

0.16

411

Use of levodopa decarboxylase inhibitor

274

0.77

0.55

1.0

1.1

0.90

1.19

u/ml

—

108

Hyperplasia of prostate

144

738

1.11

0.55

1.0

0.91

1.06

u/ml

0.15

290

Inguinal hernia

418

2958

0.94

0.55

1.1

0.94

1.14

u/ml

0.39

184

1309

Foreign body in ear

142

1.35

0.55

1.1

1.39

1.21

u/ml

—

Malignant melanoma of skin

395

0.81

0.54

1.0

1.1

1.47

0.74

u/ml

0.31

160

Congenital deformities of hip

267

1.25

0.54

1.2

0.30

1.43

u/ml

1.50

158

Dystonia

321

1.22

0.54

1.0

1.1

0.74

1.71

u/ml

0.84

138

Vasculitis limited to skin, not elsewhere classified

116

1.39

0.54

1.1

0.15

1.19

u/ml

—

Open wound of ankle and foot

833

1.13

0.54

1.0

1.1

1.89

1.40

u/ml

0.17

376

Other disorders starting during childhood or adolescence

118

1051

1.12

0.54

1.1

2.11

1.19

u/ml

0.46

621

Acute pancreatitis (for exclusion)

1006

0.88

0.54

1.1

0.93

1.23

u/ml

0.18

407

Long labour

307

2461

1.07

0.54

1.1

1.21

1.01

u/ml

0.12

135

984

Benign neoplasm of meninges

376

1.20

0.54

1.0

1.1

0.95

1.22

u/ml

0.17

152

Eustachian salpingitis and obstruction

862

1.13

0.54

1.0

1.1

0.56

1.32

u/ml

1.69

392

Open wound of hip and thigh

258

1.25

0.54

1.1

1.05

1.17

u/ml

0.04

114

Anisometropia and aniseikonia

222

1.27

0.54

1.0

1.1

0.16

1.09

u/ml

—

109

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

134

1.36

0.54

1.1

0.54

1.24

u/ml

—

Additional codes for the location of defect, injury or illness

349

1.21

0.54

1.1

0.86

1.43

u/ml

0.46

161

Other bullous disorders

125

1.37

0.54

1.1

1.0

0.47

0.78

u/ml

—

Benign neoplasm: Rectum

599

1.15

0.53

1.1

0.33

0.97

u/ml

1.63

248

Carbimazole or st.post thyroidectomy, condition for graves disease

167

1529

1.09

0.53

1.0

1.1

0.65

1.09

u/ml

1.01

601

Habit and impulse disorders

158

0.69

0.53

1.0

1.1

0.23

1.79

u/ml

—

Acute alcohol intoxication ICD-9

108

1.39

0.53

1.1

0.16

1.44

u/ml

—

Benign neoplasm: Other and unspecified parts of mouth

134

1.35

0.53

1.0

1.1

3.75

1.05

u/ml

—

Viral Sepsis

130

1176

1.11

0.53

1.1

1.85

0.97

u/ml

0.34

541

Crohn disease

131

1186

1.11

0.53

1.1

2.67

1.15

u/ml

0.45

526

Disorders of psychological development

211

1811

1.08

0.52

1.1

1.69

1.35

u/ml

0.26

113

1023

Primary open-angle glaucoma, strict

640

0.86

0.52

1.0

0.42

0.94

u/ml

1.11

260

Periodontal disease, other/unspecified

152

1.32

0.52

1.0

1.1

0.21

1.57

u/ml

—

Alcohol-induced chronic pancreatitis

282

0.78

0.52

1.0

1.1

0.15

0.96

u/ml

3.61

107

Acquired haemolytic anaemia

100

1.41

0.52

1.3

1.1

1.72

1.92

u/ml

—

Other bacterial intestinal infections

107

959

1.12

0.52

1.1

0.51

0.90

u/ml

0.94

412

Venous thromboembolism

299

2708

1.07

0.52

1.0

1.1

0.91

0.98

u/ml

0.10

127

1062

Viral and other specified intestinal infections

303

2777

1.07

0.51

1.1

1.07

1.40

u/ml

0.43

136

1425

Retention of urine

119

1082

0.90

0.51

1.1

0.88

u/ml

0.00

449

Other symptoms and signs involving general sensations and perceptions

214

0.75

0.51

1.2

1.1

0.94

1.96

u/ml

0.57

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

197

1.28

0.51

1.0

1.1

0.58

1.24

u/ml

0.53

Non-small cell lung cancer, including Hilmo

338

0.81

0.51

1.0

1.1

0.43

0.77

u/ml

0.51

132

Other sexually transmitted chlamydial diseases

160

1467

1.09

0.51

1.1

0.65

1.45

u/ml

3.02

687

Persons encountering health services for specific procedures, not carried out

649

1.14

0.51

1.1

0.27

1.09

u/ml

2.00

253

Intestinal stricture

129

1421

0.91

0.51

1.1

0.54

1.23

u/ml

1.73

592

Radial styloid tenosynovitis [de Quervain]

416

1.18

0.51

1.1

0.30

1.26

u/ml

1.73

164

Spermatocele

215

1.26

0.50

1.1

1.0

1.59

0.96

u/ml

—

Volume depletion

347

0.81

0.50

1.1

2.51

1.37

u/ml

0.33

180

Superficial injury of thorax

105

942

1.12

0.50

1.1

1.95

1.18

u/ml

0.27

405

Social disorders starting during childhood or adolecense, excluding more controls

136

1.34

0.50

1.0

1.1

0.17

0.71

u/ml

2.31

Type of accident

255

2383

1.07

0.50

1.1

1.14

1.31

u/ml

0.22

122

1069

Vestibular neuronitis

412

0.82

0.50

1.1

0.94

1.16

u/ml

0.19

167

Whooping cough

127

1.35

0.50

1.2

1.1

0.32

0.66

u/ml

—

Complications following abortion and ectopic and molar pregnancy

162

1.30

0.50

1.1

0.26

0.99

u/ml

—

Other disorders of binocular vision

101

1.40

0.50

1.1

1.0

0.48

2.11

u/ml

—

Mixed connective tissue disease

380

1.19

0.50

1.1

0.21

1.28

u/ml

2.07

151

Sequelae of injuries of head

313

0.80

0.50

1.1

0.94

1.22

u/ml

0.17

134

Other disorders of binocular movement

216

1.26

0.50

1.2

1.1

0.54

2.03

u/ml

1.09

102

Deficiency of other B group vitamins

1.50

0.50

1.2

1.0

0.09

0.89

u/ml

—

Other salmonella infections

252

1.23

0.49

1.0

1.1

0.37

1.83

u/ml

1.30

106

Other hearing loss

106

932

1.11

0.49

1.1

0.81

1.01

u/ml

0.18

381

Periapical abscess

343

3631

0.94

0.49

1.1

0.88

1.15

u/ml

0.60

163

1549

Disorders of continuity of bone

708

1.13

0.49

1.1

0.95

1.31

u/ml

0.22

296

Artificial opening status

290

0.79

0.49

1.1

0.90

1.46

u/ml

—

153

Cluster headache, wide

271

1.22

0.48

1.1

0.54

1.51

u/ml

0.85

106

Bacterial pneumonia (organism specified)

277

2356

1.07

0.48

1.1

0.99

1.16

u/ml

0.22

137

997

Cluster headache, strict

262

1.23

0.48

1.1

0.54

1.55

u/ml

0.86

102

Implicit viral Sepsis

129

1174

1.10

0.48

1.1

0.73

0.97

u/ml

0.38

541

Other/unspecified disorders of vestibular function

163

1.29

0.48

1.1

0.88

1.51

u/ml

—

Other appendicitis

549

1.15

0.48

1.0

1.1

0.71

1.04

u/ml

0.33

222

Helminthiases

391

1.18

0.48

1.0

1.1

0.90

1.49

u/ml

0.53

191

Nontoxic diffuse goitre

119

1.35

0.48

1.1

1.98

1.55

u/ml

—

Benign neoplasm of other and unspecified endocrine glands

690

1.13

0.48

1.0

1.1

1.89

1.15

u/ml

0.30

279

Other disorders involving the immune mechanism, not elsewhere classified

208

1.26

0.48

1.0

1.1

0.55

1.25

u/ml

0.60

103

Hypoplasia of dental enamel

307

0.79

0.48

1.2

0.09

1.16

u/ml

2.66

243

Cluster headache, strict, including avohilmo

419

1.17

0.48

1.1

0.56

1.25

u/ml

0.93

165

Diabetic retinopathy

127

871

0.91

0.48

1.0

1.1

2.24

0.74

u/ml

0.51

329

Respiratory and cardiovascular disorders specific to the perinatal period

610

1.14

0.48

1.2

0.93

1.01

u/ml

0.06

430

Cerebral palsy and other paralytic syndromes

784

0.88

0.48

1.1

0.49

1.35

u/ml

1.74

363

Autoimmune diseases

1189

6235

0.97

0.48

1.1

0.94

1.18

u/ml

0.82

521

2799

Infections, IBD-co-morbidities

131

851

1.10

0.48

1.1

0.57

1.43

u/ml

2.03

386

Left ventricular outflow tract obstruction, narrow definition

463

0.84

0.48

1.0

1.2

0.87

1.11

u/ml

0.16

264

Paralytic strabismus

300

0.80

0.47

1.2

1.1

0.27

1.73

u/ml

—

137

Injuries to the thorax

295

2775

1.06

0.47

1.1

1.35

1.14

u/ml

0.17

119

1179

Hypertension, essential

673

3966

0.96

0.47

1.1

1.05

1.13

u/ml

0.11

276

1582

Nail disorders

597

1.14

0.47

1.1

0.36

1.46

u/ml

2.24

259

Other heart diseases

556

3793

0.96

0.47

1.1

1.10

1.14

u/ml

0.08

242

1737

Certain zoonotic bacterial diseases

137

1.32

0.47

1.3

1.1

0.37

0.77

u/ml

—

Malnutrition

146

1.31

0.47

1.3

1.2

3.76

1.10

u/ml

0.70

L02BA Anti-estrogens

931

0.89

0.47

1.1

0.43

0.96

u/ml

1.33

349

Chromosomal abnormalities, not elsewhere classified

374

0.82

0.47

1.0

1.2

4.74

1.07

u/ml

0.93

244

Anomalies of pupillary function

155

1.30

0.47

1.2

1.1

0.18

1.66

u/ml

—

Lack of expected normal physiological development

488

0.85

0.47

1.1

1.2

2.82

0.86

u/ml

0.60

348

Viral warts

853

1.12

0.47

1.1

1.09

1.33

u/ml

0.13

397

Torsion of ovary, ovarian pedicle and fallopian tube

182

1.27

0.46

1.1

1.87

1.20

u/ml

0.18

Visual impairment including blindness (binocular or monocular)

321

0.81

0.46

1.0

1.1

0.59

1.44

u/ml

0.86

166

Recurrent dislocation of patella

617

1.14

0.46

1.1

0.34

1.32

u/ml

2.10

258

Hypotension

429

1.17

0.46

1.1

1.15

1.02

u/ml

0.08

177

Vitamin D deficiency

120

1.34

0.46

1.2

1.1

3.51

1.63

u/ml

0.35

Use of fingolimod

0.61

0.46

1.0

1.1

—

0.62

—

Ventral hernia

133

1216

1.09

0.46

1.0

1.1

2.75

1.14

u/ml

0.55

494

Supervision of high-risk pregnancy

268

1717

0.94

0.46

1.1

1.06

0.97

u/ml

0.11

101

695

Pedal cyclist injured in noncollision transport accidents

950

0.89

0.46

1.1

1.05

1.35

u/ml

0.31

428

Other benign neoplasms of uterus

129

1.32

0.45

1.1

1.0

0.40

1.95

u/ml

—

Corns and callosities

309

0.81

0.45

1.1

0.74

1.35

u/ml

—

128

Anorexia (incl.atypical)

663

0.87

0.45

1.1

1.00

1.72

u/ml

0.62

318

Mixed disorders of conduct and emotions, excluding more controls

395

0.83

0.45

1.0

1.1

0.98

1.28

u/ml

0.23

214

Other and unspecified coagulation defects

403

1.17

0.45

1.2

1.1

0.85

1.09

u/ml

0.18

176

Congenital malformations of pulmonary and tricuspid valves

163

0.72

0.45

1.0

1.3

3.17

1.41

u/ml

—

119

Other and unspecified abdominal hernia

156

1.29

0.45

1.2

1.1

0.24

1.45

u/ml

—

Vitreous haemorrhage

428

0.84

0.45

1.0

1.1

1.44

1.07

u/ml

0.20

184

Congenital deformities of feet

265

1.21

0.45

1.0

1.1

0.43

1.24

u/ml

1.03

134

Maternal care for known or suspected abnormality of pelvic organs

346

2231

1.06

0.45

1.1

1.12

1.03

u/ml

0.13

148

926

Social disorders starting during childhood or adolescence

139

1.31

0.44

1.0

1.2

0.17

0.61

u/ml

1.95

Scabies

385

1.17

0.44

1.1

0.70

1.06

u/ml

0.27

175

Ischaemic heart disease, wide definition

398

2592

0.95

0.44

1.1

1.07

1.04

u/ml

0.03

142

1011

Macular hole

112

1.34

0.44

1.0

1.1

0.37

1.88

u/ml

—

Congenital malformations of eye, ear, face and neck

809

1.12

0.44

1.1

1.08

1.20

u/ml

0.10

421

Congenital malformations of eyelid, lacrimal apparatus and orbit

148

1.30

0.44

1.1

1.2

0.19

1.10

u/ml

0.99

Cramp and spasm

302

1.20

0.44

1.1

0.50

1.31

u/ml

1.01

131

Asymmetry of jaw

130

1.32

0.44

1.0

1.1

0.28

1.63

u/ml

—

AV-block

478

0.86

0.44

1.1

2.51

0.96

u/ml

0.65

221

Left ventricular outflow tract obstruction (LVOTO), broad definition

778

0.88

0.44

1.0

1.1

0.39

1.33

u/ml

2.53

394

Superficial injury of abdomen, lower back and pelvis

136

1249

1.09

0.44

1.1

1.54

1.24

u/ml

0.20

561

Myocardial infarction, with ST-elevation

416

0.84

0.44

1.1

0.62

1.13

u/ml

0.41

168

Infectious mononucleosis

128

1173

1.09

0.44

1.1

1.37

1.42

u/ml

0.04

544

Sleep disorders, other/unspecified

321

1.19

0.44

1.2

1.1

1.14

1.82

u/ml

0.48

151

Other meningitis

1.38

0.44

1.0

1.1

2.92

0.79

u/ml

—

Congenital deformities of feet

414

1.16

0.44

1.0

1.1

0.32

1.06

u/ml

1.61

205

Arthropathic psoriasis

714

0.88

0.43

1.1

1.41

1.10

u/ml

0.10

296

Other cataract

190

1544

0.93

0.43

1.1

1.97

1.12

u/ml

0.34

612

Parkinson's disease, strict definition

285

0.81

0.43

1.0

1.1

0.79

1.22

u/ml

—

110

Aortic aneurysm

618

1.13

0.43

1.0

1.1

0.49

1.17

u/ml

1.25

249

Presence of other devices

100

902

1.11

0.43

1.0

1.1

0.55

1.02

u/ml

0.92

368

Pyogenic arthritis

303

1.19

0.43

1.2

1.1

0.72

1.37

u/ml

0.57

136

Hallux valgus (acquired)

221

1487

1.07

0.43

1.1

1.31

1.01

u/ml

0.18

542

Special screening examination for other diseases and disorders

776

0.89

0.43

1.1

0.24

1.73

u/ml

3.82

329

Bacterial intestinal infections, IBD co-morbidities

105

954

1.10

0.42

1.1

0.55

1.04

u/ml

1.15

394

Placenta praevia

521

0.86

0.42

1.0

1.1

0.38

0.89

u/ml

0.91

220

Retinoblastoma

0.00

0.42

0.0

1.0

—

5.41

—

Wide developmental disorders, excluding more controls

596

0.87

0.42

1.1

0.50

1.26

u/ml

1.26

356

Other pleural conditions

239

1.21

0.42

1.1

0.33

1.92

u/ml

1.51

101

Other and unspecified mononeuropathies of upper limb

162

0.74

0.42

1.2

1.0

0.03

2.11

u/ml

—

Burkitt lymphoma, including Hilmo

0.00

0.42

0.0

1.1

—

5.48

—

Burkitt lymphoma

0.00

0.42

0.0

1.1

—

5.48

—

Burkitt lymphoma, helper endpoint

0.00

0.42

0.0

1.1

—

5.48

—

Retinoblastoma, including Hilmo

0.00

0.42

0.0

1.0

—

5.41

—

Fracture of shoulder and upper arm

236

2507

0.94

0.42

1.1

0.94

1.38

u/ml

1.07

102

1167

Autoimmune hyperthyroidism

462

1.15

0.42

1.0

1.1

0.41

1.28

u/ml

1.52

175

Cluster headache, wide,, including avohilmo

434

1.16

0.42

1.1

0.56

1.22

u/ml

0.89

170

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

304

1.19

0.42

1.0

1.1

5.61

0.93

u/ml

0.42

120

Procreative management

418

3327

1.05

0.42

1.1

0.79

1.16

u/ml

1.12

208

1574

Carrier of infectious disease

176

1.26

0.42

1.2

1.1

3.07

1.51

u/ml

—

Kidney diseases associated to Fabry's disease

0.00

0.42

0.0

1.1

—

1.22

—

Sphingolipidosis, other/unspecified

0.00

0.41

0.0

1.1

—

1.22

—

Amenorrhoea

794

1.11

0.41

1.1

0.88

1.31

u/ml

0.37

363

Optic neuritis

359

0.83

0.41

1.0

1.1

0.24

1.22

u/ml

—

151

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

520

0.86

0.41

1.1

0.29

1.38

u/ml

1.99

212

Caught, crushed, jammed or pinched in or between objects

435

1.15

0.41

1.1

1.38

1.34

u/ml

0.02

199

Endometroid carcinoma of ovary

0.00

0.41

0.0

1.1

—

1.16

—

Other disorders of pigmentation

231

1.22

0.41

1.2

1.1

0.48

2.44

u/ml

1.51

102

Other drug-induced secondary parkinsonism

0.00

0.41

0.0

1.1

—

1.46

—

Findings of drugs and other substances, not normally found in blood

0.00

0.41

0.0

1.0

—

1.09

—

Systemic lupus erythematosus, unspecified

172

0.75

0.41

1.2

1.1

0.12

1.65

u/ml

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

0.40

0.0

1.1

—

1.01

—

Effects of foreign body entering through natural orifice

220

2067

1.07

0.40

1.1

0.89

1.21

u/ml

0.57

991

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

805

1.11

0.40

1.1

0.79

1.27

u/ml

0.45

309

Other symptoms and signs involving the urinary system

492

1.14

0.40

1.0

1.1

0.47

1.30

u/ml

1.35

214

Ectopic pregnancy

156

1448

1.08

0.40

1.1

1.01

0.96

u/ml

0.04

559

Cerebral oedema

0.00

0.40

0.0

1.1

—

7.94

—

Other symptoms and signs involving the nervous and musculoskeletal systems

351

3342

1.05

0.40

1.1

0.60

1.16

u/ml

2.21

147

1466

Multiple congenital exostoses

0.00

0.40

0.0

1.0

—

0.96

—

Unspecified urinary incontinence

389

1.16

0.40

1.0

1.1

0.56

1.39

u/ml

1.09

176

Intestinal adhesions without obstruction

296

1.18

0.40

1.0

1.1

8.98

1.11

u/ml

—

138

Labyrinthitis

0.00

0.40

0.0

1.0

—

1.21

—

Internuclear ophthalmoplegia

0.00

0.40

0.0

1.1

—

1.25

—

Thyrotoxicosis with diffuse goitre

115

1054

1.09

0.40

1.0

1.1

0.48

1.16

u/ml

1.96

414

Malignant neoplasm of colon, including Hilmo

550

0.87

0.40

1.1

1.0

1.48

0.76

u/ml

0.35

217

Coxarthrosis, primary

244

1946

1.06

0.40

1.1

1.0

0.74

1.10

u/ml

0.85

742

Early lumbar disc prolapse operation

129

1189

1.09

0.40

1.1

1.02

1.12

u/ml

0.10

487

Malignant neoplasm of gum, including Hilmo

0.00

0.40

0.0

1.1

—

0.99

—

Pneumonitis due to solids and liquids

238

0.80

0.40

1.1

0.73

1.72

u/ml

—

111

Malignant neoplasm of endocrine gland

422

0.85

0.40

1.0

1.1

0.90

1.16

u/ml

0.16

189

Etanercept

571

0.87

0.40

1.0

1.1

0.39

1.14

u/ml

1.36

253

Other osteochondrodysplasias

1.35

0.40

1.1

1.2

0.47

0.58

u/ml

—

Fracture of skull and facial bones

159

1709

0.93

0.40

1.1

1.41

1.34

u/ml

0.05

776

Hypoplasia of dental enamel , including avohilmo

737

0.89

0.39

1.2

0.84

1.26

u/ml

0.52

484

Viral infections of the central nervous system

512

1.14

0.39

1.1

0.75

1.29

u/ml

0.62

231

Nonspecific lymphadenitis

418

1.15

0.39

1.1

1.39

1.21

u/ml

0.09

162

Other maltreatment syndromes

259

0.81

0.39

1.0

1.1

0.38

1.83

u/ml

1.27

109

Foreign object accidentally left in body during surgical and medical care

0.00

0.39

0.0

1.1

—

0.96

—

Blindness or visual impairment, binocular

0.00

0.39

0.0

1.0

—

0.18

—

Gonarthrosis [arthrosis of knee](FG)

497

3009

0.96

0.39

1.1

0.85

1.03

u/ml

0.26

192

1122

Contact with heat and hot substances

466

1.14

0.39

1.1

1.35

1.16

u/ml

0.14

231

Other fall from one level to another

202

2149

0.94

0.39

1.1

0.99

1.31

u/ml

0.43

1077

Other diseases of spinal cord

148

0.74

0.38

1.0

1.1

0.54

2.74

u/ml

—

Abdominal aortic aneurysm (AAA)

114

1.31

0.38

1.1

0.37

1.13

u/ml

—

Personal history of other diseases and conditions

169

1571

1.07

0.38

1.1

0.78

1.28

u/ml

1.13

815

Hodgkin lymphoma, hilmo

159

0.75

0.38

1.2

1.1

0.69

2.12

u/ml

—

Blood alcohol or alcohol intoxication level

192

0.78

0.38

1.1

4.03

1.38

u/ml

—

Effects of other external causes

252

1.20

0.38

1.0

1.1

1.02

1.76

u/ml

0.32

108

Hirsutism in women

197

1.23

0.38

1.0

1.1

2.04

0.76

u/ml

—

Accidental poisoning by and exposure to alcohol

147

0.74

0.37

1.0

1.1

0.22

1.56

u/ml

—

Chronic respiratory disease originating in the perinatal period

0.61

0.37

1.2

0.16

1.14

u/ml

—

L04AX Other immunosuppressants

467

4855

0.96

0.37

1.1

2.17

1.06

u/ml

1.08

203

2144

Thoracic aortic aneurysm

458

1.14

0.37

1.1

0.51

1.36

u/ml

1.21

192

Postpartum hemorraghe, all women as controls

338

3175

1.05

0.37

1.1

1.44

1.07

u/ml

0.23

130

1281

Prolonged pregnancy

208

1931

0.94

0.37

1.1

1.02

1.11

u/ml

0.12

824

Traumatic subarachnoid haemorrhage

107

1.31

0.37

1.0

1.40

2.29

u/ml

—

Malignant neoplasm of rectum, including Hilmo

365

0.85

0.37

1.1

2.07

1.05

u/ml

0.52

148

Macular cyst

1.39

0.37

1.0

1.1

0.31

2.33

u/ml

—

Ulcerative colitis, NAS

109

1184

0.92

0.36

1.1

0.50

1.20

u/ml

1.77

512

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

180

1860

0.94

0.36

1.0

1.1

1.60

1.31

u/ml

0.23

985

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

384

1.15

0.36

1.1

0.38

1.19

u/ml

1.25

164

Myocardial infarction, without ST-elevation

119

1001

1.08

0.36

1.1

1.0

1.60

0.87

u/ml

0.44

391

Second line medication for Crohn's disease

488

5064

0.96

0.36

1.1

2.10

1.05

u/ml

1.06

211

2224

Other acute disseminated demyelination

0.64

0.36

1.0

1.1

—

0.62

—

Viral agents as the cause of diseases classified to other chapters

171

1.23

0.36

1.0

1.1

0.88

1.35

u/ml

0.28

Rare circulating lymphoid malignancy, including Hilmo

179

0.78

0.35

1.1

1.2

0.07

1.69

u/ml

—

114

Problems related to lifestyle

901

0.91

0.35

1.1

1.56

1.49

u/ml

0.03

368

Fracture of lumbar spine and pelvis

910

0.91

0.35

1.0

1.1

1.00

0.99

u/ml

0.01

370

Superficial injury of forearm

100

918

1.09

0.35

1.1

0.48

1.34

u/ml

2.50

434

Acute and subacute iridocyclitis

120

1296

0.92

0.35

1.1

1.00

1.08

u/ml

0.06

537

Necrosis of pulp, including avohilmo

539

5567

0.96

0.35

1.1

1.16

1.13

u/ml

0.03

238

2311

Melanocytic naevi of lower limb, including hip

310

1.16

0.35

1.0

1.1

0.53

1.41

u/ml

1.09

132

Pedestrian injured in transport accident

432

1.14

0.35

1.1

0.73

1.47

u/ml

0.61

183

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

954

6679

0.97

0.35

1.1

1.10

1.12

u/ml

0.03

469

2890

Benign neoplasm: Pituitary gland, craniopharyngeal duct

329

1.16

0.35

1.0

1.1

2.25

1.77

u/ml

0.10

139

Endometriosis diagnosis and infertility diagnosis occurring together

100

1087

0.92

0.35

1.0

1.1

1.37

0.95

u/ml

0.37

433

Transient global amnesia

255

0.82

0.35

1.1

1.0

0.86

1.23

u/ml

—

Burn and corrosion of head and neck

156

0.77

0.34

1.0

1.1

0.41

0.86

u/ml

—

Superficial injury of ankle and foot

145

1354

1.07

0.34

1.1

1.17

1.44

u/ml

0.16

647

Pneumococcal septicemia

200

0.80

0.34

1.1

0.91

1.34

u/ml

—

104

Nontraumatic intracranial haemmorrhage

637

0.89

0.34

1.1

0.33

1.20

u/ml

2.07

267

Gonarthrosis,primary

501

3200

0.96

0.34

1.1

0.85

0.97

u/ml

0.16

189

1181

Car occupant injured in other and unspecified transport accidents

192

1811

1.06

0.34

1.1

0.96

1.52

u/ml

0.92

791

Other and unspecified injuries of abdomen, lower back and pelvis

1.33

0.34

1.1

0.04

0.79

u/ml

—

Salpingitis and oophoritis

102

1106

0.92

0.34

1.0

1.1

1.38

0.78

u/ml

0.23

414

Memory loss

246

1.18

0.34

1.1

0.39

1.35

u/ml

1.02

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

758

1.10

0.33

1.1

0.84

1.31

u/ml

0.39

291

Benign neoplasm: Cerebral meninges

349

1.15

0.33

1.1

0.95

1.22

u/ml

0.16

144

Fall on same level

1235

6897

0.98

0.33

1.1

1.08

1.11

u/ml

0.06

587

3002

Pneumonia due to other infectious organisms, not elsewhere classified

136

1.25

0.33

1.2

1.1

0.38

2.56

u/ml

0.87

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

284

2964

0.95

0.33

1.1

0.90

1.07

u/ml

0.15

116

1250

Contusion of toe(s) without damage to nail

228

1.19

0.33

1.1

0.16

1.60

u/ml

1.31

103

Essential (haemorrhagic) thrombocythaemia

127

1.26

0.33

1.1

1.0

0.20

1.00

u/ml

—

Chronic ulcer of skin, not elsewhere classified

221

0.81

0.33

1.1

0.90

2.13

u/ml

0.59

Maternal care for known or suspected fetal abnormality and damage

207

1881

0.94

0.33

1.1

0.49

1.01

u/ml

2.33

788

Nonischemic cardiomyopathy

371

0.86

0.33

1.1

0.27

1.17

u/ml

1.92

158

Undescended testis, unilateral

198

0.80

0.33

1.1

1.2

1.86

1.46

u/ml

—

147

Inflammatory diseases of the central nervous system

551

0.89

0.33

1.1

2.15

1.24

u/ml

0.51

235

Subarachnoid haemorrhage

359

1.14

0.33

1.0

1.1

0.37

1.13

u/ml

1.19

145

Chronic suppurative otitis media, including avohilmo

625

1.11

0.33

1.1

0.41

1.32

u/ml

1.65

317

Unspecified misadventure during surgical and medical care

247

1.18

0.33

1.1

0.54

2.11

u/ml

1.30

107

Other endocrine disorders

801

1.09

0.33

1.1

1.2

2.07

1.08

u/ml

0.30

511

Non-small cell lung cancer

197

0.81

0.32

1.1

0.70

0.89

u/ml

—

Venous complications and haemorrhoids in pregnancy

209

0.81

0.32

1.1

0.13

0.90

u/ml

—

Bacterial, viral and other infectious agents

750

1.10

0.32

1.1

0.52

1.47

u/ml

1.72

328

Ménière disease

369

1.14

0.32

1.0

1.1

0.93

1.27

u/ml

0.28

150

Other heart diseases, wide

978

6129

0.98

0.32

1.1

1.13

u/ml

0.00

422

2687

Other and unspecified epidermal thickening

146

1.24

0.32

1.2

1.1

1.41

1.23

u/ml

—

Encephalitis

176

0.79

0.32

1.1

1.54

1.21

u/ml

—

Autism

454

0.88

0.32

1.1

0.68

1.07

u/ml

0.37

245

Benign neoplasm: Rectum, anus and anal canal

693

1.10

0.32

1.1

0.36

1.11

u/ml

1.79

291

Duodenal ulcer

257

1.17

0.32

1.1

0.86

0.88

u/ml

0.01

100

Medical abortion

665

3499

1.03

0.31

1.1

1.09

0.94

u/ml

0.20

278

1415

Symptoms and signs involving cognition, perception, emotional state and behaviour

863

6035

0.97

0.31

1.1

0.77

1.18

u/ml

2.49

384

2538

Maternal care related to the fetus and amniotic cavity and possible delivery problems

555

3151

1.03

0.31

1.1

1.06

0.98

u/ml

0.10

204

1271

Disorders in reading

258

1.17

0.31

1.1

1.67

1.34

u/ml

0.11

155

Other metabolic disorders

111

1031

1.08

0.31

1.0

1.1

0.99

1.03

u/ml

0.02

440

Other peripheral vascular diseases

465

1.12

0.31

1.1

0.75

1.09

u/ml

0.36

194

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

173

1775

0.94

0.31

1.0

1.1

1.65

1.31

u/ml

0.28

957

Other diseases of pancreas

295

1.15

0.31

1.1

0.21

1.18

u/ml

1.55

126

Other congenital malformations, not elsewhere classified

129

1.25

0.31

1.1

1.2

0.36

0.79

u/ml

—

Impacted maxillary molar

871

0.92

0.31

1.1

0.83

1.52

u/ml

0.80

399

Postprocedural endocrine and metabolic disorders, not elsewhere classified

100

926

1.08

0.31

1.0

1.1

1.11

1.10

u/ml

0.01

386

Other and unspecified acne

138

1.24

0.31

1.1

0.08

0.72

u/ml

—

Early complications of trauma

240

0.83

0.30

1.1

3.77

1.35

u/ml

0.35

102

!Aliquae complicationes praecoces traumatis

240

0.83

0.30

1.1

3.77

1.35

u/ml

0.35

102

Arthropathies in other diseases classified elsewhere

164

0.79

0.30

1.0

1.1

1.24

1.29

u/ml

—

Pustular psoriasis

240

0.83

0.30

1.1

0.31

1.58

u/ml

1.51

102

Diabetic maculopathy

506

0.89

0.30

1.0

1.1

1.11

0.74

u/ml

0.19

201

Malignant neoplasm of colon

400

0.87

0.30

1.0

1.1

1.72

0.91

u/ml

0.28

163

Other sexually transmitted chlamydial diseases

898

1.08

0.30

1.1

0.55

1.34

u/ml

2.30

406

Mandibular prognathia

175

1.21

0.30

1.0

1.2

3.88

0.66

u/ml

0.43

109

Other disorders of fluid, electrolyte and acid-base balance

129

1312

0.94

0.30

1.1

1.76

0.81

u/ml

0.41

572

Implicit fungal Sepsis

129

1.24

0.30

1.1

2.13

0.90

u/ml

—

Specific development disorders of scholastic skills

801

1.09

0.30

1.2

1.1

1.49

1.27

u/ml

0.16

471

Optic atrophy

111

1.27

0.30

1.0

1.1

0.43

1.41

u/ml

—

Arthropathy in Crohn disease

1.28

0.30

1.0

—

0.78

—

Benign neoplasm of ovary

908

1.08

0.30

1.0

1.1

1.48

0.92

u/ml

0.33

350

Other disorders of amniotic fluid and membranes

171

1765

0.94

0.30

1.1

0.96

1.05

u/ml

0.08

740

Respiratory tuberculosis, confirmed and not-confirmed

111

1.26

0.30

1.1

0.46

2.19

u/ml

—

Respiratory tuberculosis

111

1.26

0.30

1.1

0.46

2.19

u/ml

—

Herpesviral keratitis and keratoconjunctivitis

203

1.18

0.30

1.0

1.1

4.99

1.60

u/ml

0.42

Gout, idiopatic and unspecified

714

0.91

0.30

1.1

0.46

1.09

u/ml

1.37

286

Emotionally unstable personality disorder

139

1479

0.94

0.30

1.1

0.44

1.37

u/ml

3.18

635

Abnormal findings on examination of urine, without diagnosis

231

1.17

0.30

1.1

0.31

1.26

u/ml

1.16

105

Other disorders of nervous system

282

0.85

0.29

1.1

0.25

1.78

u/ml

—

115

Isolated proteinuria

157

1.21

0.29

1.0

1.1

0.43

0.76

u/ml

—

Benign neoplasm: Skin, unspecified

194

1.19

0.29

1.0

1.1

0.32

1.93

u/ml

—

Enteropathic arthropathies

148

1.22

0.29

1.1

0.45

1.39

u/ml

—

Other aneurysm

148

1.22

0.29

1.1

1.0

1.61

0.68

u/ml

—

Pedal cyclist injured in other and unspecified transport accidents

871

1.08

0.29

1.1

0.63

1.39

u/ml

1.48

376

Infections of breast associated with childbirth

392

1.13

0.29

1.1

0.61

1.23

u/ml

0.83

159

Abnormal weight loss

468

1.11

0.29

1.1

0.77

1.48

u/ml

0.60

222

Sudden idiopathic hearing loss

411

1.12

0.29

1.1

1.45

1.63

u/ml

0.06

166

Injury of intra-abdominal organs

173

0.81

0.28

1.1

1.29

1.61

u/ml

—

Syphilis

121

1.24

0.28

1.1

7.13

0.99

u/ml

—

Syphilis

121

1.24

0.28

1.1

7.13

0.99

u/ml

—

Normotensive glaucoma

184

0.81

0.28

1.0

0.03

1.47

u/ml

—

Fracture of forearm

454

4295

0.97

0.28

1.1

1.59

1.20

u/ml

0.55

215

1888

Hydrocephalus

270

0.85

0.28

1.0

1.1

1.31

1.95

u/ml

—

135

Other congenital malformations of face and neck

251

1.16

0.28

1.1

0.60

1.52

u/ml

0.72

114

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

193

1834

1.05

0.28

1.1

0.57

1.17

u/ml

1.83

711

Glucagon-like peptide-1 (GLP-1) analogues

193

1834

1.05

0.28

1.1

0.57

1.17

u/ml

1.83

711

Toxic effect of ethanol

323

0.86

0.28

1.0

1.1

0.46

1.06

u/ml

0.63

138

Erythema multiforme

112

1.25

0.28

1.2

1.1

3.81

0.76

u/ml

—

1.30

0.28

1.1

1.11

2.02

u/ml

—

Other lack of coordination

1.32

0.28

1.0

1.1

0.11

0.62

u/ml

—

Gestational diabetes (for exclusion)

525

3542

1.03

0.28

1.1

0.96

1.13

u/ml

0.25

210

1437

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

186

1.19

0.28

1.1

1.2

0.51

1.63

u/ml

0.80

119

Other misadventures during surgical and medical care

1.28

0.28

1.3

1.1

0.08

0.85

u/ml

—

Convulsions, not elsewhere classified

213

2205

0.95

0.28

1.1

1.11

1.29

u/ml

0.21

103

1097

Hypertrophic scar

479

1.11

0.28

1.1

0.34

1.28

u/ml

1.66

207

Unspecified lump in breast

103

960

1.07

0.28

1.1

0.93

u/ml

0.00

378

Bacterial meningitis

194

0.82

0.27

1.1

2.77

0.81

u/ml

—

Other benign neoplasms of connective and other soft tissue

564

0.90

0.27

1.0

1.1

0.42

1.27

u/ml

1.56

230

Other congenital malformations of male genital organs

193

0.82

0.27

1.3

1.2

3.80

1.69

u/ml

—

150

Ankylosing spondylitis

585

1.10

0.27

1.0

1.1

0.61

1.64

u/ml

1.40

245

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

797

1.08

0.27

1.0

1.1

0.71

1.12

u/ml

0.60

316

Open bite

798

1.08

0.27

1.1

0.59

1.10

u/ml

1.09

435

Melanoma in situ

122

1.23

0.27

1.1

1.0

1.02

2.10

u/ml

—

Hyperfunction of pituitary gland

471

1.11

0.27

1.1

1.97

1.36

u/ml

0.17

214

Conduction disorders

150

1149

1.06

0.27

1.1

1.35

0.92

u/ml

0.47

519

Hydatidiform mole

104

1.26

0.26

1.0

2.39

1.40

u/ml

—

Graves disease, strict definition

837

1.08

0.26

1.0

1.1

0.49

1.04

u/ml

1.35

342

Enterobiasis

278

0.86

0.26

1.1

1.05

1.35

u/ml

0.17

145

Other epidermal thickening

234

1.16

0.26

1.1

2.42

1.23

u/ml

0.36

104

Cellulitis of external ear

0.69

0.26

1.0

1.1

0.29

1.15

u/ml

—

Heart failure and bmi 25plus

109

786

0.94

0.26

1.0

1.12

1.14

u/ml

0.01

300

Other and unspecified iron deficiency

221

2113

1.05

0.26

1.1

0.93

1.08

u/ml

0.16

102

918

Bacterial pneumonia, not elsewhere classified

248

2094

1.04

0.26

1.0

1.1

1.06

1.09

u/ml

0.03

123

898

Chronic pancreatitis

530

0.90

0.25

1.0

1.1

0.24

1.18

u/ml

2.02

223

Injuries to the shoulder and upper arm

717

5638

1.02

0.25

1.1

0.72

1.24

u/ml

2.94

290

2466

Hyperkinetic disorders (excl. ADHD)

383

1.12

0.25

1.2

1.41

1.28

u/ml

0.07

251

Pneumothorax

263

1.14

0.25

1.0

1.1

0.30

1.73

u/ml

1.43

115

Molar incisor enamel hypoplasia

769

0.92

0.25

1.1

1.2

0.82

1.22

u/ml

0.52

505

Gonarthrosis, primary, with knee surgery

215

1789

0.96

0.25

1.0

1.26

0.93

u/ml

0.20

644

Glaucoma-related operations

123

1.22

0.25

1.0

1.1

0.35

1.90

u/ml

—

Hyperkalaemia

123

1.22

0.25

1.0

0.84

0.76

u/ml

—

Mandibular retrognathia

817

0.93

0.25

1.1

0.33

1.46

u/ml

3.70

410

Complications of the puerperium, not elsewhere classified

454

1.10

0.25

1.0

1.1

0.44

0.80

u/ml

0.72

194

All dysplastic lesions of the cervix uteri

313

2995

1.04

0.25

1.1

1.40

0.92

u/ml

0.49

117

1209

conjunctival haemorrhage

254

1.14

0.25

1.0

1.1

0.36

1.68

u/ml

1.15

102

Obstructed labour due to malposition and malpresentation of fetus

260

2521

0.96

0.25

1.1

1.71

0.93

u/ml

0.47

108

986

Other and unspecified injuries of head

466

0.90

0.25

1.1

0.63

1.55

u/ml

1.11

215

Benign neoplasm: Skin of other and unspecified parts of face

454

1.10

0.25

1.1

0.65

1.42

u/ml

0.73

193

Pregnancy examination and test

255

1521

1.04

0.25

1.1

1.42

0.94

u/ml

0.45

115

635

Erosion and ectropion of cervix uteri

105

1.24

0.25

1.0

1.1

0.73

1.66

u/ml

—

Hemiplegia

245

1.14

0.24

1.0

1.1

0.40

1.98

u/ml

1.44

108

Disorders of optic nerve and visual pathways

777

0.93

0.24

1.1

1.94

1.17

u/ml

0.22

371

Injury of eye and orbit

133

1259

1.06

0.24

1.1

0.90

1.38

u/ml

0.46

568

Hyphaema and other vascular disorders of iris and ciliary body

0.74

0.24

1.2

1.0

2.32

3.57

u/ml

—

Other/unspecified reactive arthropathies

436

1.10

0.24

1.0

1.1

0.65

1.43

u/ml

0.99

188

Parkinson's disease, excluding more controls

270

0.87

0.24

1.0

0.70

1.34

u/ml

—

100

Other embolism and thrombosis

609

1.08

0.24

1.1

1.08

1.00

u/ml

0.05

245

Gout, strict definition

444

0.90

0.24

1.1

0.52

1.14

u/ml

0.97

167

Gout

756

0.93

0.24

1.1

0.46

1.37

u/ml

1.92

301

Tuberculosis

124

1.21

0.24

1.1

0.46

2.01

u/ml

—

Intracranial trauma

634

4350

1.02

0.24

1.1

1.09

1.32

u/ml

0.49

306

1985

122

1153

1.06

0.23

1.1

1.18

1.45

u/ml

0.20

470

Bursitis of shoulder

115

1.22

0.23

1.1

1.0

0.46

1.47

u/ml

—

Torticollis

143

1.19

0.23

1.2

1.1

0.56

2.01

u/ml

—

Peripheral retinal degeneration

143

1.19

0.23

1.0

0.18

1.78

u/ml

—

Visual field defects

380

0.89

0.23

1.0

1.1

0.22

1.69

u/ml

2.38

163

Lesion of lateral popliteal nerve

243

0.86

0.23

1.0

1.1

0.83

1.98

u/ml

—

103

Speech disturbances, not elsewhere classified

338

0.89

0.23

1.0

1.1

1.00

1.77

u/ml

0.46

140

Weight loss

572

1.09

0.23

1.1

0.69

1.28

u/ml

0.57

279

Intentional self-harm by sharp object

285

0.87

0.23

1.0

1.1

0.20

1.77

u/ml

1.94

135

LSIL lesion of the cervix uteri

129

1223

1.06

0.23

1.1

0.45

0.97

u/ml

1.19

494

Superficial injury of head

193

1848

1.04

0.23

1.1

1.50

1.37

u/ml

0.06

101

869

Sequelae of other and unspecified infectious and parasitic diseases

390

0.90

0.23

1.1

0.20

1.27

u/ml

2.04

149

Anankastic personality disorder

348

0.89

0.23

1.2

1.1

0.09

1.77

u/ml

—

142

Glaucoma suspect

160

1526

1.05

0.22

1.0

1.1

1.03

1.09

u/ml

0.05

608

Eating disorder

137

1300

1.05

0.22

1.1

0.96

1.29

u/ml

0.47

623

Open wound of head

398

3947

0.97

0.22

1.1

0.91

1.16

u/ml

0.66

197

1796

Hypokalaemia

515

1.09

0.22

1.1

2.98

0.75

u/ml

0.47

243

Disorder of external ear, unspecified

157

0.83

0.22

1.1

1.0

1.16

0.83

u/ml

—

Complications of other internal prosthetic devices, implants and grafts

157

0.83

0.22

1.1

0.04

2.15

u/ml

—

Scarlet fever

116

1.22

0.22

1.0

1.2

9.27

0.75

u/ml

—

Cholesteatoma of middle ear

189

0.85

0.22

1.0

1.1

0.56

2.40

u/ml

—

Androgen resistance syndrome

0.00

0.22

0.0

1.0

—

0.09

—

Thyrotoxicosis with toxic multinodular goitre

219

1.14

0.22

1.0

1.1

1.61

1.51

u/ml

0.03

Optic atrophy

116

1.21

0.22

1.0

1.1

0.43

1.38

u/ml

—

231

0.86

0.22

1.0

1.1

0.21

0.91

u/ml

—

Psychotic depression

410

1.10

0.22

1.1

1.0

0.36

1.37

u/ml

1.75

189

Generalized epilepsy

468

1.09

0.22

1.1

0.45

1.27

u/ml

1.48

235

Primary coxarthrosis, bilateral

824

0.93

0.22

1.1

1.0

0.56

0.93

u/ml

0.78

329

Foreign body on external eye

118

1118

1.06

0.22

1.0

1.1

1.14

1.45

u/ml

0.25

502

Chronic suppurative otitis media

487

1.09

0.22

1.1

0.47

1.71

u/ml

1.62

232

Hypoglycaemia, other or unspecified

503

0.91

0.22

1.1

1.12

1.39

u/ml

0.17

257

Congenital malposition of the kidney

0.00

0.21

0.0

1.3

—

10.26

—

Disorders of copper metabolism

0.00

0.21

0.0

1.0

—

1.39

—

Disorder of amino-acid metabolism, other/unspecified

0.00

0.21

0.0

1.0

—

5.30

—

Reduction defects of unspecified limb

0.00

0.21

0.0

1.0

—

0.26

—

Reactive arthropathies, FINNGEN

497

1.09

0.21

1.0

1.1

0.65

1.12

u/ml

0.67

205

Hyposplenism

0.00

0.21

0.0

1.0

—

1.87

—

Malignant neoplasm of other endocrine glands and related structures

0.00

0.21

0.0

1.2

—

0.81

—

Amiodarone users

252

0.87

0.21

1.0

1.1

0.48

1.47

u/ml

0.99

Failure of sterile precautions during surgical operation

0.00

0.21

0.0

1.0

—

1.37

—

Malignant neoplasm of meninges, including Hilmo

0.00

0.21

0.0

1.0

—

1.60

—

Other sideroblastic anaemias

0.00

0.21

0.0

1.0

—

1.62

—

Postinflammatory hyperpigmentation

0.00

0.21

0.0

1.1

—

1.42

—

Benign leiomyoma with endometriosis

792

0.93

0.21

1.1

0.86

0.97

u/ml

0.11

320

Recurrent cholesteatoma of postmastoidectomy cavity

0.00

0.21

0.0

1.0

—

1.46

—

Other specified congenital malformation syndromes affecting multiple systems

272

0.88

0.21

1.1

1.2

1.57

1.12

u/ml

0.13

180

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.0

—

1.38

—

Thromboangiitis obliterans

0.00

0.21

0.0

1.1

—

0.24

—

Hernia

794

5425

0.98

0.21

1.1

1.23

1.05

u/ml

0.28

358

2280

Malignant neoplasm of ureter, including Hilmo

0.00

0.21

0.0

1.0

—

0.54

—

Exposure to other specified electric current

209

0.86

0.21

1.0

1.1

1.49

1.32

u/ml

—

Lung diseases due to external agents

459

1.09

0.21

1.1

0.47

1.28

u/ml

0.98

200

Vitamin deficiency, wide

258

1.13

0.21

1.2

1.1

2.20

1.71

u/ml

0.13

119

Vitamin deficiency

258

1.13

0.21

1.2

1.1

2.20

1.71

u/ml

0.13

119

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

239

1.13

0.21

1.0

1.1

0.46

1.55

u/ml

—

101

Physiological and behavioural disorders associated with sexual development and orientation

0.00

0.21

0.0

1.0

—

0.33

—

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.0

—

1.07

—

Azathioprine

120

1263

0.95

0.21

1.1

0.86

1.29

u/ml

0.52

561

Complications of internal orthopaedic prosthetic devices, implants and grafts

750

0.93

0.21

1.0

1.1

0.54

0.99

u/ml

0.96

312

Cardiac arrhythmias

684

4537

0.98

0.21

1.1

1.10

1.13

u/ml

0.04

291

1980

Malignant neoplasm of floor of mouth

0.00

0.21

0.0

1.1

—

1.90

—

Congenital musculoskeletal deformities of head, face, spine and chest

145

1.18

0.21

1.2

1.23

1.36

u/ml

0.05

Gingival hyperplasia

293

0.89

0.21

1.0

1.1

0.68

1.05

u/ml

0.27

169

Other disorders of ear

766

4916

1.02

0.21

1.1

0.75

1.13

u/ml

2.10

325

2111

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

838

1.06

0.20

1.1

0.79

1.03

u/ml

0.22

336

Measles

1.26

0.20

1.1

1.0

17.99

1.87

u/ml

—

Congenital iodine-deficiency syndrome/hypothyroidism

145

1.17

0.20

1.1

0.27

2.24

u/ml

—

Varicella [chickenpox]

595

1.08

0.20

1.1

0.80

1.21

u/ml

0.47

335

Multiple delivery

749

0.93

0.20

1.1

0.96

0.70

u/ml

0.22

310

Congenital absence of the vagina

0.00

0.20

0.0

1.1

—

1.21

—

Male infertility

412

1.09

0.20

1.1

0.73

1.92

u/ml

1.17

194

Scissor bite

513

1.08

0.20

1.1

1.2

0.67

1.48

u/ml

1.60

326

Lumbosacral spina bifida and hydrocephalus

0.00

0.20

0.0

1.1

—

0.26

—

Angina pectoris

246

1582

1.04

0.20

1.1

1.0

0.85

1.10

u/ml

0.37

617

Other strabismus

237

2280

1.04

0.20

1.1

1.15

1.30

u/ml

0.12

111

1108

Polyglandular dysfunction

0.00

0.20

0.0

1.0

—

0.13

—

Exposure to sunlight

0.00

0.20

0.0

1.1

—

0.70

—

Eccrine sweat disorders

0.00

0.20

0.0

1.1

—

1.06

—

Non-seminoma of testis

0.00

0.20

0.0

1.1

—

11.24

—

Fitting and adjustment of external prosthetic device

0.00

0.20

0.0

1.1

—

1.39

—

Fluid overload

0.00

0.20

0.0

1.1

—

1.23

—

Other parasitologically confirmed or unspecified malaria

0.00

0.20

0.0

1.0

—

1.31

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.20

0.0

1.0

—

1.15

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.20

0.0

1.1

—

0.95

—

Elevated blood glucose level

499

1.08

0.20

1.2

1.1

0.60

1.46

u/ml

1.10

237

Complications peculiar to reattachment and amputation

0.00

0.20

0.0

1.1

—

0.27

—

Collapsed vertebra, not elsewhere classified

0.00

0.20

0.0

1.1

—

1.75

—

Dislocation, sprain and strain of joints and ligaments of elbow

625

1.07

0.20

1.1

1.40

1.41

u/ml

0.01

300

Polycystic ovarian syndrome

738

0.93

0.20

1.1

0.25

1.16

u/ml

2.38

322

Other disorders of skin and subcutaneous tissue, not elsewhere classified

728

0.93

0.20

1.0

1.1

0.83

1.09

u/ml

0.22

301

Polymyalgia rheumatica

282

0.89

0.20

1.0

1.1

0.48

1.33

u/ml

0.86

114

Exclusion endpoint for supernumerary teeth

176

0.85

0.20

1.2

1.1

4.05

1.62

u/ml

—

112

Mixed and other personality disorders

732

1.07

0.20

1.1

0.55

1.23

u/ml

1.47

307

Nephrotic syndrome

229

0.87

0.20

1.2

0.12

1.17

u/ml

—

142

Abnormal findings on antenatal screening of mother

121

1152

1.05

0.20

1.1

0.41

1.16

u/ml

3.19

500

Malignant neoplasm of small intestine

1.20

0.19

1.0

1.1

—

0.65

—

Supervision of normal pregnancy

308

1813

0.97

0.19

1.1

1.64

1.00

u/ml

0.56

126

738

Causalgia

1.22

0.19

1.0

0.34

0.68

u/ml

—

Injury of muscle and tendon at forearm level

1.22

0.19

1.0

1.1

2.25

u/ml

—

Patent foramen ovale

260

0.88

0.19

1.0

1.2

0.54

1.02

u/ml

0.59

164

Foreign body or object entering through skin

471

1.08

0.19

1.1

0.65

1.36

u/ml

0.86

201

Myositis

1.21

0.19

1.3

1.0

1.68

0.95

u/ml

—

Other CVD

587

1.07

0.19

1.0

1.1

0.99

0.92

u/ml

0.05

261

Symptoms and signs involving the urinary system

556

4143

1.02

0.19

1.1

1.12

u/ml

0.00

249

1769

Other vitreous opacities

146

1.17

0.19

1.1

0.30

1.55

u/ml

—

Scabies

167

1604

1.04

0.19

1.1

1.77

1.25

u/ml

0.30

740

Fetus and newborn affected by maternal complications of pregnancy

194

1.15

0.19

1.1

1.3

0.42

0.79

u/ml

0.45

144

Monoarthritis, not elsewhere classified

241

1.12

0.19

1.1

0.90

1.17

u/ml

0.21

106

Leisure time condition

147

1408

1.04

0.19

1.1

0.82

1.18

u/ml

0.82

634

Injury of muscle and tendon at wrist and hand level

921

0.94

0.19

1.1

0.46

1.35

u/ml

2.23

397

Cardiomyopathy

767

0.94

0.19

1.1

1.49

1.29

u/ml

0.12

342

Tuberculosis, IBD comorbidity

165

1.15

0.19

1.1

0.36

1.96

u/ml

—

Superficial injuries involving multiple body regions

175

0.86

0.19

1.1

0.23

1.46

u/ml

—

Presbycusis

173

1.15

0.19

1.1

1.0

0.36

1.65

u/ml

—

Use of antiglaucoma preparations and miotics

175

0.86

0.18

1.0

1.1

0.32

2.34

u/ml

—

Psoriasis (vulgaris), strict definition

196

0.87

0.18

1.1

0.16

1.66

u/ml

—

Reactive arthropathies

579

1.07

0.18

1.0

1.1

0.67

1.22

u/ml

0.97

242

Disorders of puberty, all

338

1.10

0.18

1.1

1.2

2.54

1.19

u/ml

0.65

208

Diseases of peritoneum

463

1.08

0.18

1.1

0.22

1.41

u/ml

2.23

195

Other diseases of pericardium

164

0.85

0.18

1.0

1.1

0.24

1.37

u/ml

—

Coxarthrosis

247

1684

0.97

0.18

1.1

0.67

1.22

u/ml

1.43

614

Other diseases of arteries and capillaries

386

1.09

0.18

1.0

1.1

0.39

1.65

u/ml

1.69

158

UC patients in KELA-register (code 208), prior to 1994

185

0.86

0.18

1.0

1.1

0.41

1.73

u/ml

—

Diseases of liver

213

2059

1.03

0.18

1.1

0.95

1.17

u/ml

0.31

853

Hypertrophic disorders of skin

512

1.08

0.18

1.1

0.34

1.37

u/ml

1.97

225

Transitory endocrine and metabolic disorders specific to fetus and newborn

407

1.09

0.18

1.1

1.2

1.00

1.10

u/ml

0.05

301

Ovarian dysfunction

939

0.95

0.18

1.1

0.26

1.19

u/ml

3.12

396

Lactose intolerance, other/unspecified

204

1.13

0.18

1.0

1.1

0.77

1.83

u/ml

0.75

108

Polyhydramnios

522

1.07

0.18

1.1

0.73

0.89

u/ml

0.14

225

Abnormal spermatozoa

290

1.10

0.18

1.0

1.1

0.40

0.83

u/ml

—

127

Other osteochondrodysplasias

1.22

0.18

1.1

1.2

0.52

0.58

u/ml

—

Outcome of delivery

235

1500

0.97

0.18

1.1

1.36

0.93

u/ml

0.54

125

618

Constipation

729

4956

1.02

0.17

1.1

0.79

1.09

u/ml

0.83

305

2199

Toxic effects of substances chiefly nonmedicinal as to source

102

971

1.05

0.17

1.1

0.66

1.29

u/ml

1.15

437

Other facial nerve disorders

138

1.16

0.17

1.4

1.1

0.13

2.73

u/ml

—

Disorders resulting from impaired renal tubular function

163

0.86

0.17

1.0

1.1

0.74

2.14

u/ml

—

Motor disorders

441

0.92

0.17

1.1

1.2

1.69

1.28

u/ml

0.17

324

Psoriatic arthropathies, ICD10

640

0.94

0.17

1.1

1.37

1.24

u/ml

0.04

254

Neuromuscular dysfunction of bladder

407

1.08

0.17

1.1

1.0

0.65

0.86

u/ml

0.23

172

Benign neoplasm of brain and other parts of central nervous system

361

0.91

0.17

1.1

0.39

1.33

u/ml

1.13

168

Distal bite

685

1.06

0.17

1.1

2.44

1.39

u/ml

0.28

412

Constitutional tall stature

120

1.18

0.17

1.1

1.2

0.42

1.07

u/ml

—

Other and unspecified injuries of shoulder and upper arm

167

1.14

0.17

1.2

1.1

1.30

1.97

u/ml

0.19

Disorders of mineral metabolism

417

1.08

0.16

1.1

0.66

1.35

u/ml

0.62

199

Other congenital malformations of male genital organs

183

0.87

0.16

1.3

1.2

3.80

1.78

u/ml

—

142

Other noninfective disorders of lymphatic vessels and lymph nodes

194

0.87

0.16

1.2

1.1

0.73

1.64

u/ml

—

Hypopituitarism

690

0.94

0.16

1.0

1.1

2.67

1.10

u/ml

0.64

383

Cholelithiasis, broad definition with cholecystitis

648

4437

0.98

0.16

1.1

0.47

1.02

u/ml

5.17

256

1764

Bicuspidal aortic valve syndrome

246

0.89

0.16

1.0

1.1

1.23

1.10

u/ml

—

127

Acute appendicitis, with complications

116

1211

0.96

0.16

1.1

2.03

1.09

u/ml

0.26

486

Pleural effusion

412

0.92

0.16

1.0

1.1

0.50

1.53

u/ml

1.41

181

Other and unspecified psoriasis

321

1.09

0.16

1.2

1.1

0.57

1.85

u/ml

1.02

141

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

162

0.86

0.16

1.0

1.1

0.03

1.83

u/ml

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

168

1.14

0.16

1.1

1.2

0.19

1.05

u/ml

1.09

106

Maternal care for cervical incompetence

283

1.10

0.16

1.0

1.1

2.03

1.31

u/ml

—

110

Diabetes mellitus in pregnancy

481

3018

1.02

0.15

1.1

1.02

1.20

u/ml

0.22

190

1252

Methotrexate

791

0.95

0.15

1.0

0.23

1.22

u/ml

3.02

304

Malignant neoplasm of small intestine, including Hilmo

0.79

0.15

1.0

—

1.14

—

Certain zoonotic bacterial diseases

0.77

0.15

1.0

1.1

—

1.00

—

Coarctation of the aorta

140

0.85

0.15

1.0

1.2

0.76

1.18

u/ml

—

Follow-up examination after treatment for malignant neoplasms

297

0.91

0.15

1.1

1.0

0.38

1.12

u/ml

—

106

Other diseases of biliary tract

322

1.09

0.15

1.1

0.50

1.56

u/ml

1.17

143

Abscess of anal and rectal regions

604

1.06

0.15

1.0

1.1

1.23

1.20

u/ml

0.01

266

Disorder of the sleep-wake schedule

182

0.88

0.15

1.1

2.70

1.81

u/ml

—

104

Retinal vascular occlusion

274

1.10

0.15

1.0

1.1

1.14

1.43

u/ml

0.10

106

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

234

0.89

0.15

1.0

1.2

1.80

1.42

u/ml

0.14

145

Hypothyroidism, drug reimbursement

149

1090

0.96

0.15

1.1

1.11

0.95

u/ml

0.11

479

Polycystic ovarian syndrome, broad definition

153

1478

1.04

0.15

1.1

0.56

1.14

u/ml

1.54

631

Melanocytic naevi of trunk

871

0.95

0.15

1.1

0.67

1.19

u/ml

0.73

374

Senile cataract

288

1720

1.03

0.15

1.1

1.0

0.91

0.94

u/ml

0.05

132

626

Wet age-related macular degeneration

238

1.10

0.15

1.0

1.04

1.18

u/ml

0.08

Golimumab

296

0.91

0.15

1.0

1.1

0.30

1.81

u/ml

1.69

128

Fracture of foot, except ankle

218

2242

0.97

0.14

1.1

0.90

1.30

u/ml

0.39

981

Cholelithiasis

621

4350

0.98

0.14

1.1

0.49

1.02

u/ml

4.71

245

1729

Phlebitis and thrombophlebitis (not including DVT)

122

1268

0.96

0.14

1.1

0.55

1.20

u/ml

0.96

511

Pathological resorption of teeth

217

1.11

0.14

1.0

1.1

0.17

1.45

u/ml

—

Tuberculosis, wide

169

1.12

0.14

1.1

0.36

1.94

u/ml

—

Conductive and sensorineural hearing loss

497

3414

0.98

0.14

1.1

0.62

1.20

u/ml

2.70

196

1384

Gout, unspecified

553

0.94

0.14

1.1

0.30

1.34

u/ml

2.17

214

Arthrosis

585

3156

1.02

0.14

1.1

0.70

1.09

u/ml

0.96

243

1242

Specific developmental disorder of motor function

429

0.93

0.14

1.1

1.2

1.69

1.23

u/ml

0.19

313

Pneumonia derived septicemia

181

0.88

0.14

1.1

0.91

1.41

u/ml

—

Iron deficiency anaemia

269

2586

1.02

0.14

1.1

0.93

1.07

u/ml

0.17

120

1110

Benign neoplasm of breast

743

1.05

0.14

1.1

0.77

0.95

u/ml

0.15

298

Malignant neoplasm of bladder, including Hilmo

235

1.10

0.14

1.1

1.0

0.86

0.72

u/ml

—

Other salmonella infections

179

1.12

0.14

1.1

0.17

2.42

u/ml

—

Paroxysmal tachycardia

192

1654

0.97

0.14

1.1

0.95

1.25

u/ml

0.44

746

Clubfoot

1.20

0.14

1.0

1.1

0.13

0.91

u/ml

—

Preterm labour and delivery

215

2208

0.97

0.14

1.1

2.82

0.83

u/ml

0.72

855

Inguinal hernia, bilateral

353

1.08

0.14

1.1

0.14

1.07

u/ml

1.94

151

Other disorders of male genital organs

237

1.10

0.14

1.0

1.1

0.34

1.96

u/ml

1.54

112

Systemic sclerosis (FG)

103

1.17

0.13

1.0

1.1

1.35

0.88

u/ml

—

All dysplastic lesions of the vulva

284

0.91

0.13

1.0

1.1

0.04

1.24

u/ml

—

121

Sixth [abducent] nerve palsy

132

1.14

0.13

1.1

0.40

0.86

u/ml

—

Other specified and unspecified personality disorders

804

1.05

0.13

1.1

1.37

1.16

u/ml

0.11

342

Chronic hepatitis, not elsewhere classified

159

0.88

0.13

1.0

1.1

0.16

2.16

u/ml

—

Other problems related to primary support group, including family circumstances

170

1606

1.03

0.13

1.1

1.21

1.26

u/ml

0.04

858

Autism spe

417

0.93

0.13

1.1

0.68

1.33

u/ml

0.62

226

Other and unspecified vascular occlusions

211

0.90

0.13

1.1

1.51

1.66

u/ml

0.04

Short stature, not elsewhere classified

591

1.05

0.13

1.1

1.2

2.36

1.10

u/ml

0.34

415

Labour and delivery complicated by fetal stress [distress]

353

2357

0.98

0.13

1.1

0.63

0.99

u/ml

1.22

157

966

Nutritional anaemias

292

2875

0.98

0.13

1.1

0.87

1.01

u/ml

0.19

129

1222

Missing teeth due to accident, extraction or parodontitis

318

3057

0.98

0.13

1.1

0.58

1.04

u/ml

2.05

144

1200

Eating disorders

146

1413

1.03

0.13

1.1

0.92

1.32

u/ml

0.64

670

Specific development disorders of speech and language

898

1.04

0.13

1.1

1.2

1.48

1.15

u/ml

0.14

536

Social phobias

112

1080

1.04

0.12

1.0

1.1

0.41

1.38

u/ml

3.74

504

Pustulosis palmaris et plantaris

221

0.90

0.12

1.1

0.31

1.66

u/ml

1.44

Contact with sharp glass

355

0.93

0.12

1.0

1.1

0.18

1.04

u/ml

1.53

153

Congenital malformations of ovaries, fallopian tubes and broad ligaments

560

1.05

0.12

1.1

2.19

0.95

u/ml

0.55

240

Other disorders of glucose regulation and pancreatic internal secretion

611

0.95

0.12

1.1

0.94

1.35

u/ml

0.35

301

Unspecified haematuria

207

1672

1.03

0.12

1.1

1.66

1.19

u/ml

0.34

727

Assault by sharp object

127

0.86

0.12

1.0

1.1

0.30

2.05

u/ml

—

Contusion of ankle

365

0.93

0.12

1.1

0.47

0.97

u/ml

0.72

166

Autism spe, excluding more controls

416

0.94

0.12

1.1

0.68

1.04

u/ml

0.33

224

All pneumoniae

1032

6820

1.01

0.12

1.1

1.13

1.10

u/ml

0.04

513

2940

Unspecified jaundice

179

0.89

0.12

1.0

1.1

0.74

1.48

u/ml

—

Dislocation, sprain and strain of joints and ligaments of head

424

1.06

0.12

1.1

0.88

1.33

u/ml

0.22

196

Disorders of speech understanding and production

648

0.95

0.12

1.2

2.06

1.14

u/ml

0.29

412

Aneurysms, operations, SAH

708

1.05

0.12

1.1

0.49

0.94

u/ml

0.99

284

Coxarthrosis, primary, with hip surgery

148

1426

0.97

0.12

1.1

1.0

0.63

1.02

u/ml

1.03

549

Manic episode

220

0.91

0.12

1.0

1.1

0.45

1.77

u/ml

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

397

1.07

0.12

1.1

1.2

0.36

1.10

u/ml

1.60

294

Retinal vascular disorders

278

1.08

0.12

1.0

1.1

1.14

1.41

u/ml

0.10

108

Postprocedural musculoskeletal disorders, not elsewhere classified

251

0.92

0.12

1.0

0.96

1.59

u/ml

—

HSIL lesion of the cervix uteri

214

2090

1.02

0.12

1.0

1.1

1.65

0.96

u/ml

0.51

865

Corneal scars and opacities

114

1.14

0.12

1.0

1.1

0.67

0.89

u/ml

—

Torsion of testis

230

0.91

0.11

1.1

0.49

1.46

u/ml

0.96

117

Gout, FINNGEN

831

0.96

0.11

1.1

0.46

1.38

u/ml

2.03

340

Somnolence, stupor and coma

199

0.90

0.11

1.1

0.74

0.87

u/ml

—

Endometriosis ASRM stages 3,4

192

1873

1.03

0.11

1.1

0.74

0.92

u/ml

0.35

745

Other obstetric trauma

611

1.05

0.11

1.0

1.1

1.35

0.74

u/ml

0.25

247

Sequelae of injuries of neck and trunk

147

0.88

0.11

1.1

0.85

1.93

u/ml

—

Divergent concomitant strabismus

611

1.05

0.11

1.1

0.33

1.30

u/ml

1.99

272

Ulcerative enterocolitis

201

1.10

0.11

1.1

0.61

1.53

u/ml

0.54

Arterial embolism and thrombosis

143

1.12

0.11

1.0

0.12

0.99

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP)

798

1.04

0.11

1.1

0.84

1.06

u/ml

0.17

320

ILD medications: azathioprine

120

1238

0.97

0.11

1.1

0.86

1.18

u/ml

0.36

546

Myeloproliferative diseases

281

0.92

0.11

1.0

1.1

0.13

1.33

u/ml

—

112

Tooth eruption problems

241

2301

1.02

0.11

1.1

0.83

1.47

u/ml

1.84

132

1188

Other disorders of skin and subcutaneous tissue

484

4237

1.01

0.11

1.1

0.94

1.13

u/ml

0.42

216

1739

Other eating disorders

700

1.04

0.11

1.2

1.1

1.09

1.65

u/ml

0.47

353

Malignant neoplasm of thyroid gland

373

0.94

0.11

1.0

1.1

0.90

0.91

u/ml

0.01

158

Osteomyelitis

289

1.07

0.11

1.1

1.80

2.03

u/ml

0.07

132

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

208

0.91

0.11

1.1

1.0

2.83

0.95

u/ml

—

Inflammatory bowel disease, strict (require KELA)

217

2218

0.98

0.11

1.1

1.73

1.34

u/ml

0.15

993

Liveborn infants according to place of birth

196

1.09

0.11

1.1

1.2

0.45

0.69

u/ml

0.36

130

Other symptoms and signs involving cognitive functions and awareness

221

2056

0.98

0.11

1.1

0.71

1.15

u/ml

1.05

100

856

Other and unspecified disease of Bartholin gland

134

1.12

0.11

1.3

1.1

0.73

1.30

u/ml

—

Problems related to social environment

163

1.11

0.10

1.1

1.14

1.61

u/ml

—

Entropion and trichiasis of eyelid

163

1.10

0.10

1.0

0.25

1.44

u/ml

—

Pregnancy with abortive outcome

691

3562

1.01

0.10

1.1

1.18

0.99

u/ml

0.24

274

1443

Failed induction of labour

780

1.04

0.10

1.1

0.26

1.05

u/ml

2.84

322

Burns and corrosions of external body surface, specified by site

983

0.97

0.10

1.1

1.05

1.36

u/ml

0.38

462

Congenital musculoskeletal deformities of head, face, spine and chest

173

1.10

0.10

1.2

1.23

1.24

u/ml

0.00

115

Paralytic ileus

115

1.13

0.10

1.2

1.0

0.27

2.05

u/ml

—

Contact with sharp object, undetermined intent

177

0.90

0.10

1.0

1.1

0.32

1.43

u/ml

—

Other dialysis

177

0.90

0.10

1.3

1.1

0.12

1.33

u/ml

—

Fungal Sepsis

144

1.11

0.10

1.1

2.13

1.61

u/ml

—

Assault

139

1427

0.97

0.10

1.1

0.94

1.40

u/ml

0.55

642

Orchitis and epididymitis

443

0.95

0.10

1.0

1.1

0.38

1.74

u/ml

1.97

205

Mental disorders, not otherwise specified

799

0.96

0.10

1.1

0.75

1.20

u/ml

0.58

343

Abnormalities of gait and mobility

545

0.95

0.10

1.1

1.51

1.59

u/ml

0.04

265

Congenital malformations of genital organs

123

1257

0.97

0.10

1.1

1.76

1.17

u/ml

0.39

642

Injuries involving multiple body regions

269

0.93

0.10

1.0

1.1

0.35

1.50

u/ml

1.36

117

Anorexia

106

1.13

0.10

1.2

1.1

0.18

0.72

u/ml

—

Antenatal screening

327

1866

0.98

0.09

1.1

1.65

1.11

u/ml

0.47

132

761

Other abnormal findings of blood chemistry

232

1.08

0.09

1.0

1.1

0.32

0.91

u/ml

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

524

0.95

0.09

1.1

0.48

1.43

u/ml

1.32

208

Disorders of calcium metabolism

279

0.93

0.09

1.1

0.94

1.76

u/ml

—

134

Pediculosis, acariasis and other infestations

467

1.05

0.09

1.1

0.67

1.23

u/ml

0.45

203

Vertical strabismus

203

1.09

0.09

1.1

0.50

0.72

u/ml

—

Chronic lymphocytic leukaemia

1.06

0.09

1.2

1.0

—

1.10

—

Chronic lymphocytic leukaemia, helper endpoint

1.06

0.09

1.2

1.0

—

1.10

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

1.06

0.09

1.2

1.0

—

1.10

—

Endometriosis of intestine

145

0.89

0.09

1.0

0.27

0.57

u/ml

—

Injuries to the hip and thigh

282

2510

1.02

0.09

1.1

1.01

1.27

u/ml

0.25

132

1084

Injury of other and unspecified intrathoracic organs

289

0.93

0.09

1.1

1.98

1.24

u/ml

0.23

121

Benign neoplasm: Adrenal gland

291

1.07

0.09

1.0

1.1

1.81

1.27

u/ml

0.17

122

Molar incisor enamel hypoplasia, with caries

276

0.93

0.09

1.2

0.09

1.40

u/ml

3.01

215

Scoliosis

777

0.96

0.09

1.0

1.1

0.46

1.42

u/ml

2.48

381

Other renal tubulo-interstitial diseases

155

0.90

0.09

1.1

1.0

0.59

2.32

u/ml

—

Other encephalitis

155

0.90

0.09

1.1

1.54

1.36

u/ml

—

Complications of surgical and medical care, not elsewhere classified

888

6025

1.01

0.09

1.1

0.96

1.11

u/ml

0.33

375

2495

All dysplastic lesions of the cervix uteri, vagina or vulva

332

3222

1.02

0.09

1.1

1.35

0.92

u/ml

0.46

124

1287

Papillary adenocarcinoma of thyroid gland

278

0.93

0.09

1.0

1.1

0.91

1.00

u/ml

0.04

120

Haemorrhage, not elsewhere classified

126

1.11

0.09

1.1

0.07

1.78

u/ml

—

Other noninflammatory disorders of cervix uteri

194

1.08

0.09

1.1

1.0

0.14

1.16

u/ml

—

Assault by bodily force

837

0.97

0.09

1.1

1.06

1.34

u/ml

0.19

364

Frostbite

1.09

0.09

1.2

1.1

0.41

3.18

u/ml

—

Disorders of adult personality and behaviour

311

3157

0.98

0.09

1.1

0.89

1.31

u/ml

0.94

141

1349

Epilepsy

230

2334

0.98

0.09

1.1

0.54

1.20

u/ml

3.30

100

1123

Purpura and other haemorrhagic conditions

867

0.97

0.08

1.1

0.90

1.17

u/ml

0.18

405

Other ulcerative colitis

461

0.95

0.08

1.2

1.1

0.24

1.56

u/ml

2.18

197

Birth asphyxia

146

1.10

0.08

1.2

0.35

0.90

u/ml

—

104

Deep endometriosis

735

1.03

0.08

1.1

0.71

0.99

u/ml

0.32

317

Bell's palsy

735

1.03

0.08

1.0

1.1

2.14

1.26

u/ml

0.54

306

In situ neoplasms

201

2048

0.98

0.08

1.0

1.1

1.51

0.87

u/ml

0.48

826

Carcinoma in situ of cervix uteri

998

0.97

0.08

1.1

2.27

0.89

u/ml

0.48

423

Bacterial sepsis of newborn

185

1.09

0.08

1.2

0.39

0.96

u/ml

0.81

142

DVT of lower extremities

836

0.97

0.08

1.0

1.1

0.55

0.92

u/ml

0.70

324

Coagulation defects, purpura and other haemorrhagic conditions

138

1412

0.98

0.08

1.2

1.1

0.90

1.12

u/ml

0.23

636

Dermatophytosis

686

1.04

0.08

1.1

0.96

1.17

u/ml

0.17

309

Other disorders of kidney and ureter

562

0.96

0.08

1.1

0.61

1.41

u/ml

0.99

243

Raynaud syndrome

647

1.04

0.08

1.1

0.62

1.34

u/ml

1.18

267

Anxious personality disorder

195

0.92

0.08

1.0

1.1

1.16

1.41

u/ml

—

Fracture of rib(s), sternum and thoracic spine

146

1492

0.98

0.08

1.1

0.55

1.09

u/ml

1.83

621

Spondylopathies (FG)

122

1191

1.02

0.08

1.0

1.1

0.58

1.29

u/ml

1.98

493

Follow-up care involving plastic surgery

195

1.08

0.08

1.1

0.33

1.30

u/ml

—

Hypermetropia

743

0.97

0.08

1.2

1.1

0.47

1.27

u/ml

2.10

420

Bacterial, viral and other infectious agents

687

1.03

0.08

1.0

1.1

0.53

1.55

u/ml

1.71

303

Other diseases of the digestive system

146

1491

0.98

0.08

1.1

0.78

1.00

u/ml

0.28

659

Hernia of abdominal wall, postoperative

107

1043

1.03

0.08

1.0

1.1

1.31

1.01

u/ml

0.19

414

Cyst of Bartholin Gland

303

1.06

0.08

1.1

0.42

0.78

u/ml

0.65

124

Sequelae of infectious and parasitic diseases

419

0.95

0.08

1.1

0.22

1.26

u/ml

2.17

161

Cutaneous lupus erythematosus

1.12

0.07

1.4

1.1

1.85

2.26

u/ml

—

Pneumonias (Asthma/COPD co-morbidities)

1021

6803

1.01

0.07

1.1

1.14

1.10

u/ml

0.07

507

2930

Traumatic amputation of wrist and hand

174

0.92

0.07

1.1

0.66

2.33

u/ml

—

Other disorders originating in the perinatal period

284

1.06

0.07

1.2

1.3

1.19

0.87

u/ml

0.12

214

Twin gestation

975

0.97

0.07

1.1

0.74

0.94

u/ml

0.21

401

Neoplasms

1048

5514

1.01

0.07

1.1

0.95

1.24

u/ml

0.86

460

2527

Other psoriatic arthropathies

621

0.97

0.07

1.1

1.37

1.26

u/ml

0.03

245

Disorders of acoustic nerve

108

1.11

0.07

1.1

0.85

0.90

u/ml

—

Medical treatment for female infertility

266

2681

0.99

0.07

1.0

1.1

1.10

0.96

u/ml

0.13

1091

Slow fetal growth and fetal malnutrition

175

1.08

0.07

1.1

1.2

0.38

0.87

u/ml

0.56

134

Other diseases of blood and blood-forming organs, wide

131

1338

0.98

0.07

1.1

0.46

1.05

u/ml

1.84

582

Other pulmonary heart/vessel disease

147

1.09

0.07

1.0

1.1

0.73

1.87

u/ml

—

Crohn's disease NAS

560

1.04

0.07

1.1

1.61

1.20

u/ml

0.19

255

Diabetic retinopathy, strict definition

655

0.97

0.07

1.0

1.1

1.35

0.74

u/ml

0.37

260

Fibrosis and cirrhosis of liver

306

0.95

0.07

1.0

1.1

1.11

1.18

u/ml

0.03

140

Inguinal or femoral hernia, bilateral

363

1.05

0.07

1.1

0.14

1.08

u/ml

2.06

156

Bipolar affective disorders

190

1869

1.02

0.07

1.1

0.51

1.40

u/ml

4.08

781

Injuries to the elbow and forearm

666

5900

0.99

0.07

1.1

1.38

1.10

u/ml

0.51

310

2613

Endovascular or surgical operations to intracerebral aneurysms

265

0.94

0.07

1.1

0.73

1.53

u/ml

—

105

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

214

0.93

0.07

1.1

0.10

1.20

u/ml

—

Donors of organs and tissues

1.13

0.07

1.0

1.1

0.34

1.97

u/ml

—

Other mental disorders due to brain damage and dysfunction and to physical disease

336

0.95

0.06

1.0

1.1

1.41

1.54

u/ml

0.05

135

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

848

1.03

0.06

1.1

0.39

1.03

u/ml

1.73

333

Specific personality disorders

250

2534

0.99

0.06

1.1

0.83

1.26

u/ml

0.85

114

1074

Cardiovascular diseases (excluding rheumatic etc)

942

5380

1.01

0.06

1.1

1.32

1.14

u/ml

0.31

415

2470

Other infectious diseases

356

0.95

0.06

1.0

1.1

1.03

1.38

u/ml

0.23

156

Hypertensive Heart Disease

509

1.03

0.06

1.0

1.1

0.65

1.14

u/ml

0.68

207

Personality disorders

292

2885

1.01

0.06

1.1

0.84

1.23

u/ml

0.86

131

1231

Iron deficiency anaemia secondary to blood loss (chronic)

700

0.97

0.06

1.1

0.79

1.09

u/ml

0.31

284

Osteonecrosis

244

0.94

0.06

1.0

1.1

0.05

1.47

u/ml

—

Other diseases of blood and blood-forming organs

305

1.05

0.06

1.0

1.1

0.11

1.88

u/ml

2.14

124

Iridocyclitis

150

1526

0.98

0.06

1.1

1.61

1.05

u/ml

0.29

646

Parkinson's disease, strict definition, excluding more controls

232

0.94

0.06

1.0

0.79

1.18

u/ml

—

468

0.97

0.06

1.0

0.85

0.87

u/ml

0.01

197

Other or unspecified ileus, impaction or obstruction

681

1.03

0.06

1.1

0.20

1.10

u/ml

2.67

295

Car occupant injured in noncollision transport accident

294

0.95

0.06

1.1

2.76

1.38

u/ml

0.31

116

Artificial joint re-operation

172

0.93

0.06

1.0

1.1

0.35

1.72

u/ml

—

Fracture of lower leg, including ankle

431

4228

1.01

0.05

1.1

1.09

1.06

u/ml

0.03

204

1799

Other specified/unspecified inflammatory spondylopathies

375

1.04

0.05

1.1

0.45

1.58

u/ml

1.37

158

Labour and delivery complicated by umbilical cord complications

464

1.04

0.05

1.0

1.1

0.76

0.98

u/ml

0.18

189

HSIL lesion of the cervix uteri, vagina or vulva

221

2182

1.01

0.05

1.0

1.1

1.62

0.94

u/ml

0.52

888

Other disorders of the genitourinary system

476

0.97

0.05

1.2

1.0

0.84

1.05

u/ml

0.18

189

Other and unspecified disorders of skin and subcutaneous tissue

316

1.04

0.05

1.1

0.27

1.42

u/ml

1.34

133

Evidence of alcohol involvement determined by blood alcohol level

1.11

0.05

1.1

1.0

5.56

1.15

u/ml

—

Brachial plexus disorders

821

1.02

0.05

1.1

1.00

1.29

u/ml

0.19

329

Thiazolidinediones

336

1.04

0.05

1.0

1.1

1.85

1.23

u/ml

0.35

143

Malignant neoplasm of thyroid gland, including Hilmo

425

1.04

0.05

1.0

1.1

0.76

0.88

u/ml

0.09

180

Cutaneous abscess, furuncle and carbuncle

218

2207

0.99

0.05

1.1

1.40

1.15

u/ml

0.14

121

970

Foreign body entering into or through eye or natural orifice

633

1.03

0.05

1.1

0.56

1.44

u/ml

1.66

287

Colectomy operation

637

0.97

0.05

1.1

0.26

1.23

u/ml

2.57

267

Family history of other conditions

151

0.93

0.05

1.1

0.24

1.43

u/ml

—

Agoraphobia

364

0.96

0.05

1.1

0.08

1.30

u/ml

2.38

154

Bacterial pneumoniae

262

2284

1.01

0.05

1.0

1.1

1.03

1.16

u/ml

0.16

128

970

Personal history of certain other diseases

222

0.94

0.05

1.0

1.1

2.54

1.21

u/ml

—

Burns and corrosions

127

1249

1.02

0.05

1.1

0.98

1.37

u/ml

0.65

594

Antepartum haemorrhage, not elsewhere classified

105

1031

1.02

0.05

1.1

0.51

0.81

u/ml

0.74

429

Injuries to the head

1149

7029

1.00

0.05

1.1

1.09

1.11

u/ml

0.04

537

3045

Spontaneous rupture of synovium and tendon

317

1.04

0.05

1.0

1.1

0.20

1.10

u/ml

—

120

Zoster [herpes zoster]

817

0.98

0.04

1.1

4.20

1.05

u/ml

0.86

349

IBD patients in KELA-register

217

2194

0.99

0.04

1.1

1.73

1.29

u/ml

0.18

973

Postpartum haemorrhage due to retained placenta

141

1390

1.01

0.04

1.0

1.1

0.54

1.28

u/ml

1.82

548

Feeding problems of newborn

150

1.07

0.04

1.2

0.14

0.96

u/ml

1.25

122

Burn and corrosion of hip and lower limb, except ankle and foot

150

0.93

0.04

1.0

1.1

1.67

1.57

u/ml

—

Otosclerosis

312

0.96

0.04

1.0

1.1

0.27

1.40

u/ml

—

121

Abscess of Bartholin gland

229

1.05

0.04

1.1

1.0

0.44

0.90

u/ml

—

Other arthritis (FG)

235

2373

0.99

0.04

1.1

0.72

1.25

u/ml

1.16

104

992

Contact with nonpowered hand tool

249

1.04

0.04

1.0

1.1

1.98

1.81

u/ml

0.04

102

Unspecified abortion

358

1.03

0.04

1.0

1.1

0.84

1.10

u/ml

0.30

143

Gestational [pregnancy-induced] hypertension

292

2890

1.01

0.04

1.1

0.66

1.06

u/ml

1.21

105

1180

Other and unspecified disorders of psychological development

305

0.96

0.04

1.2

0.51

0.79

u/ml

0.42

223

Artificial joint operation, meniscal resection

613

3999

0.99

0.04

1.1

1.11

1.04

u/ml

0.08

229

1582

Meningitis

311

0.96

0.03

1.1

1.89

1.64

u/ml

0.08

136

Squamous cell neoplasms and carcinomas of the skin

121

1.07

0.03

1.1

1.0

2.13

0.95

u/ml

—

Hydrocele

462

0.97

0.03

1.1

0.58

1.39

u/ml

1.10

209

Maternal care for known or suspected malpresentation of fetus

273

1962

1.01

0.03

1.1

1.63

0.97

u/ml

0.36

105

814

Hidradenitis suppurativa

329

1.03

0.03

1.0

1.1

3.11

1.89

u/ml

0.27

128

LSIL lesion of the cervix uteri, vagina or vulva

146

1443

1.01

0.03

1.1

0.43

1.00

u/ml

1.46

569

Embedded teeth, including avohilmo

122

1236

0.99

0.03

1.0

1.1

0.78

1.41

u/ml

1.34

575

Ankylosing spondylitis, ICD10

627

1.02

0.03

1.0

1.1

0.61

1.23

u/ml

1.02

261

Idiopathic gout

230

0.96

0.03

1.2

1.0

0.84

1.54

u/ml

0.50

Adjustment and management of implanted device

542

0.98

0.03

1.1

1.05

1.11

u/ml

0.03

237

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

562

0.98

0.03

1.2

1.1

0.81

1.37

u/ml

0.40

311

Statin medication

715

4036

1.00

0.03

1.1

1.07

1.03

u/ml

0.04

306

1700

Pneumonia, organism unspecified

861

6011

1.00

0.03

1.1

1.12

u/ml

0.00

421

2605

Spasmodic torticollis

179

0.95

0.03

1.0

1.1

0.84

1.26

u/ml

0.23

Conduct disorder

310

0.97

0.03

1.0

1.1

4.51

0.93

u/ml

0.40

164

Open wound of forearm

688

1.02

0.03

1.1

0.36

1.24

u/ml

2.30

289

Cardiodefibrillation

108

1091

0.99

0.03

1.0

1.1

0.41

1.12

u/ml

1.88

449

Infections of genitourinary tract in pregnancy

858

1.01

0.02

1.1

2.09

1.24

u/ml

0.48

375

Viral haemorrhagic fevers, not elsewhere classified/unspecified

430

0.98

0.02

1.1

0.57

1.50

u/ml

1.00

180

Inflammatory bowel disease

280

2817

0.99

0.02

1.1

1.55

1.26

u/ml

0.15

114

1250

Pyothorax

132

1.06

0.02

1.0

1.1

4.48

2.09

u/ml

—

Psoriasis vulgaris

121

1223

0.99

0.02

1.1

0.68

1.18

u/ml

0.54

512

Ventricular septal defect, a heart condition

409

1.02

0.02

1.0

1.2

1.92

1.33

u/ml

0.30

272

Diseases of pulp and periapical tissues, including avohilmo

1131

5871

1.00

0.02

1.1

0.99

1.17

u/ml

0.39

511

2570

Melanocytic naevi, other sites/unspecified

550

1.02

0.02

1.1

0.57

1.26

u/ml

0.82

231

Cirrhosis of liver, NAS

172

1.05

0.02

1.1

1.36

1.72

u/ml

—

Degeneration of macula and posterior pole

132

1060

0.99

0.02

1.0

1.1

0.68

1.03

u/ml

0.58

409

Other assisted single delivery

198

0.96

0.02

1.0

1.1

0.49

0.47

u/ml

0.03

Foreign body in respiratory tract

391

1.02

0.02

1.1

0.59

1.54

u/ml

1.13

194

Juvenile rheumatoid arthirtis

212

1.04

0.02

1.1

0.13

1.63

u/ml

—

100

Other infectious diseases

471

1.02

0.02

1.0

1.1

1.85

1.57

u/ml

0.11

210

Psoriatic and enteropathic arthropathies

800

0.99

0.02

1.1

1.15

1.19

u/ml

0.02

312

Congenital malformations of the circulatory system

159

1553

0.99

0.02

1.0

1.1

1.12

1.09

u/ml

0.03

848

Pedal cyclist injured in transport accident

198

1968

1.01

0.02

1.1

0.95

1.39

u/ml

0.94

890

Other specified/unspecified arthritis

199

1978

1.01

0.02

1.1

0.75

1.25

u/ml

0.88

830

Other congenital malformations of limb(s)

117

0.94

0.02

1.1

0.07

1.37

u/ml

—

Infections specific to the perinatal period

322

1.03

0.01

1.2

0.45

1.06

u/ml

1.28

230

Malignant neoplasm of mesothelium and soft tissue

123

1.06

0.01

1.1

1.0

0.26

0.70

u/ml

—

Primary gonarthrosis, bilateral

208

1791

0.99

0.01

1.0

1.1

0.94

0.87

u/ml

0.04

643

Other inflammatory liver diseases

342

1.02

0.01

1.1

0.29

1.61

u/ml

—

142

Other secondary coxarthrosis

133

1.05

0.01

1.0

1.1

0.18

1.98

u/ml

—

Hypo-osmolality and hyponatraemia

588

1.01

0.01

1.1

0.69

0.92

u/ml

0.28

271

Paralytic ileus and intestinal obstruction

110

1109

0.99

0.01

1.1

2.42

1.06

u/ml

0.33

470

GI-bleeding

147

1480

0.99

0.01

1.1

1.24

1.11

u/ml

0.09

664

308

0.98

0.01

1.0

0.45

1.10

u/ml

—

123

Extreme obesity with alveolar hypoventilation

167

0.96

0.01

1.1

0.51

2.08

u/ml

—

Primary ovarian failure

177

0.96

0.01

1.0

1.1

0.33

0.64

u/ml

—

Ulcerative proctitis

498

0.98

0.01

1.1

0.80

1.46

u/ml

0.51

203

Other osteochondropathies

508

0.98

0.01

1.1

1.19

1.28

u/ml

0.05

222

Mental and behavioural disorders due to tobacco

528

0.98

0.01

1.0

1.1

2.29

1.31

u/ml

0.19

218

Suppurative and necrotic conditions of lower respiratory tract

197

0.96

0.01

1.0

1.1

4.48

2.64

u/ml

—

Other surgical follow-up care

243

1.03

0.01

1.0

1.1

0.93

1.61

u/ml

0.36

109

Total colectomy operation

253

1.03

0.01

1.1

0.21

1.44

u/ml

1.46

105

Total colectomy

253

1.03

0.01

1.1

0.21

1.44

u/ml

1.46

105

Calcific tendinitis of shoulder

297

0.98

0.01

1.0

0.25

1.44

u/ml

—

107

Behavioural disorders

307

0.98

0.01

1.0

1.1

4.51

1.37

u/ml

0.34

163

Cardiomyopathy, other and unspecified

303

1.02

0.01

1.0

1.1

2.00

1.89

u/ml

0.03

137

Other disorders of optic [2nd] nerve and visual pathways

463

1.02

0.01

1.1

2.61

1.32

u/ml

0.28

239

Recurrent dislocation and subluxation of joint

647

0.99

0.01

1.0

1.1

0.43

1.47

u/ml

1.97

271

Traumatic subdural haemorrhage

323

0.98

0.01

1.1

1.0

0.71

1.90

u/ml

0.83

131

Dependent personality disorder

106

0.94

0.01

1.1

1.0

1.97

0.89

u/ml

—

Other and unspecified glaucoma

156

0.96

0.00

1.0

2.49

1.66

u/ml

—

Gender identity disorders

186

0.97

0.00

1.0

1.1

1.60

1.58

u/ml

0.00

Pregnancy hypertension

447

3996

1.00

0.00

1.1

1.08

1.03

u/ml

0.04

165

1573

Other secondary gonarthrosis

204

1.03

0.00

1.0

1.1

0.21

1.03

u/ml

2.40

Focal brain injury

296

0.98

0.00

1.1

1.0

1.11

1.82

u/ml

0.42

122

Pedal cyclist injured in collision with motor vehicle

234

1.03

0.00

1.1

1.05

1.76

u/ml

—

101

Sensorineural hearing loss

438

2967

1.00

0.00

1.1

0.67

1.13

u/ml

1.69

172

1186

Strabismus

255

2550

1.00

0.00

1.1

1.10

1.27

u/ml

0.15

117

1231

Other obstructed labour

626

0.99

0.00

1.1

0.34

0.97

u/ml

1.43

248

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mugwort IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS